Other Sites:
Robert J. Robbins is a biologist, an educator, a science administrator, a publisher, an information technologist, and an IT leader and manager who specializes in advancing biomedical knowledge and supporting education through the application of information technology. More About: RJR | OUR TEAM | OUR SERVICES | THIS WEBSITE
RJR: Recommended Bibliography 22 Nov 2026 at 01:52 Created:
Microbiome
It has long been known that every multicellular organism coexists with large prokaryotic ecosystems — microbiomes — that completely cover its surfaces, external and internal. Recent studies have shown that these associated microbiomes are not mere contamination, but instead have profound effects upon the function and fitness of the multicellular organism. We now know that all MCEs are actually functional composites, holobionts, composed of more prokaryotic cells than eukaryotic cells and expressing more prokaryotic genes than eukaryotic genes. A full understanding of the biology of "individual" eukaryotes will now depend on an understanding of their associated microbiomes.
Created with PubMed® Query: microbiome[tiab] NOT pmcbook NOT ispreviousversion
Citations The Papers (from PubMed®)
RevDate: 2026-11-20
CmpDate: 2026-11-20
Fish gut microbiota mediate pollutant-induced lipid toxicity via bidirectional biotransformation and dysbiosis.
PNAS nexus, 5(11):pgag388.
The gut microbiota acts simultaneously as a target of environmental pollutants and as a driver of their biotransformation, but how these two roles jointly determine host toxicity remains insufficiently defined. Using zebrafish as a One Health model, we show that dietary exposure to environmentally relevant levels of triphenyl phosphate (TPHP), an organophosphate flame retardant, causes intestinal lipid accumulation, barrier disruption, and peroxisome proliferator-activated receptor (PPAR) pathway dysregulation. By combining antibiotic-treated zebrafish models, stable isotope-assisted metabolomics, and multiomics profiling, we found that the gut microbiota transforms TPHP through a bidirectional network. It reactivates host-derived glucuronidated metabolites via deconjugation and ferments TPHP carbon skeletons into small-molecule metabolites, including L-phenylalanine and N-acetyltyramine, that are integrated into host lipid and energy metabolism. The functional disruption of the microbiota abolishes these metabolite signals, supporting a key role of the gut microbiota in TPHP biotransformation. Metagenomics identifies specific bacterial taxa (such as Acinetobacter, Pseudomonas, and Aeromonas) and hydrolytic enzyme families responsible for these transformations. Our findings suggest that the gut microbiota functions beyond a passive target of pollutant exposure: it expands the metabolic fate of TPHP and generates pollutant-derived metabolic signals that intersect with host lipid homeostasis, collectively mediating the observed lipotoxicity through host-microbe interactions. This work provides a mechanistic framework for incorporating gut microbiome dynamics into chemical risk assessment under the One Health paradigm.
Additional Links: PMID-43061617
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43061617,
year = {2026},
author = {Zhang, S and Hou, R and Chen, B and Wang, Y and Li, H and Xu, X},
title = {Fish gut microbiota mediate pollutant-induced lipid toxicity via bidirectional biotransformation and dysbiosis.},
journal = {PNAS nexus},
volume = {5},
number = {11},
pages = {pgag388},
pmid = {43061617},
issn = {2752-6542},
abstract = {The gut microbiota acts simultaneously as a target of environmental pollutants and as a driver of their biotransformation, but how these two roles jointly determine host toxicity remains insufficiently defined. Using zebrafish as a One Health model, we show that dietary exposure to environmentally relevant levels of triphenyl phosphate (TPHP), an organophosphate flame retardant, causes intestinal lipid accumulation, barrier disruption, and peroxisome proliferator-activated receptor (PPAR) pathway dysregulation. By combining antibiotic-treated zebrafish models, stable isotope-assisted metabolomics, and multiomics profiling, we found that the gut microbiota transforms TPHP through a bidirectional network. It reactivates host-derived glucuronidated metabolites via deconjugation and ferments TPHP carbon skeletons into small-molecule metabolites, including L-phenylalanine and N-acetyltyramine, that are integrated into host lipid and energy metabolism. The functional disruption of the microbiota abolishes these metabolite signals, supporting a key role of the gut microbiota in TPHP biotransformation. Metagenomics identifies specific bacterial taxa (such as Acinetobacter, Pseudomonas, and Aeromonas) and hydrolytic enzyme families responsible for these transformations. Our findings suggest that the gut microbiota functions beyond a passive target of pollutant exposure: it expands the metabolic fate of TPHP and generates pollutant-derived metabolic signals that intersect with host lipid homeostasis, collectively mediating the observed lipotoxicity through host-microbe interactions. This work provides a mechanistic framework for incorporating gut microbiome dynamics into chemical risk assessment under the One Health paradigm.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Tn7 Integration Efficiently Introduces Gene Expression Cassettes into a Gut-Native Escherichia coli Strain.
ACS synthetic biology, 15(11):4889-4894.
Native bacteria are strains isolated from the host and often require greater development and optimization of genetic manipulation tools than lab-adapted strains. We have previously shown that the native murine Escherichia coli strain EcAZ-1, which colonizes the conventional mouse gut long term, is genetically tractable, and the engineered strain can elicit physiological effects while residing in the mouse gut. Given the interest in using EcAZ-1 and other native E. coli as a chassis for heterologous gene expression in the mouse gut, researchers need more efficient tools to rapidly and reliably introduce heterologous gene expression into the strain. Here, we demonstrate that a gene expression cassette can be integrated into the EcAZ-1 genome with high efficiency using the site-specific Tn7 transposon. Furthermore, we demonstrate that EcAZ-1 modified to express sfGFP using this method stably engrafts in the gut of conventional mouse. Taken together, Tn7-mediated integration is an effective method for stably introducing genetic cassettes into the native murine strain EcAZ-1 for expression in the mouse gut.
Additional Links: PMID-43061965
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43061965,
year = {2026},
author = {Zong, DM and Bailey, S and Fatima, Z and Kanne, CK and Siguenza, N and Richter, RA and Campbell, IW and Waldor, MK and Ding, Y and Hasty, J and Zarrinpar, A},
title = {Tn7 Integration Efficiently Introduces Gene Expression Cassettes into a Gut-Native Escherichia coli Strain.},
journal = {ACS synthetic biology},
volume = {15},
number = {11},
pages = {4889-4894},
doi = {10.1021/acssynbio.6c00472},
pmid = {43061965},
issn = {2161-5063},
support = {R01 EB030134/EB/NIBIB NIH HHS/United States ; P30 DK034854/DK/NIDDK NIH HHS/United States ; R01 AI042347//National Institute of Allergy and Infectious Diseases/ ; R01 AI163483//National Institute of Allergy and Infectious Diseases/ ; R21 AI194932//National Institute of Allergy and Infectious Diseases/ ; R01 CA310170/CA/NCI NIH HHS/United States ; U01 CA265719/CA/NCI NIH HHS/United States ; /HHMI/Howard Hughes Medical Institute/United States ; 1000340660//National Science Foundation Graduate Research Fellowship Program/ ; //Harvard Digestive Diseases Center, Harvard University/ ; EDUC4-12804//California Institute for Regenerative Medicine/ ; I01 RD001332//U.S. Department of Veterans Affairs/ ; },
mesh = {*Escherichia coli/genetics/metabolism ; Animals ; Mice ; *DNA Transposable Elements/genetics ; Gene Expression ; Genetic Engineering/methods ; Green Fluorescent Proteins/genetics/metabolism ; },
abstract = {Native bacteria are strains isolated from the host and often require greater development and optimization of genetic manipulation tools than lab-adapted strains. We have previously shown that the native murine Escherichia coli strain EcAZ-1, which colonizes the conventional mouse gut long term, is genetically tractable, and the engineered strain can elicit physiological effects while residing in the mouse gut. Given the interest in using EcAZ-1 and other native E. coli as a chassis for heterologous gene expression in the mouse gut, researchers need more efficient tools to rapidly and reliably introduce heterologous gene expression into the strain. Here, we demonstrate that a gene expression cassette can be integrated into the EcAZ-1 genome with high efficiency using the site-specific Tn7 transposon. Furthermore, we demonstrate that EcAZ-1 modified to express sfGFP using this method stably engrafts in the gut of conventional mouse. Taken together, Tn7-mediated integration is an effective method for stably introducing genetic cassettes into the native murine strain EcAZ-1 for expression in the mouse gut.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Escherichia coli/genetics/metabolism
Animals
Mice
*DNA Transposable Elements/genetics
Gene Expression
Genetic Engineering/methods
Green Fluorescent Proteins/genetics/metabolism
RevDate: 2026-11-20
Integrative multi-database analysis of a microbiome-based survival model in gastric cancer.
Microbiology spectrum [Epub ahead of print].
This study evaluated a gastric cancer survival model based on tumor-associated microbial DNA profiles and examined their relationships with bulk host marker-expression scores. Microbiome, host-transcriptome, and clinical data from 118 matched TCMA/TCGA-STAD specimens (109 primary tumors and nine adjacent tissues) were integrated. After random 7:3 split and exclusion of incomplete samples, 68 training cases and 32 validation cases remained. A multi-step screening identified survival-associated microbial features, followed by PCA to construct a microbial risk score (MRS). An integrated model combining MRS, age, and sex was built, with reviewer-requested tumor-only sensitivity analyses for pathologic stage and Helicobacter. Neisseria and Veillonella showed hazard ratio estimates below 1 across multiple transformations, with Actinomyces showing the same direction at a trend-level significance threshold. Within the original age-sex model, MRS was associated with overall survival (HR = 1.73, P = 0.002). The integrated model (C-index 0.707) outperformed the age-sex comparator (0.590) and the microbiological-only model (0.672) in the training set. In the training set, high-risk patients had shorter median survival (457 vs 2,100 days, P = 0.001; 1-/2-/3-year AUCs: 0.683, 0.760, 0.768). In the held-out internal validation subset, the model yielded a C-index of 0.636 (P = 0.0494). In 109 primary-tumor specimens, genus-level Helicobacter DNA signal correlated with bulk B-cell and mast-cell marker-expression scores after multiple-testing correction (rho = 0.247, q = 0.049; rho = 0.282, q = 0.030); the dendritic-cell association was not retained (q = 0.271), and Helicobacter did not improve a tumor-only three-genus survival model (likelihood-ratio P = 0.803). The age-sex-microbiome model showed exploratory survival discrimination; a post hoc tumor-only analysis did not demonstrate incremental value of the three genera beyond age, sex, and pathologic stage (likelihood-ratio P = 0.571). The Helicobacter associations with bulk B-cell and mast-cell marker-expression scores require orthogonal validation.IMPORTANCEThis study examines microbiome-informed survival stratification in gastric cancer. Using tumor-associated microbial DNA profiles from 118 matched specimens, the researchers built a survival model combining three genus-level features (Actinomyces, Neisseria, and Veillonella) with age and sex. In the training set, this model outperformed the age-sex comparator and distinguished high-risk patients (median survival 457 days) from low-risk patients (2,100 days). In the held-out internal validation subset, the model yielded a C-index of 0.636. Additionally, genus-level Helicobacter DNA signal correlated with bulk B-cell and mast-cell marker-expression scores in the tumor-only analysis. These results define an exploratory microbiome-based framework for further prognostic and biological validation in gastric cancer.
Additional Links: PMID-43062050
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43062050,
year = {2026},
author = {Zhou, X and Yan, B and Liu, M and Kuang, S and Ding, H and Luo, X},
title = {Integrative multi-database analysis of a microbiome-based survival model in gastric cancer.},
journal = {Microbiology spectrum},
volume = {},
number = {},
pages = {e0153326},
doi = {10.1128/spectrum.01533-26},
pmid = {43062050},
issn = {2165-0497},
abstract = {This study evaluated a gastric cancer survival model based on tumor-associated microbial DNA profiles and examined their relationships with bulk host marker-expression scores. Microbiome, host-transcriptome, and clinical data from 118 matched TCMA/TCGA-STAD specimens (109 primary tumors and nine adjacent tissues) were integrated. After random 7:3 split and exclusion of incomplete samples, 68 training cases and 32 validation cases remained. A multi-step screening identified survival-associated microbial features, followed by PCA to construct a microbial risk score (MRS). An integrated model combining MRS, age, and sex was built, with reviewer-requested tumor-only sensitivity analyses for pathologic stage and Helicobacter. Neisseria and Veillonella showed hazard ratio estimates below 1 across multiple transformations, with Actinomyces showing the same direction at a trend-level significance threshold. Within the original age-sex model, MRS was associated with overall survival (HR = 1.73, P = 0.002). The integrated model (C-index 0.707) outperformed the age-sex comparator (0.590) and the microbiological-only model (0.672) in the training set. In the training set, high-risk patients had shorter median survival (457 vs 2,100 days, P = 0.001; 1-/2-/3-year AUCs: 0.683, 0.760, 0.768). In the held-out internal validation subset, the model yielded a C-index of 0.636 (P = 0.0494). In 109 primary-tumor specimens, genus-level Helicobacter DNA signal correlated with bulk B-cell and mast-cell marker-expression scores after multiple-testing correction (rho = 0.247, q = 0.049; rho = 0.282, q = 0.030); the dendritic-cell association was not retained (q = 0.271), and Helicobacter did not improve a tumor-only three-genus survival model (likelihood-ratio P = 0.803). The age-sex-microbiome model showed exploratory survival discrimination; a post hoc tumor-only analysis did not demonstrate incremental value of the three genera beyond age, sex, and pathologic stage (likelihood-ratio P = 0.571). The Helicobacter associations with bulk B-cell and mast-cell marker-expression scores require orthogonal validation.IMPORTANCEThis study examines microbiome-informed survival stratification in gastric cancer. Using tumor-associated microbial DNA profiles from 118 matched specimens, the researchers built a survival model combining three genus-level features (Actinomyces, Neisseria, and Veillonella) with age and sex. In the training set, this model outperformed the age-sex comparator and distinguished high-risk patients (median survival 457 days) from low-risk patients (2,100 days). In the held-out internal validation subset, the model yielded a C-index of 0.636. Additionally, genus-level Helicobacter DNA signal correlated with bulk B-cell and mast-cell marker-expression scores in the tumor-only analysis. These results define an exploratory microbiome-based framework for further prognostic and biological validation in gastric cancer.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Global Trends in Pseudomonas aeruginosa and Gut Microbiota Research from 2011 to 2025: A Bibliometric Analysis via CiteSpace and VOSviewer.
Journal of visualized experiments : JoVE.
Pseudomonas aeruginosa is a major opportunistic, often multidrug-resistant pathogen, and the gastrointestinal tract is increasingly recognized as a reservoir from which intestinal translocation and gut-lung interactions may influence infection risk; although publication output on P. aeruginosa and the gut microbiota has grown rapidly, no comprehensive bibliometric analysis has mapped this specific research combination through 2025. This study therefore characterized temporal publication growth, leading countries, institutions, authors and journals, the conceptual keyword structure, and rapidly emerging terms. On April 26, 2026, a topic search of the Web of Science Core Collection (WoSCC; Science Citation Index Expanded and Social Sciences Citation Index) for records published from 2011 to 2025, followed by deduplication and two-stage screening, retained 483 English articles and reviews from 687 initially identified records. CiteSpace 6.3.R1 (1-year time slices, g-index k = 25, pathfinder and pruning-sliced-networks, and Kleinberg burst detection) and VOSviewer 1.6.20 (full counting, association-strength normalization, resolution 1.0) were used to build the networks, and the compound annual growth rate (CAGR) was calculated. Annual output rose from 4 in 2011 to 68 in 2025 (CAGR 22.4%). The United States led with 112 publications (23.2%), followed by China (87; 18.0%) and the United Kingdom (45; 9.3%), and showed the highest betweenness centrality; Frontiers in Microbiology was the most productive journal (24; 5.0%). The leading keywords were biofilm formation, virulence factor, dysbiosis, gut-lung axis, and colonization, and the strongest burst terms were the gut-lung axis, dysbiosis, probiotic modulation, phage therapy, and multi-omics. Publication output on P. aeruginosa and the gut microbiota thus increased markedly, with a growing share of microbiome-oriented and intervention-related themes; these patterns describe publication trends rather than proving clinical efficacy, and the safety, specificity and durability of microbiota- and phage-based approaches remain to be established.
Additional Links: PMID-43062052
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43062052,
year = {2026},
author = {Wang, W and Liu, Q and Gu, Y and Zhang, P and Zhang, F},
title = {Global Trends in Pseudomonas aeruginosa and Gut Microbiota Research from 2011 to 2025: A Bibliometric Analysis via CiteSpace and VOSviewer.},
journal = {Journal of visualized experiments : JoVE},
volume = {},
number = {237},
pages = {},
doi = {10.3791/72362},
pmid = {43062052},
issn = {1940-087X},
mesh = {*Pseudomonas aeruginosa ; *Bibliometrics ; *Gastrointestinal Microbiome/physiology ; Humans ; },
abstract = {Pseudomonas aeruginosa is a major opportunistic, often multidrug-resistant pathogen, and the gastrointestinal tract is increasingly recognized as a reservoir from which intestinal translocation and gut-lung interactions may influence infection risk; although publication output on P. aeruginosa and the gut microbiota has grown rapidly, no comprehensive bibliometric analysis has mapped this specific research combination through 2025. This study therefore characterized temporal publication growth, leading countries, institutions, authors and journals, the conceptual keyword structure, and rapidly emerging terms. On April 26, 2026, a topic search of the Web of Science Core Collection (WoSCC; Science Citation Index Expanded and Social Sciences Citation Index) for records published from 2011 to 2025, followed by deduplication and two-stage screening, retained 483 English articles and reviews from 687 initially identified records. CiteSpace 6.3.R1 (1-year time slices, g-index k = 25, pathfinder and pruning-sliced-networks, and Kleinberg burst detection) and VOSviewer 1.6.20 (full counting, association-strength normalization, resolution 1.0) were used to build the networks, and the compound annual growth rate (CAGR) was calculated. Annual output rose from 4 in 2011 to 68 in 2025 (CAGR 22.4%). The United States led with 112 publications (23.2%), followed by China (87; 18.0%) and the United Kingdom (45; 9.3%), and showed the highest betweenness centrality; Frontiers in Microbiology was the most productive journal (24; 5.0%). The leading keywords were biofilm formation, virulence factor, dysbiosis, gut-lung axis, and colonization, and the strongest burst terms were the gut-lung axis, dysbiosis, probiotic modulation, phage therapy, and multi-omics. Publication output on P. aeruginosa and the gut microbiota thus increased markedly, with a growing share of microbiome-oriented and intervention-related themes; these patterns describe publication trends rather than proving clinical efficacy, and the safety, specificity and durability of microbiota- and phage-based approaches remain to be established.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Pseudomonas aeruginosa
*Bibliometrics
*Gastrointestinal Microbiome/physiology
Humans
RevDate: 2026-11-20
CmpDate: 2026-11-20
Traditional Chinese Medicine in Hepatocellular Carcinoma: Appraising Microbial Bile Acid and Tryptophan Pathways.
Journal of visualized experiments : JoVE.
Hepatocellular carcinoma (HCC) generally arises in a chronically injured liver in which metabolic dysregulation, vascular remodeling, and immune tolerance coexist. The intestinal microbiome can influence this setting through barrier-dependent translocation of microbial products and portal delivery of metabolites, including bile acids and tryptophan derivatives. Traditional Chinese medicine (TCM) formulas, extracts, fractions, and natural products may modify microbial ecology, microbial biotransformation, and host signaling. However, parallel changes in microbial taxa, metabolite profiles, and tumor burden do not establish a microbiome-mediated pharmacological mechanism. This critical narrative review separates established metabolite-sensitive immune mechanisms from the intervention-specific evidence linking TCM to microbial metabolism and HCC outcomes. The most compelling bile acid mechanisms are the microbiota-dependent primary bile acid-CXCL16-CXCR6-positive natural killer T-cell circuit and the direct impairment of tumor-specific CD8-positive T cells by selected conjugated and secondary bile acids. Within the tryptophan network, host indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO2) promote kynurenine-aryl hydrocarbon receptor (AhR) signaling, whereas Phocaeicola vulgatus-associated depletion of indole-3-acetic acid compromises CD8-positive T-cell function and response to anti-programmed cell death protein 1 (PD-1) therapy. Limosilactobacillus reuteri-derived indole-3-lactic acid limits transarterial chemoembolization-related liver injury by restraining the heat shock protein 90 (HSP90)-dependent NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammatory pathway, but this mechanism pertains to treatment toxicity rather than antitumor surveillance. Xiayuxue decoction and Huaier polysaccharides provide the most informative HCC-specific TCM-associated pathways, whereas celastrol and Jiawei Xiaoyao San support more limited or incompletely connected mechanistic evidence. No TCM investigation has yet established a complete microbial tryptophan-to-immune-to-HCC mechanism, and direct biochemical crosstalk between bile acid and tryptophan metabolism remains unproven. The evidence supports specific experimentally testable pathways and functional convergence, but not a general conclusion that TCM restores microbial balance or antitumor immunity in HCC.
Additional Links: PMID-43062055
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43062055,
year = {2026},
author = {Zhang, M and Li, X and Guo, Y and Yuan, Y},
title = {Traditional Chinese Medicine in Hepatocellular Carcinoma: Appraising Microbial Bile Acid and Tryptophan Pathways.},
journal = {Journal of visualized experiments : JoVE},
volume = {},
number = {237},
pages = {},
doi = {10.3791/74850},
pmid = {43062055},
issn = {1940-087X},
mesh = {*Tryptophan/metabolism ; *Carcinoma, Hepatocellular/metabolism/drug therapy/microbiology/immunology ; Humans ; *Liver Neoplasms/metabolism/drug therapy/microbiology/immunology ; *Bile Acids and Salts/metabolism ; *Medicine, Chinese Traditional/methods ; Animals ; },
abstract = {Hepatocellular carcinoma (HCC) generally arises in a chronically injured liver in which metabolic dysregulation, vascular remodeling, and immune tolerance coexist. The intestinal microbiome can influence this setting through barrier-dependent translocation of microbial products and portal delivery of metabolites, including bile acids and tryptophan derivatives. Traditional Chinese medicine (TCM) formulas, extracts, fractions, and natural products may modify microbial ecology, microbial biotransformation, and host signaling. However, parallel changes in microbial taxa, metabolite profiles, and tumor burden do not establish a microbiome-mediated pharmacological mechanism. This critical narrative review separates established metabolite-sensitive immune mechanisms from the intervention-specific evidence linking TCM to microbial metabolism and HCC outcomes. The most compelling bile acid mechanisms are the microbiota-dependent primary bile acid-CXCL16-CXCR6-positive natural killer T-cell circuit and the direct impairment of tumor-specific CD8-positive T cells by selected conjugated and secondary bile acids. Within the tryptophan network, host indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO2) promote kynurenine-aryl hydrocarbon receptor (AhR) signaling, whereas Phocaeicola vulgatus-associated depletion of indole-3-acetic acid compromises CD8-positive T-cell function and response to anti-programmed cell death protein 1 (PD-1) therapy. Limosilactobacillus reuteri-derived indole-3-lactic acid limits transarterial chemoembolization-related liver injury by restraining the heat shock protein 90 (HSP90)-dependent NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammatory pathway, but this mechanism pertains to treatment toxicity rather than antitumor surveillance. Xiayuxue decoction and Huaier polysaccharides provide the most informative HCC-specific TCM-associated pathways, whereas celastrol and Jiawei Xiaoyao San support more limited or incompletely connected mechanistic evidence. No TCM investigation has yet established a complete microbial tryptophan-to-immune-to-HCC mechanism, and direct biochemical crosstalk between bile acid and tryptophan metabolism remains unproven. The evidence supports specific experimentally testable pathways and functional convergence, but not a general conclusion that TCM restores microbial balance or antitumor immunity in HCC.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Tryptophan/metabolism
*Carcinoma, Hepatocellular/metabolism/drug therapy/microbiology/immunology
Humans
*Liver Neoplasms/metabolism/drug therapy/microbiology/immunology
*Bile Acids and Salts/metabolism
*Medicine, Chinese Traditional/methods
Animals
RevDate: 2026-11-20
CmpDate: 2026-11-20
QYZ Compound Associates with Modulation of Gut Microbiota, FoxO and NF-κB Signaling in Homeostasis-Disrupted Mammary Gland Hyperplasia.
Journal of visualized experiments : JoVE.
Mammary gland hyperplasia (MGH) is a hormone-driven disorder involving structural remodeling, stromal fibrosis, and endocrine dysregulation. While conventional modulators often cause multi-organ toxicity, Qiyuzhi (QYZ) tonic paste, a Traditional Chinese Medicine (TCM) formulation, offers a multi-targeted alternative. This study investigates the mechanistic efficacy of QYZ in an estradiol/progesterone-induced MGH rat model using a comprehensive multi-omics approach, including LC-MS/MS, network pharmacology, serum metabolomics, and 16S rRNA sequencing. Phytochemical profiling identified naringenin and m-coumaric acid as pivotal active constituents. Results showed that QYZ restored hormonal equilibrium and significantly reduced mammary epithelial hyperproliferation and collagen deposition by downregulating Fibronectin and COL1A1. Mechanistically, QYZ mitigated oxidative stress and suppressed the NF-κB inflammatory cascade. It further arrested aberrant cell cycle progression by modulating the PI3K-Akt and FoxO signaling network, specifically downregulating Cyclin D1/CDK4 and upregulating P16/P21. Additionally, QYZ reshapes the gut microbiome and enriches keystone species such as Lactobacillus and Bifidobacterium, ameliorating systemic dysbiosis. Collectively, these findings indicate that QYZ restores mammary tissue cell cycle disturbance, inflammatory response, oxidative stress and gut microbiome dysbiosis induced by mammary gland hyperplasia.
Additional Links: PMID-43062058
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43062058,
year = {2026},
author = {Cai, F and Ji, M and Wang, J and Wang, Q and Cheng, J and Wang, J and Zhang, C and Wu, Y and Li, H and Zhang, Y and Yang, X and You, H and Qu, W and Du, M},
title = {QYZ Compound Associates with Modulation of Gut Microbiota, FoxO and NF-κB Signaling in Homeostasis-Disrupted Mammary Gland Hyperplasia.},
journal = {Journal of visualized experiments : JoVE},
volume = {},
number = {237},
pages = {},
doi = {10.3791/73627},
pmid = {43062058},
issn = {1940-087X},
mesh = {Animals ; Female ; *Mammary Glands, Animal/pathology/drug effects/metabolism ; Rats ; Hyperplasia/drug therapy/metabolism ; Signal Transduction/drug effects ; *NF-kappa B/metabolism ; *Gastrointestinal Microbiome/drug effects ; *Drugs, Chinese Herbal/pharmacology ; Rats, Sprague-Dawley ; Homeostasis/drug effects ; Forkhead Transcription Factors/metabolism ; },
abstract = {Mammary gland hyperplasia (MGH) is a hormone-driven disorder involving structural remodeling, stromal fibrosis, and endocrine dysregulation. While conventional modulators often cause multi-organ toxicity, Qiyuzhi (QYZ) tonic paste, a Traditional Chinese Medicine (TCM) formulation, offers a multi-targeted alternative. This study investigates the mechanistic efficacy of QYZ in an estradiol/progesterone-induced MGH rat model using a comprehensive multi-omics approach, including LC-MS/MS, network pharmacology, serum metabolomics, and 16S rRNA sequencing. Phytochemical profiling identified naringenin and m-coumaric acid as pivotal active constituents. Results showed that QYZ restored hormonal equilibrium and significantly reduced mammary epithelial hyperproliferation and collagen deposition by downregulating Fibronectin and COL1A1. Mechanistically, QYZ mitigated oxidative stress and suppressed the NF-κB inflammatory cascade. It further arrested aberrant cell cycle progression by modulating the PI3K-Akt and FoxO signaling network, specifically downregulating Cyclin D1/CDK4 and upregulating P16/P21. Additionally, QYZ reshapes the gut microbiome and enriches keystone species such as Lactobacillus and Bifidobacterium, ameliorating systemic dysbiosis. Collectively, these findings indicate that QYZ restores mammary tissue cell cycle disturbance, inflammatory response, oxidative stress and gut microbiome dysbiosis induced by mammary gland hyperplasia.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
Female
*Mammary Glands, Animal/pathology/drug effects/metabolism
Rats
Hyperplasia/drug therapy/metabolism
Signal Transduction/drug effects
*NF-kappa B/metabolism
*Gastrointestinal Microbiome/drug effects
*Drugs, Chinese Herbal/pharmacology
Rats, Sprague-Dawley
Homeostasis/drug effects
Forkhead Transcription Factors/metabolism
RevDate: 2026-11-20
Multi-omics characterization of different dietary fiber levels on microbiota and metabolism in Erhualian and large white pigs.
mSystems [Epub ahead of print].
UNLABELLED: Erhualian pigs (EHL) exhibit tolerance to high-fiber diets, yet the underlying mechanisms involving gut microbiota and metabolism remain unclear. Here, we integrated colonic short-chain fatty acid (SCFA) profiling, 16S rRNA sequencing, and liver metabolomics to evaluate the effects of graded wheat bran fiber levels (total dietary fiber [TDF]: 14.07%, 16.32%, 17.99%, and 18.85%) on fiber digestibility, gut microbiota, and metabolism in EHL, compared with two large white pigs (LW) groups: large LW (LLW, same initial physiological stage as EHL) and small LW (SLW, same initial body weight as EHL). Apparent total tract digestibility (ATTD) of TDF in EHL was unaffected by increasing TDF intake (P > 0.05), whereas ATTD of TDF and insoluble dietary fiber in LLW decreased significantly (P < 0.01). High-fiber diet elevated acetate and butyrate, and total SCFAs in LLW (P < 0.05), but only trended toward higher isobutyrate and isovalerate in EHL (0.05 < P < 0.1). Regardless of diet, EHL exhibited higher colonic microbiota diversity (Simpson, P < 0.05) than LW, whereas richness (Chao and ACE) was unaffected by diet or breed (P > 0.05). Breed was the primary factor shaping swine gut microbiota (P < 0.05), with diet showing a trend toward significance, shaping colonic microbiota (P = 0.0586). Multi-omics integration identified 29 key genera and 10 metabolites associated with high-fiber digestibility in EHL. These key bacteria and metabolites were co-enriched in carbohydrate metabolism pathways, including butanoate metabolism and starch and sucrose metabolism, and collectively contribute to the high-fiber digestibility phenotype.
IMPORTANCE: Indigenous Chinese pig breeds, such as the Erhualian pig (EHL), exhibit a superior capacity for high-fiber tolerance compared with commercial lean-type breeds, which currently account for approximately 90% of China's pig inventory. Reliance on lean-type breeds has increased concentrate feed demand, intensifying human-livestock food competition. While low-cost unconventional feedstuffs (such as rice bran and wheat bran) are available, their high insoluble fiber content limits utilization in modern breeds. Elucidating the mechanisms underlying the high-fiber tolerance of EHL is of critical importance, specifically the gut microbiota, metabolites that enable efficient utilization of higher fiber levels. In this study, we integrated colonic short-chain fatty acid (SCFA), microbiome profiling, liver metabolomics, and functional correlation analyses to demonstrate that the high-fiber digestibility of EHL is associated with breed-specific microbial compositional features and a distinct hepatic metabolic profile, characterized by enrichment of carbohydrate and butanoate metabolism. The integration of microbiota functional prediction and metabolomic data reveals potential microbial-host co-metabolic networks that underpin this phenotype. Collectively, this work will advance understanding of the metabolic and microbial mechanisms underlying high-fiber tolerance, offering potential strategies for improving feed efficiency in monogastric animals through microbiome and metabolic modulation.
Additional Links: PMID-43062246
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43062246,
year = {2026},
author = {Du, T and Zheng, C and Hao, Y and Niu, Q and Xu, L and He, J and Zhang, Z and Wu, C and Li, P and Huang, R},
title = {Multi-omics characterization of different dietary fiber levels on microbiota and metabolism in Erhualian and large white pigs.},
journal = {mSystems},
volume = {},
number = {},
pages = {e0066926},
doi = {10.1128/msystems.00669-26},
pmid = {43062246},
issn = {2379-5077},
abstract = {UNLABELLED: Erhualian pigs (EHL) exhibit tolerance to high-fiber diets, yet the underlying mechanisms involving gut microbiota and metabolism remain unclear. Here, we integrated colonic short-chain fatty acid (SCFA) profiling, 16S rRNA sequencing, and liver metabolomics to evaluate the effects of graded wheat bran fiber levels (total dietary fiber [TDF]: 14.07%, 16.32%, 17.99%, and 18.85%) on fiber digestibility, gut microbiota, and metabolism in EHL, compared with two large white pigs (LW) groups: large LW (LLW, same initial physiological stage as EHL) and small LW (SLW, same initial body weight as EHL). Apparent total tract digestibility (ATTD) of TDF in EHL was unaffected by increasing TDF intake (P > 0.05), whereas ATTD of TDF and insoluble dietary fiber in LLW decreased significantly (P < 0.01). High-fiber diet elevated acetate and butyrate, and total SCFAs in LLW (P < 0.05), but only trended toward higher isobutyrate and isovalerate in EHL (0.05 < P < 0.1). Regardless of diet, EHL exhibited higher colonic microbiota diversity (Simpson, P < 0.05) than LW, whereas richness (Chao and ACE) was unaffected by diet or breed (P > 0.05). Breed was the primary factor shaping swine gut microbiota (P < 0.05), with diet showing a trend toward significance, shaping colonic microbiota (P = 0.0586). Multi-omics integration identified 29 key genera and 10 metabolites associated with high-fiber digestibility in EHL. These key bacteria and metabolites were co-enriched in carbohydrate metabolism pathways, including butanoate metabolism and starch and sucrose metabolism, and collectively contribute to the high-fiber digestibility phenotype.
IMPORTANCE: Indigenous Chinese pig breeds, such as the Erhualian pig (EHL), exhibit a superior capacity for high-fiber tolerance compared with commercial lean-type breeds, which currently account for approximately 90% of China's pig inventory. Reliance on lean-type breeds has increased concentrate feed demand, intensifying human-livestock food competition. While low-cost unconventional feedstuffs (such as rice bran and wheat bran) are available, their high insoluble fiber content limits utilization in modern breeds. Elucidating the mechanisms underlying the high-fiber tolerance of EHL is of critical importance, specifically the gut microbiota, metabolites that enable efficient utilization of higher fiber levels. In this study, we integrated colonic short-chain fatty acid (SCFA), microbiome profiling, liver metabolomics, and functional correlation analyses to demonstrate that the high-fiber digestibility of EHL is associated with breed-specific microbial compositional features and a distinct hepatic metabolic profile, characterized by enrichment of carbohydrate and butanoate metabolism. The integration of microbiota functional prediction and metabolomic data reveals potential microbial-host co-metabolic networks that underpin this phenotype. Collectively, this work will advance understanding of the metabolic and microbial mechanisms underlying high-fiber tolerance, offering potential strategies for improving feed efficiency in monogastric animals through microbiome and metabolic modulation.},
}
RevDate: 2026-11-20
Whole-soil microbial inoculation accelerates post-fire soil recovery in a mixed conifer forest.
The ISME journal pii:9104282 [Epub ahead of print].
High-severity wildfires of increasing size and frequency result in release of carbon dioxide and destroy timber resources, and reduce biodiversity, soil integrity, water quality, and recreational opportunities. Forest recovery strongly depends on the reestablishment of soil microbial communities, motivating research on how restoration of soil microbiomes in burned forests can be accelerated. Here, we used a high-intensity burn pile experiment to test the effectiveness of post-fire native soil amendment as a microbial coalescence experiment. This design enabled simultaneous and repeated sampling of unburned, burned, and inoculated burned soils while holding abiotic factors constant. All conditions were sampled at six time points across an annual hydrological cycle and analyzed using amplicon sequencing, genome-resolved metagenomics, metatranscriptomics, and soil chemistry. Fire sharply reduced bacterial and fungal diversity in surface soils and nearly eliminated ectomycorrhizal fungi. Inoculation shifted bulk community composition toward the unburned reference state, without measurably accelerating subsequent convergence. Inoculation also accelerated recovery of functions associated with nutrient cycling, especially nitrogen transformations, and introduced a diverse assemblage of mycorrhizal fungi, including genera capable of forming essential symbioses with conifers, though this signal declined over the study period. However, the introduction of host plants and the establishment of functional plant-fungal symbioses, which may prolong persistence, were not tested. Despite introducing the full diversity of soil microbes, only a subset of organisms engrafted, likely due to selection linked to pyrogenic effects. We conclude that whole-soil inoculation can shorten the dispersal-limited phase of post-fire microbial recovery, a promising step towards restoration of the soil microbiome.
Additional Links: PMID-43062364
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43062364,
year = {2026},
author = {Weiss, EL and Banfield, JF},
title = {Whole-soil microbial inoculation accelerates post-fire soil recovery in a mixed conifer forest.},
journal = {The ISME journal},
volume = {},
number = {},
pages = {},
doi = {10.1093/ismejo/wrag277},
pmid = {43062364},
issn = {1751-7370},
abstract = {High-severity wildfires of increasing size and frequency result in release of carbon dioxide and destroy timber resources, and reduce biodiversity, soil integrity, water quality, and recreational opportunities. Forest recovery strongly depends on the reestablishment of soil microbial communities, motivating research on how restoration of soil microbiomes in burned forests can be accelerated. Here, we used a high-intensity burn pile experiment to test the effectiveness of post-fire native soil amendment as a microbial coalescence experiment. This design enabled simultaneous and repeated sampling of unburned, burned, and inoculated burned soils while holding abiotic factors constant. All conditions were sampled at six time points across an annual hydrological cycle and analyzed using amplicon sequencing, genome-resolved metagenomics, metatranscriptomics, and soil chemistry. Fire sharply reduced bacterial and fungal diversity in surface soils and nearly eliminated ectomycorrhizal fungi. Inoculation shifted bulk community composition toward the unburned reference state, without measurably accelerating subsequent convergence. Inoculation also accelerated recovery of functions associated with nutrient cycling, especially nitrogen transformations, and introduced a diverse assemblage of mycorrhizal fungi, including genera capable of forming essential symbioses with conifers, though this signal declined over the study period. However, the introduction of host plants and the establishment of functional plant-fungal symbioses, which may prolong persistence, were not tested. Despite introducing the full diversity of soil microbes, only a subset of organisms engrafted, likely due to selection linked to pyrogenic effects. We conclude that whole-soil inoculation can shorten the dispersal-limited phase of post-fire microbial recovery, a promising step towards restoration of the soil microbiome.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Integrative Multi-Omics in Glaucoma: Defining Mechanistic Axes and Enabling Precision Management.
Investigative ophthalmology & visual science, 67(13):39.
Glaucoma is increasingly recognized not as a uniform pressure-defined optic neuropathy, but rather as a heterogeneous neurodegenerative disorder driven by interacting genetic, metabolic, mechanical, vascular, inflammatory, and environmental factors. Although genomics, transcriptomics, proteomics, and metabolomics have each yielded important insights, no single omics layer can fully capture the multilevel architecture underlying differences in disease susceptibility, progression, and treatment response. Multi-omics therefore offers a more integrated framework for linking inherited risk, gene regulation, cellular states, protein activity, metabolic vulnerability, and imaging phenotypes to clinically relevant outcomes. This review summarizes recent advances in multi-omics research in glaucoma, spanning genomics, epigenomics and transcriptomics, proteomics, metabolomics and lipidomics, microbiome studies, and emerging approaches such as spatial omics, single-cell multi-omics, radiomics, and exposomics. We further discuss how cross-layer integration, network analysis, Mendelian randomization, imaging genomics, and multimodal artificial intelligence are helping to define convergent pathogenic pathways and clinically relevant molecular subtypes. Particular attention is given to four major pathological axes: extracellular matrix-mechanical stress, mitochondrial-metabolic dysfunction, immune-microbiome dysregulation, and exposure-vascular burden. Despite ongoing challenges in standardization, cohort size, validation, and interpretability, multi-omics is shifting glaucoma research toward mechanism-based stratification and deployable precision care.
Additional Links: PMID-43062417
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43062417,
year = {2026},
author = {Yang, Q and Xu, K and Yan, F and Qin, M and Luo, H and Zhang, X},
title = {Integrative Multi-Omics in Glaucoma: Defining Mechanistic Axes and Enabling Precision Management.},
journal = {Investigative ophthalmology & visual science},
volume = {67},
number = {13},
pages = {39},
doi = {10.1167/iovs.67.13.39},
pmid = {43062417},
issn = {1552-5783},
mesh = {Humans ; *Multiomics ; *Glaucoma/genetics/metabolism/therapy ; Proteomics/methods ; Metabolomics/methods ; *Genomics/methods ; *Precision Medicine/methods ; Epigenomics ; },
abstract = {Glaucoma is increasingly recognized not as a uniform pressure-defined optic neuropathy, but rather as a heterogeneous neurodegenerative disorder driven by interacting genetic, metabolic, mechanical, vascular, inflammatory, and environmental factors. Although genomics, transcriptomics, proteomics, and metabolomics have each yielded important insights, no single omics layer can fully capture the multilevel architecture underlying differences in disease susceptibility, progression, and treatment response. Multi-omics therefore offers a more integrated framework for linking inherited risk, gene regulation, cellular states, protein activity, metabolic vulnerability, and imaging phenotypes to clinically relevant outcomes. This review summarizes recent advances in multi-omics research in glaucoma, spanning genomics, epigenomics and transcriptomics, proteomics, metabolomics and lipidomics, microbiome studies, and emerging approaches such as spatial omics, single-cell multi-omics, radiomics, and exposomics. We further discuss how cross-layer integration, network analysis, Mendelian randomization, imaging genomics, and multimodal artificial intelligence are helping to define convergent pathogenic pathways and clinically relevant molecular subtypes. Particular attention is given to four major pathological axes: extracellular matrix-mechanical stress, mitochondrial-metabolic dysfunction, immune-microbiome dysregulation, and exposure-vascular burden. Despite ongoing challenges in standardization, cohort size, validation, and interpretability, multi-omics is shifting glaucoma research toward mechanism-based stratification and deployable precision care.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Multiomics
*Glaucoma/genetics/metabolism/therapy
Proteomics/methods
Metabolomics/methods
*Genomics/methods
*Precision Medicine/methods
Epigenomics
RevDate: 2026-11-20
Advanced Medical Therapeutic Approaches to Treat Chronic Coronary Syndromes: A Narrative Review.
Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir [Epub ahead of print].
Chronic coronary syndromes (CCSs) encompass obstructive and non-obstructive coronary artery disease, including epicardial atherosclerosis, coronary microvascular dysfunction, and coronary vasospasm, which may lead to angina pectoris, myocardial infarction, heart attack, and sudden death. Understanding the pathophysiology of CCS has led to targeted therapeutic approaches aimed at managing dyslipidemia, inflammation, and thrombus formation to reduce cardiovascular burden and mortality risk. This review aimed to explore advanced and emerging therapeutic strategies for the treatment of CCS, including advanced lipid-lowering therapies, Lp(a)-lowering RNA agents, novel anti-inflammatory agents, including interleukin-6 (IL-6)-targeted therapy, Factor XIa-targeted antithrombotic therapy, cholesteryl ester transfer protein inhibitors (CETP), angiopoietin-like protein 3 (ANGPTL3) inhibitors, glucagon-like peptide-1 receptor agonists (GLP-1RAs), nanoparticle-based targeted therapies, and microbiome-modifying therapies. This review situates each therapeutic agent within the 2024 ESC and 2023 ACC/AHA chronic coronary syndrome guidelines and, because regulatory approval, guideline recommendations, and cardiovascular outcome evidence are distinct concepts, considers each separately: high-intensity statins, ezetimibe, PCSK9 inhibitors, low-dose colchicine, and semaglutide are approved and guideline-recommended for defined populations with outcome-trial support; inclisiran and bempedoic acid are approved and guideline-endorsed as add-on lipid-lowering therapies, although inclisiran's dedicated cardiovascular outcomes trial remains ongoing; and pelacarsen, olpasiran, lepodisiran, zerlasiran, ziltivekimab, and obicetrapib remain investigational, with regulatory approval and guideline recommendations contingent on cardiovascular outcomes trial (CVOT) data. Nanomedicine- and microbiome-based approaches remain preclinical or early-phase and are considered hypothesis-generating. Despite promising advances, long-term safety, optimal patient selection, and cardiovascular outcome benefits remain uncertain. Future research should prioritize outcome-driven trials and personalized therapeutic strategies to address residual cardiovascular risk.
Additional Links: PMID-43062463
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43062463,
year = {2026},
author = {Saleem, S and Saleem, MF and Marryam, H and Saleem, MF},
title = {Advanced Medical Therapeutic Approaches to Treat Chronic Coronary Syndromes: A Narrative Review.},
journal = {Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir},
volume = {},
number = {},
pages = {},
doi = {10.5543/tkda.2026.88638},
pmid = {43062463},
issn = {1308-4488},
abstract = {Chronic coronary syndromes (CCSs) encompass obstructive and non-obstructive coronary artery disease, including epicardial atherosclerosis, coronary microvascular dysfunction, and coronary vasospasm, which may lead to angina pectoris, myocardial infarction, heart attack, and sudden death. Understanding the pathophysiology of CCS has led to targeted therapeutic approaches aimed at managing dyslipidemia, inflammation, and thrombus formation to reduce cardiovascular burden and mortality risk. This review aimed to explore advanced and emerging therapeutic strategies for the treatment of CCS, including advanced lipid-lowering therapies, Lp(a)-lowering RNA agents, novel anti-inflammatory agents, including interleukin-6 (IL-6)-targeted therapy, Factor XIa-targeted antithrombotic therapy, cholesteryl ester transfer protein inhibitors (CETP), angiopoietin-like protein 3 (ANGPTL3) inhibitors, glucagon-like peptide-1 receptor agonists (GLP-1RAs), nanoparticle-based targeted therapies, and microbiome-modifying therapies. This review situates each therapeutic agent within the 2024 ESC and 2023 ACC/AHA chronic coronary syndrome guidelines and, because regulatory approval, guideline recommendations, and cardiovascular outcome evidence are distinct concepts, considers each separately: high-intensity statins, ezetimibe, PCSK9 inhibitors, low-dose colchicine, and semaglutide are approved and guideline-recommended for defined populations with outcome-trial support; inclisiran and bempedoic acid are approved and guideline-endorsed as add-on lipid-lowering therapies, although inclisiran's dedicated cardiovascular outcomes trial remains ongoing; and pelacarsen, olpasiran, lepodisiran, zerlasiran, ziltivekimab, and obicetrapib remain investigational, with regulatory approval and guideline recommendations contingent on cardiovascular outcomes trial (CVOT) data. Nanomedicine- and microbiome-based approaches remain preclinical or early-phase and are considered hypothesis-generating. Despite promising advances, long-term safety, optimal patient selection, and cardiovascular outcome benefits remain uncertain. Future research should prioritize outcome-driven trials and personalized therapeutic strategies to address residual cardiovascular risk.},
}
RevDate: 2026-11-20
Bergenin ameliorates anxiety- and depression-like behavior in antibiotic-treated mice: behavioral and in silico insights.
Naunyn-Schmiedeberg's archives of pharmacology [Epub ahead of print].
Broad-spectrum antibiotic exposure perturbs the gut microbiota and has been linked to anxiety- and depression-like behavior in rodents. Bergenin, an anti-inflammatory, antioxidant isocoumarin C-glycoside, has not previously been evaluated in this setting. Swiss albino mice received a 14-day oral-gavage antibiotic regimen (ampicillin, neomycin, metronidazole ≈10 mg/kg/day each; vancomycin ≈5 mg/kg/day), followed by 14 days of oral bergenin (25 or 50 mg/kg/day) or fluoxetine (10 mg/kg/day, reference). Anxiety-like behavior was assessed by the elevated plus maze and open field test, and depression-like behavior by the forced swim and tail suspension tests. Docking and 100 ns molecular dynamics characterized bergenin's predicted binding to TLR4-MD-2 and the serotonin transporter (SERT), and ADMET/toxicity profiles were predicted. Antibiotic treatment produced weight loss and anxiety- and depression-like phenotypes across all four assays. Bergenin dose-dependently attenuated these deficits (high dose = ≈70-92% recovery) without altering behavior or body weight in antibiotic-free animals. Bergenin was predicted to occupy the SERT S1 site (ΔG = - 7.9 kcal/mol) with simulated stability resembling fluoxetine, whereas its TLR4-MD-2 interaction (ΔG = - 5.4 kcal/mol) was shallow and hydrogen bond poor relative to Eritoran. Its predicted ADMET profile was Lipinski-compliant, with some unverified toxicity alerts. Limitations include antibiotic doses lower than published protocols and no microbiome, biochemical, or molecular assays; dysbiosis, microbial recovery, and mechanism were not verified. Effects are interpreted in antibiotic-treated mice, and in silico findings are hypothesis-generating. Bergenin ameliorated anxiety- and depression-like behavior in antibiotic-treated mice; in silico data favored serotonergic over direct TLR4-MD-2 involvement, warranting experimental validation.
Additional Links: PMID-43062479
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43062479,
year = {2026},
author = {Shadin, M and Rakib, AI and Tahmid, JZ and Hosen, SA and Aziz, T and Bristy, AH and Islam, MT and Ansari, MA},
title = {Bergenin ameliorates anxiety- and depression-like behavior in antibiotic-treated mice: behavioral and in silico insights.},
journal = {Naunyn-Schmiedeberg's archives of pharmacology},
volume = {},
number = {},
pages = {},
pmid = {43062479},
issn = {1432-1912},
support = {ORF-2026-996//King Saud University/ ; },
abstract = {Broad-spectrum antibiotic exposure perturbs the gut microbiota and has been linked to anxiety- and depression-like behavior in rodents. Bergenin, an anti-inflammatory, antioxidant isocoumarin C-glycoside, has not previously been evaluated in this setting. Swiss albino mice received a 14-day oral-gavage antibiotic regimen (ampicillin, neomycin, metronidazole ≈10 mg/kg/day each; vancomycin ≈5 mg/kg/day), followed by 14 days of oral bergenin (25 or 50 mg/kg/day) or fluoxetine (10 mg/kg/day, reference). Anxiety-like behavior was assessed by the elevated plus maze and open field test, and depression-like behavior by the forced swim and tail suspension tests. Docking and 100 ns molecular dynamics characterized bergenin's predicted binding to TLR4-MD-2 and the serotonin transporter (SERT), and ADMET/toxicity profiles were predicted. Antibiotic treatment produced weight loss and anxiety- and depression-like phenotypes across all four assays. Bergenin dose-dependently attenuated these deficits (high dose = ≈70-92% recovery) without altering behavior or body weight in antibiotic-free animals. Bergenin was predicted to occupy the SERT S1 site (ΔG = - 7.9 kcal/mol) with simulated stability resembling fluoxetine, whereas its TLR4-MD-2 interaction (ΔG = - 5.4 kcal/mol) was shallow and hydrogen bond poor relative to Eritoran. Its predicted ADMET profile was Lipinski-compliant, with some unverified toxicity alerts. Limitations include antibiotic doses lower than published protocols and no microbiome, biochemical, or molecular assays; dysbiosis, microbial recovery, and mechanism were not verified. Effects are interpreted in antibiotic-treated mice, and in silico findings are hypothesis-generating. Bergenin ameliorated anxiety- and depression-like behavior in antibiotic-treated mice; in silico data favored serotonergic over direct TLR4-MD-2 involvement, warranting experimental validation.},
}
RevDate: 2026-11-20
The human post-mortem microbiome in forensic practice: a scoping review with critical appraisal.
International journal of legal medicine [Epub ahead of print].
BACKGROUND: The human post-mortem microbiome is increasingly investigated as a potential source of complementary information in forensic practice, particularly for post-mortem interval estimation and decomposition assessment. Its relevance to other medico-legal questions remains less clearly established.
OBJECTIVE: This scoping review aimed to map and critically assess the forensic applicability of microbial communities identified in human cadaveric and post-mortem biological samples, with particular attention to applications beyond post-mortem interval estimation.
METHODS: PubMed, Scopus, Web of Science, and the Cochrane Library were systematically searched for publications available up to 19 January 2026. Original human post-mortem studies were eligible. Data were extracted using a structured framework, and methodological quality was assessed using validated tools selected according to study design.
RESULTS: Thirty-eight studies were included, encompassing multiple external and internal biological matrices and predominantly bacterial profiling. Microbial succession related to decomposition and post-mortem interval represented the most extensively investigated directly forensic domain. Evidence concerning cause or manner of death, infection-related investigation, disease- or tissue-associated signatures, and sample preservation was more limited, while drowning was supported by a single proof-of-concept study. Across domains, methodological heterogeneity, small cohorts, contamination-related concerns, and limited external validation restricted forensic transferability.
CONCLUSIONS: Post-mortem microbial analysis remains an investigational adjunct rather than a validated standalone forensic tool. Progress toward routine implementation requires matrix-specific, contamination-controlled protocols and independent validation in larger, geographically diverse human cohorts.
Additional Links: PMID-43062692
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43062692,
year = {2026},
author = {Ferorelli, D and Vinci, A and Sirago, G and Visci, P and Dell'Erba, G and Mercuri, G and Solarino, B and Oliva, A},
title = {The human post-mortem microbiome in forensic practice: a scoping review with critical appraisal.},
journal = {International journal of legal medicine},
volume = {},
number = {},
pages = {},
pmid = {43062692},
issn = {1437-1596},
abstract = {BACKGROUND: The human post-mortem microbiome is increasingly investigated as a potential source of complementary information in forensic practice, particularly for post-mortem interval estimation and decomposition assessment. Its relevance to other medico-legal questions remains less clearly established.
OBJECTIVE: This scoping review aimed to map and critically assess the forensic applicability of microbial communities identified in human cadaveric and post-mortem biological samples, with particular attention to applications beyond post-mortem interval estimation.
METHODS: PubMed, Scopus, Web of Science, and the Cochrane Library were systematically searched for publications available up to 19 January 2026. Original human post-mortem studies were eligible. Data were extracted using a structured framework, and methodological quality was assessed using validated tools selected according to study design.
RESULTS: Thirty-eight studies were included, encompassing multiple external and internal biological matrices and predominantly bacterial profiling. Microbial succession related to decomposition and post-mortem interval represented the most extensively investigated directly forensic domain. Evidence concerning cause or manner of death, infection-related investigation, disease- or tissue-associated signatures, and sample preservation was more limited, while drowning was supported by a single proof-of-concept study. Across domains, methodological heterogeneity, small cohorts, contamination-related concerns, and limited external validation restricted forensic transferability.
CONCLUSIONS: Post-mortem microbial analysis remains an investigational adjunct rather than a validated standalone forensic tool. Progress toward routine implementation requires matrix-specific, contamination-controlled protocols and independent validation in larger, geographically diverse human cohorts.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Temporal dynamics of the rhizosphere microbiome and associated factors across lotus phenological stages.
Planta, 265(1):.
Lotus rhizosphere microbiome structure, predicted function, and networks varied across four sequential phenological stages. Soil organic carbon and total nitrogen were associated with microbial composition and predicted nitrogen and phosphorus cycling functions. Root microecology and plant physiological adaptation are critical to the growth and environmental adaptability of aquatic plants. Lotus (Nelumbo nucifera), a perennial aquatic crop with distinct phenological growth cycles, experiences continuous changes in rhizosphere conditions during seasonal development. However, the temporal relationships among plant physiological and soil physicochemical properties variation and rhizosphere microbial community succession across sequential lotus phenological stages remain poorly understood. Under ambient field conditions, this study characterized rhizosphere bacterial and fungal communities, soil properties, and plant traits at four sequential phenological stages: standing leaf, flowering, rhizome formation, and dormancy stages. Soil nutrient contents, plant physiological activity, and microbial α-diversity differed significantly among sampling stages, with relatively high values occurring during the standing leaf and flowering periods. Soil organic carbon and total nitrogen were strongly associated with microbial community composition. ANCOM-BC2 analysis identified significant differences among stages in bacterial genera, including Rhodomicrobium, Bacteroides, and Smithella, and fungal genera, including Mortierella, Lophotrichus, and Cladorrhinum. The study revealed a shift in rhizosphere bacterial assembly from stochastic to deterministic dominance across the sampling sequence. Microbial co-occurrence network complexity peaked during the standing leaf period. Predicted functions associated with denitrification were more abundant during the standing leaf and flowering periods, whereas predicted functions associated with nitrification and inorganic phosphate solubilization were more abundant during dormancy. These findings characterize temporal covariation among lotus phenology, plant traits, soil properties, and the rhizosphere microbiome under natural seasonal progression. This study provides useful insights into temporal microbiome dynamics in aquatic plant cultivation systems.
Additional Links: PMID-43062717
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43062717,
year = {2026},
author = {Meng, S and Xu, G and Zhang, Z and He, J and Kong, D and Ku, Y and Liu, Y},
title = {Temporal dynamics of the rhizosphere microbiome and associated factors across lotus phenological stages.},
journal = {Planta},
volume = {265},
number = {1},
pages = {},
pmid = {43062717},
issn = {1432-2048},
support = {GZC20230712//Post-Doctoral Science Foundation of China/ ; 30602956//2024 Provincial-Level Financial Afforestation Germplasm Resources Construction Project/ ; },
mesh = {*Rhizosphere ; *Microbiota/physiology ; Soil Microbiology ; Nitrogen/metabolism ; Soil/chemistry ; Bacteria/genetics/classification ; Carbon/metabolism ; Fungi/genetics ; *Nelumbo/microbiology/growth & development/physiology ; Plant Leaves/microbiology ; Seasons ; Phosphorus/metabolism ; Plant Roots/microbiology ; Rhizome/microbiology ; *Lotus/microbiology ; },
abstract = {Lotus rhizosphere microbiome structure, predicted function, and networks varied across four sequential phenological stages. Soil organic carbon and total nitrogen were associated with microbial composition and predicted nitrogen and phosphorus cycling functions. Root microecology and plant physiological adaptation are critical to the growth and environmental adaptability of aquatic plants. Lotus (Nelumbo nucifera), a perennial aquatic crop with distinct phenological growth cycles, experiences continuous changes in rhizosphere conditions during seasonal development. However, the temporal relationships among plant physiological and soil physicochemical properties variation and rhizosphere microbial community succession across sequential lotus phenological stages remain poorly understood. Under ambient field conditions, this study characterized rhizosphere bacterial and fungal communities, soil properties, and plant traits at four sequential phenological stages: standing leaf, flowering, rhizome formation, and dormancy stages. Soil nutrient contents, plant physiological activity, and microbial α-diversity differed significantly among sampling stages, with relatively high values occurring during the standing leaf and flowering periods. Soil organic carbon and total nitrogen were strongly associated with microbial community composition. ANCOM-BC2 analysis identified significant differences among stages in bacterial genera, including Rhodomicrobium, Bacteroides, and Smithella, and fungal genera, including Mortierella, Lophotrichus, and Cladorrhinum. The study revealed a shift in rhizosphere bacterial assembly from stochastic to deterministic dominance across the sampling sequence. Microbial co-occurrence network complexity peaked during the standing leaf period. Predicted functions associated with denitrification were more abundant during the standing leaf and flowering periods, whereas predicted functions associated with nitrification and inorganic phosphate solubilization were more abundant during dormancy. These findings characterize temporal covariation among lotus phenology, plant traits, soil properties, and the rhizosphere microbiome under natural seasonal progression. This study provides useful insights into temporal microbiome dynamics in aquatic plant cultivation systems.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Rhizosphere
*Microbiota/physiology
Soil Microbiology
Nitrogen/metabolism
Soil/chemistry
Bacteria/genetics/classification
Carbon/metabolism
Fungi/genetics
*Nelumbo/microbiology/growth & development/physiology
Plant Leaves/microbiology
Seasons
Phosphorus/metabolism
Plant Roots/microbiology
Rhizome/microbiology
*Lotus/microbiology
RevDate: 2026-11-20
Consensus Statement on the Role of Dermoceuticals in the Management of Atopic Dermatitis in the United Arab Emirates.
Dermatology and therapy [Epub ahead of print].
INTRODUCTION: Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease characterized by epidermal barrier dysfunction, immune dysregulation, microbiome alterations, and persistent pruritus. Dermoceuticals have become an integral component of AD management because of their role in restoring skin barrier function, maintaining hydration, reducing symptoms, and complementing pharmacological therapies. However, practical guidance on their optimal selection and integration into routine clinical practice remains limited within the United Arab Emirates (UAE). This consensus manuscript aimed to develop evidence-informed statements on the use of dermoceuticals in the management of AD in the UAE.
METHODS: A panel of 13 experienced dermatologists representing public and private healthcare sectors across the UAE, together with an international expert serving as an external scientific validator, developed the statements through a structured modified Delphi process informed by a targeted literature review. Consensus was defined as ≥ 80% agreement.
RESULTS: Following two rounds of anonymous voting, consensus was achieved for 13 of the 14 proposed statements. One statement concerning treatment selection in active and mild AD did not achieve consensus and was excluded. The 13 final statements addressed AD pathophysiology, treatment goals, the definition and role of dermoceuticals, moisturizer formulations, microbiome-supportive skincare, gentle cleansers, ceramide-containing formulations, proactive maintenance therapy, shared decision-making, and patient and caregiver education. The panel emphasized that dermoceuticals should be considered a lifelong component of individualized AD management, serving as monotherapy in selected patients with mild disease and as adjunctive therapy alongside pharmacological treatment in moderate-to-severe AD.
CONCLUSIONS: These consensus recommendations provide practical guidance for integrating dermoceuticals into routine clinical practice in the UAE and aim to support standardized, evidence-informed, patient-centered care while optimizing long-term disease control and quality of life.
Additional Links: PMID-43062795
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43062795,
year = {2026},
author = {Al Naeem, A and Ameen, A and Al Awadhi, A and Reda, AM and Attia, E and Albreiki, F and Almarzooqi, F and Rajab Ali, H and Abdel Dayem, H and Aljefri, K and Al Murrawi, M and Al Maashari, R and Goturu, S and Steinhoff, M},
title = {Consensus Statement on the Role of Dermoceuticals in the Management of Atopic Dermatitis in the United Arab Emirates.},
journal = {Dermatology and therapy},
volume = {},
number = {},
pages = {},
pmid = {43062795},
issn = {2193-8210},
abstract = {INTRODUCTION: Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease characterized by epidermal barrier dysfunction, immune dysregulation, microbiome alterations, and persistent pruritus. Dermoceuticals have become an integral component of AD management because of their role in restoring skin barrier function, maintaining hydration, reducing symptoms, and complementing pharmacological therapies. However, practical guidance on their optimal selection and integration into routine clinical practice remains limited within the United Arab Emirates (UAE). This consensus manuscript aimed to develop evidence-informed statements on the use of dermoceuticals in the management of AD in the UAE.
METHODS: A panel of 13 experienced dermatologists representing public and private healthcare sectors across the UAE, together with an international expert serving as an external scientific validator, developed the statements through a structured modified Delphi process informed by a targeted literature review. Consensus was defined as ≥ 80% agreement.
RESULTS: Following two rounds of anonymous voting, consensus was achieved for 13 of the 14 proposed statements. One statement concerning treatment selection in active and mild AD did not achieve consensus and was excluded. The 13 final statements addressed AD pathophysiology, treatment goals, the definition and role of dermoceuticals, moisturizer formulations, microbiome-supportive skincare, gentle cleansers, ceramide-containing formulations, proactive maintenance therapy, shared decision-making, and patient and caregiver education. The panel emphasized that dermoceuticals should be considered a lifelong component of individualized AD management, serving as monotherapy in selected patients with mild disease and as adjunctive therapy alongside pharmacological treatment in moderate-to-severe AD.
CONCLUSIONS: These consensus recommendations provide practical guidance for integrating dermoceuticals into routine clinical practice in the UAE and aim to support standardized, evidence-informed, patient-centered care while optimizing long-term disease control and quality of life.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
The microbial world of male reproduction.
Proceedings of the National Academy of Sciences of the United States of America, 123(48):e2615606123.
The last decade has brought renewed interest to microbial influences on host biology, yet the roles of microbes in host reproductive biology are underappreciated and often defined by a profound maternal bias. This perspective synthesizes emerging evidence across the tree of life to highlight the paternal microbiome as an overlooked driver of fitness, reproductive output, and intergenerational health, impacting epigenetic sculpting of the sperm and embryo, sexual transmission of microbes, and male gamete functions. These contributions indicate that mating can involve interactions between holobionts rather than simply the union of the maternal and paternal genomes. Thus, uniting male reproduction with the growing generalizations of microbial symbiosis guides several conceptual, theoretical, and empirical avenues for research in the life sciences.
Additional Links: PMID-43062952
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43062952,
year = {2026},
author = {Imchen, M and Kaur, R and Bordenstein, SR},
title = {The microbial world of male reproduction.},
journal = {Proceedings of the National Academy of Sciences of the United States of America},
volume = {123},
number = {48},
pages = {e2615606123},
doi = {10.1073/pnas.2615606123},
pmid = {43062952},
issn = {1091-6490},
support = {R01 AI189624 and AI179743//HHS | National Institutes of Health (NIH)/ ; GBMF13798//Gordon and Betty Moore Foundation (GBMF)/ ; },
mesh = {*Reproduction/physiology ; Animals ; *Microbiota/physiology ; Male ; Humans ; Symbiosis ; Spermatozoa/microbiology/physiology ; Epigenesis, Genetic ; },
abstract = {The last decade has brought renewed interest to microbial influences on host biology, yet the roles of microbes in host reproductive biology are underappreciated and often defined by a profound maternal bias. This perspective synthesizes emerging evidence across the tree of life to highlight the paternal microbiome as an overlooked driver of fitness, reproductive output, and intergenerational health, impacting epigenetic sculpting of the sperm and embryo, sexual transmission of microbes, and male gamete functions. These contributions indicate that mating can involve interactions between holobionts rather than simply the union of the maternal and paternal genomes. Thus, uniting male reproduction with the growing generalizations of microbial symbiosis guides several conceptual, theoretical, and empirical avenues for research in the life sciences.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Reproduction/physiology
Animals
*Microbiota/physiology
Male
Humans
Symbiosis
Spermatozoa/microbiology/physiology
Epigenesis, Genetic
RevDate: 2026-11-21
CmpDate: 2026-11-20
Metabolic retraction and virulence gene repertoire expansion in a tropical urban river microbiome under dry-season stress.
PloS one, 21(11):e0352290.
Anthropogenic pollution and seasonal flow reduction concentrate untreated organic waste in tropical rivers, yet the coupled response of microbial metabolism and virulence gene repertoires remains poorly understood. We applied shotgun metagenomics to samples from the Shitalakshya River (Bangladesh) in a comparative study of early (December 2024) and peak (February 2025) dry season conditions. Dissolved oxygen fell to near-hypoxic levels, ammonia nearly doubled (5 → 9.87 mg L [-] [1]), and total organic carbon surged. KEGG profiling revealed a contracting metabolic core, with amino acid, carbohydrate, and energy metabolism showing lower relative representation (59-86%). In comparison, xenobiotic biodegradation showed 4.6-fold higher relative abundance, and secondary metabolite biosynthesis showed 7.4-fold higher relative abundance. An exploratory KEGG functional-response similarity network revealed distinct groupings characterized by decreasing core metabolic pathways and increasing pollution-responsive functions, including xenobiotic degradation and secondary metabolite biosynthesis. Parallel virulence gene profiling (VFDB) revealed compositional restructuring of the virulence-associated gene repertoire, with a larger number of detected VFDB-annotated genes in February than in December (378 vs. 294). Motility and chemotaxis genes nearly doubled, biofilm determinants (algD, alg8, mrk operon) were newly detected in February, and selected Type VI secretion system-associated genes showed higher relative representation. Conversely, siderophore-mediated iron acquisition and immune evasion factor genes showed substantially lower relative abundance. These coordinated shifts are consistent with a transition from a growth-oriented metabolic profile to a persistence-oriented one, based on environmental sensing and surface colonization. The co-enrichment of motility, biofilm, and T6SS traits alongside pollution-responsive pathways is associated with a dual ecological filter, in which dry-season conditions are linked to xenobiotic-tolerant generalists and bacteria carrying markers of opportunistic pathogens. Our findings provide preliminary evidence for a quantitative framework linking seasonal pollution to shifts in microbial functional potential in urban rivers, with direct implications for drinking water abstraction and public health monitoring.
Additional Links: PMID-43063148
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43063148,
year = {2026},
author = {Haque, ME and Rahman, MS and Sultana, M and Begum, A},
title = {Metabolic retraction and virulence gene repertoire expansion in a tropical urban river microbiome under dry-season stress.},
journal = {PloS one},
volume = {21},
number = {11},
pages = {e0352290},
pmid = {43063148},
issn = {1932-6203},
mesh = {*Rivers/microbiology ; *Seasons ; Virulence/genetics ; *Microbiota/genetics ; *Bacteria/genetics/metabolism/pathogenicity ; Tropical Climate ; *Stress, Physiological ; },
abstract = {Anthropogenic pollution and seasonal flow reduction concentrate untreated organic waste in tropical rivers, yet the coupled response of microbial metabolism and virulence gene repertoires remains poorly understood. We applied shotgun metagenomics to samples from the Shitalakshya River (Bangladesh) in a comparative study of early (December 2024) and peak (February 2025) dry season conditions. Dissolved oxygen fell to near-hypoxic levels, ammonia nearly doubled (5 → 9.87 mg L [-] [1]), and total organic carbon surged. KEGG profiling revealed a contracting metabolic core, with amino acid, carbohydrate, and energy metabolism showing lower relative representation (59-86%). In comparison, xenobiotic biodegradation showed 4.6-fold higher relative abundance, and secondary metabolite biosynthesis showed 7.4-fold higher relative abundance. An exploratory KEGG functional-response similarity network revealed distinct groupings characterized by decreasing core metabolic pathways and increasing pollution-responsive functions, including xenobiotic degradation and secondary metabolite biosynthesis. Parallel virulence gene profiling (VFDB) revealed compositional restructuring of the virulence-associated gene repertoire, with a larger number of detected VFDB-annotated genes in February than in December (378 vs. 294). Motility and chemotaxis genes nearly doubled, biofilm determinants (algD, alg8, mrk operon) were newly detected in February, and selected Type VI secretion system-associated genes showed higher relative representation. Conversely, siderophore-mediated iron acquisition and immune evasion factor genes showed substantially lower relative abundance. These coordinated shifts are consistent with a transition from a growth-oriented metabolic profile to a persistence-oriented one, based on environmental sensing and surface colonization. The co-enrichment of motility, biofilm, and T6SS traits alongside pollution-responsive pathways is associated with a dual ecological filter, in which dry-season conditions are linked to xenobiotic-tolerant generalists and bacteria carrying markers of opportunistic pathogens. Our findings provide preliminary evidence for a quantitative framework linking seasonal pollution to shifts in microbial functional potential in urban rivers, with direct implications for drinking water abstraction and public health monitoring.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Rivers/microbiology
*Seasons
Virulence/genetics
*Microbiota/genetics
*Bacteria/genetics/metabolism/pathogenicity
Tropical Climate
*Stress, Physiological
RevDate: 2026-11-20
Butyrate and palmitoylethanolamide: Exploring their metabolic potential in explaining clinical improvement in irritable bowel syndrome patients, data from a randomised, placebo-controlled trial.
Clinical nutrition (Edinburgh, Scotland), 67:106846 pii:S0261-5614(26)00273-6 [Epub ahead of print].
BACKGROUND: Irritable bowel syndrome (IBS) is a disorder of gut-brain interaction in which gut microbiome plays a major role. Butyrate and palmitoylethanolamide (PEA) exert anti-inflammatory and neuromodulator effects and may represent promising adjunctive treatments. We evaluated the clinical and microbiome-related effects of a combined formulation of sodium butyrate and PEA (BP 3:1) in patients with IBS.
METHODS: In a randomized, double-blnd, placebo-controlled, 2 × 2 crossover trial, adults with diarrhoea-predominant or mixed IBS received BP 3:1 or placebo for two 6-week periods separated by washout. Gastrointestinal symptoms, IBS Severity Scoring System (IBS-SSS), intestinal permeability, and safety were assessed. Fecal microbiota composition and predicted functional potential were analyzed using 16S-rRNA sequencing and PICRUSt2.
RESULTS: Forty-four patients completed the study. Alpha and beta diversity and taxonomic composition remained stable. In contrast, functional profiling revealed treatment-specific enrichment of microbial pathways involved in methionine and S-adenosyl-L-methionine biosynthesis, while placebo was associated with pathways related to complex carbohydrate degradation. BP 3:1 significantly improved abdominal bloating (p = 0.020), stomach gurgling (p = 0.014) and nausea (p = 0.030) compared with placebo, with consistent estimates in mixed-effects models adjusting for period and sequence effects, while IBS-SSS showed a clinically relevant but non-significant numerical reduction (p = 0.070). No effects were observed on intestinal permeability. Among clinically improving patients, BP 3:1 was associated with modulation of polyphenol-degrading, biosynthetic and proteolytic microbial pathways. BP 3:1 was well tolerated, with a safety profile comparable to placebo.
CONCLUSIONS: BP 3:1 significantly improves IBS symptoms and modulates microbial metabolic potential without inducing a quantitative and/or qualitative alteration in the taxonomic composition of the microbiota. These findings support a functional microbiome-mediated effect in IBS.
CLINICALTRIAL: gov NCT06432569 (https://clinicaltrials.gov/study/NCT06432569).
Additional Links: PMID-43063611
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43063611,
year = {2026},
author = {Facchin, S and Bertin, L and Benvenuto, G and De Barba, C and Agostini, E and Valle, G and Barberio, B and Zingone, F and Valente, M and Francescato, S and Chahuán, J and Savarino, EV},
title = {Butyrate and palmitoylethanolamide: Exploring their metabolic potential in explaining clinical improvement in irritable bowel syndrome patients, data from a randomised, placebo-controlled trial.},
journal = {Clinical nutrition (Edinburgh, Scotland)},
volume = {67},
number = {},
pages = {106846},
doi = {10.1016/j.clnu.2026.106846},
pmid = {43063611},
issn = {1532-1983},
abstract = {BACKGROUND: Irritable bowel syndrome (IBS) is a disorder of gut-brain interaction in which gut microbiome plays a major role. Butyrate and palmitoylethanolamide (PEA) exert anti-inflammatory and neuromodulator effects and may represent promising adjunctive treatments. We evaluated the clinical and microbiome-related effects of a combined formulation of sodium butyrate and PEA (BP 3:1) in patients with IBS.
METHODS: In a randomized, double-blnd, placebo-controlled, 2 × 2 crossover trial, adults with diarrhoea-predominant or mixed IBS received BP 3:1 or placebo for two 6-week periods separated by washout. Gastrointestinal symptoms, IBS Severity Scoring System (IBS-SSS), intestinal permeability, and safety were assessed. Fecal microbiota composition and predicted functional potential were analyzed using 16S-rRNA sequencing and PICRUSt2.
RESULTS: Forty-four patients completed the study. Alpha and beta diversity and taxonomic composition remained stable. In contrast, functional profiling revealed treatment-specific enrichment of microbial pathways involved in methionine and S-adenosyl-L-methionine biosynthesis, while placebo was associated with pathways related to complex carbohydrate degradation. BP 3:1 significantly improved abdominal bloating (p = 0.020), stomach gurgling (p = 0.014) and nausea (p = 0.030) compared with placebo, with consistent estimates in mixed-effects models adjusting for period and sequence effects, while IBS-SSS showed a clinically relevant but non-significant numerical reduction (p = 0.070). No effects were observed on intestinal permeability. Among clinically improving patients, BP 3:1 was associated with modulation of polyphenol-degrading, biosynthetic and proteolytic microbial pathways. BP 3:1 was well tolerated, with a safety profile comparable to placebo.
CONCLUSIONS: BP 3:1 significantly improves IBS symptoms and modulates microbial metabolic potential without inducing a quantitative and/or qualitative alteration in the taxonomic composition of the microbiota. These findings support a functional microbiome-mediated effect in IBS.
CLINICALTRIAL: gov NCT06432569 (https://clinicaltrials.gov/study/NCT06432569).},
}
RevDate: 2026-11-20
Polymer-specific eco-coronas redirect microplastic effects in a freshwater macrophyte.
Water research, 309(Pt C):127324 pii:S0043-1354(26)01995-0 [Epub ahead of print].
Microplastics (MPs) entering freshwater environments are rapidly transformed by adsorption of environmental biomolecules, creating an eco-corona that redefines their biological identity. Whether this transformation merely alters effect magnitude or redirects biological responses remains unresolved. Here, we compared the effects of pristine and eco-corona-bearing polystyrene (PS) and polylactic acid (PLA) MPs on the freshwater macrophyte Myriophyllum aquaticum by integrating interfacial characterization, plant physiology, metabolomics, and endophytic microbiome profiling. Despite exposure to the same extracellular polymeric substance pool, PS and PLA formed compositionally and structurally distinct eco-coronas. These acquired interfaces altered plant responses in opposing directions relative to their pristine counterparts. The PS eco-corona increased fresh weight by 40.4% relative to pristine PS, moderated oxidative disruption, and supported a recovery-compatible state. In contrast, the PLA eco-corona reduced fresh weight by 18.4% relative to pristine PLA and redirected resource allocation toward an energetically costly defense program. This divergence was linked to contrasting regulation of photosynthetic energy metabolism, redox balance, and secondary metabolism: the PLA eco-corona increased ATPase activity and promoted defense-related metabolite accumulation, whereas the PS eco-corona was associated with photosynthetic recovery and repair-related metabolic pathways. Host metabolic reprogramming further coincided with distinct patterns of endophytic microbiome assembly, consistent with a metabolic-filtering framework. These findings show that MP effects emerge from interactions between polymer chemistry and environmentally acquired interfaces, and that assessments based solely on pristine particles may misrepresent the direction and magnitude of changes in plant physiology, metabolism, and the associated microbiome.
Additional Links: PMID-43063673
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43063673,
year = {2026},
author = {Liu, Y and Kang, M and Weng, Y and Bai, X and Chen, K and Guo, Z and Zhang, P},
title = {Polymer-specific eco-coronas redirect microplastic effects in a freshwater macrophyte.},
journal = {Water research},
volume = {309},
number = {Pt C},
pages = {127324},
doi = {10.1016/j.watres.2026.127324},
pmid = {43063673},
issn = {1879-2448},
abstract = {Microplastics (MPs) entering freshwater environments are rapidly transformed by adsorption of environmental biomolecules, creating an eco-corona that redefines their biological identity. Whether this transformation merely alters effect magnitude or redirects biological responses remains unresolved. Here, we compared the effects of pristine and eco-corona-bearing polystyrene (PS) and polylactic acid (PLA) MPs on the freshwater macrophyte Myriophyllum aquaticum by integrating interfacial characterization, plant physiology, metabolomics, and endophytic microbiome profiling. Despite exposure to the same extracellular polymeric substance pool, PS and PLA formed compositionally and structurally distinct eco-coronas. These acquired interfaces altered plant responses in opposing directions relative to their pristine counterparts. The PS eco-corona increased fresh weight by 40.4% relative to pristine PS, moderated oxidative disruption, and supported a recovery-compatible state. In contrast, the PLA eco-corona reduced fresh weight by 18.4% relative to pristine PLA and redirected resource allocation toward an energetically costly defense program. This divergence was linked to contrasting regulation of photosynthetic energy metabolism, redox balance, and secondary metabolism: the PLA eco-corona increased ATPase activity and promoted defense-related metabolite accumulation, whereas the PS eco-corona was associated with photosynthetic recovery and repair-related metabolic pathways. Host metabolic reprogramming further coincided with distinct patterns of endophytic microbiome assembly, consistent with a metabolic-filtering framework. These findings show that MP effects emerge from interactions between polymer chemistry and environmentally acquired interfaces, and that assessments based solely on pristine particles may misrepresent the direction and magnitude of changes in plant physiology, metabolism, and the associated microbiome.},
}
RevDate: 2026-11-20
Perilla frutescens extract alleviates ovarian oxidative stress in a validated HELP-induced FLHS model through ovarian metabolic reprogramming and cecal microbiome modulation.
Poultry science, 106(1):108148 pii:S0032-5791(26)01785-2 [Epub ahead of print].
Perilla frutescens extract (PFE) is rich in bioactive compounds with multiple physiological functions. This study evaluated the effects of dietary PFE on laying performance and ovarian antioxidant capacity in a validated hen model of fatty liver haemorrhagic syndrome (FLHS) induced by a high-energy low-protein (HELP) diet. Hepatic histopathology and biochemical analyses confirmed the successful establishment of the FLHS model. A total of 360 laying hens were randomly assigned to five groups: control, FLHS model, and model supplemented with 200, 400, or 600 mg/kg PFE. The trial consisted of a 2-week adaptation period followed by a 12-week experimental period. Compared with the model group, all PFE treatments significantly increased laying rate, elevated ovarian antioxidant enzyme activities (SOD, GSH-Px, CAT, T-AOC), and reduced MDA and AST levels. Mechanistically, PFE was associated with the modulation of FoxO signaling-related metabolic pathways, remodeled ovarian lipid and nucleotide metabolism, and replenished coenzyme precursors. Moreover, PFE reshaped the cecal microbiota by enriching beneficial genera (Bacteroides, Prevotella) and reducing opportunistic pathogens (Eisenbergiella), while moderately promoting Desulfovibrio-driven sulfur metabolism and restoring bacterial two‑component signal transduction. Collectively, dietary PFE at 200-600 mg/kg alleviates ovarian oxidative stress and metabolic disturbances in HELP-challenged laying hens, with potential relevance to FLHS, through coordinated antioxidant, metabolic, and microbial mechanisms. Notably, although 600 mg/kg yielded the numerically highest laying rate, the 400 mg/kg dose provided the most balanced improvements across multiple ovarian antioxidant and metabolic parameters. Therefore, 400 mg/kg PFE is recommended as the optimal dosage for maintaining ovarian health and improving performance in HELP-challenged hens.
Additional Links: PMID-43063911
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43063911,
year = {2026},
author = {Fei, D and Xie, M and Guang, YL and Zhou, YM},
title = {Perilla frutescens extract alleviates ovarian oxidative stress in a validated HELP-induced FLHS model through ovarian metabolic reprogramming and cecal microbiome modulation.},
journal = {Poultry science},
volume = {106},
number = {1},
pages = {108148},
doi = {10.1016/j.psj.2026.108148},
pmid = {43063911},
issn = {1525-3171},
abstract = {Perilla frutescens extract (PFE) is rich in bioactive compounds with multiple physiological functions. This study evaluated the effects of dietary PFE on laying performance and ovarian antioxidant capacity in a validated hen model of fatty liver haemorrhagic syndrome (FLHS) induced by a high-energy low-protein (HELP) diet. Hepatic histopathology and biochemical analyses confirmed the successful establishment of the FLHS model. A total of 360 laying hens were randomly assigned to five groups: control, FLHS model, and model supplemented with 200, 400, or 600 mg/kg PFE. The trial consisted of a 2-week adaptation period followed by a 12-week experimental period. Compared with the model group, all PFE treatments significantly increased laying rate, elevated ovarian antioxidant enzyme activities (SOD, GSH-Px, CAT, T-AOC), and reduced MDA and AST levels. Mechanistically, PFE was associated with the modulation of FoxO signaling-related metabolic pathways, remodeled ovarian lipid and nucleotide metabolism, and replenished coenzyme precursors. Moreover, PFE reshaped the cecal microbiota by enriching beneficial genera (Bacteroides, Prevotella) and reducing opportunistic pathogens (Eisenbergiella), while moderately promoting Desulfovibrio-driven sulfur metabolism and restoring bacterial two‑component signal transduction. Collectively, dietary PFE at 200-600 mg/kg alleviates ovarian oxidative stress and metabolic disturbances in HELP-challenged laying hens, with potential relevance to FLHS, through coordinated antioxidant, metabolic, and microbial mechanisms. Notably, although 600 mg/kg yielded the numerically highest laying rate, the 400 mg/kg dose provided the most balanced improvements across multiple ovarian antioxidant and metabolic parameters. Therefore, 400 mg/kg PFE is recommended as the optimal dosage for maintaining ovarian health and improving performance in HELP-challenged hens.},
}
RevDate: 2026-11-20
Ketogenic Diet enhances the efficacy of immunotherapy for Colorectal Cancer through modulating intestinal Branched-Chain Amino Acids metabolism.
Cancer letters pii:S0304-3835(26)00725-1 [Epub ahead of print].
Dietary therapy, the gut microbiota, and immune responses interact in complex ways. Our study demonstrates that a ketogenic diet (KD) enhances the efficacy of an anti-programmed cell death protein 1 (anti-PD-1) monoclonal antibody in colorectal cancer (CRC). Integrated microbiome and metabolome analyses revealed a marked increase in the abundance of branched-chain amino acid (BCAA)-producing bacteria, along with elevated levels of their metabolic products, the BCAAs, in the combination treatment group. Furthermore, exogenous BCAA supplementation improved the anti-tumor efficacy of anti-PD-1. Mechanistically, BCAAs maintain the proteostasis of the stimulator of interferon genes (STING) in CRC by promoting its K63-linked ubiquitination and inhibiting K48-linked ubiquitination-mediated proteasomal degradation, thereby activating the interferon-β (IFN-β) pathway within the tumor microenvironment (TME) to enhance anti-tumor CD8[+] T cell immunity. In patients with metastatic CRC (mCRC) receiving immunotherapy, BCAA levels and the STING-IFN-β axis were associated with prognosis. These findings provide a theoretical and practical rationale for combining dietary modulation with immune-based therapies in the clinical management of CRC.
Additional Links: PMID-43064057
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43064057,
year = {2026},
author = {Li, S and Yao, Y and Yang, P and Wang, X and Zhao, Y and Xu, Q and Chen, Y and Cao, L and Jiang, L and Zhu, X and Sun, S and Shao, X and Wang, B},
title = {Ketogenic Diet enhances the efficacy of immunotherapy for Colorectal Cancer through modulating intestinal Branched-Chain Amino Acids metabolism.},
journal = {Cancer letters},
volume = {},
number = {},
pages = {218961},
doi = {10.1016/j.canlet.2026.218961},
pmid = {43064057},
issn = {1872-7980},
abstract = {Dietary therapy, the gut microbiota, and immune responses interact in complex ways. Our study demonstrates that a ketogenic diet (KD) enhances the efficacy of an anti-programmed cell death protein 1 (anti-PD-1) monoclonal antibody in colorectal cancer (CRC). Integrated microbiome and metabolome analyses revealed a marked increase in the abundance of branched-chain amino acid (BCAA)-producing bacteria, along with elevated levels of their metabolic products, the BCAAs, in the combination treatment group. Furthermore, exogenous BCAA supplementation improved the anti-tumor efficacy of anti-PD-1. Mechanistically, BCAAs maintain the proteostasis of the stimulator of interferon genes (STING) in CRC by promoting its K63-linked ubiquitination and inhibiting K48-linked ubiquitination-mediated proteasomal degradation, thereby activating the interferon-β (IFN-β) pathway within the tumor microenvironment (TME) to enhance anti-tumor CD8[+] T cell immunity. In patients with metastatic CRC (mCRC) receiving immunotherapy, BCAA levels and the STING-IFN-β axis were associated with prognosis. These findings provide a theoretical and practical rationale for combining dietary modulation with immune-based therapies in the clinical management of CRC.},
}
RevDate: 2026-11-21
Could gut microbiome modulation improve cognitive outcomes during chemotherapy?.
Additional Links: PMID-43064060
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43064060,
year = {2026},
author = {Singh, A and Jain, P},
title = {Could gut microbiome modulation improve cognitive outcomes during chemotherapy?.},
journal = {Cancer letters},
volume = {},
number = {},
pages = {218987},
doi = {10.1016/j.canlet.2026.218987},
pmid = {43064060},
issn = {1872-7980},
}
RevDate: 2026-11-20
Fermented Foods Target Multiple Hallmarks of Aging to Promote Healthy Longevity.
The Journal of nutrition pii:S0022-3166(26)00599-7 [Epub ahead of print].
Aging is associated with progressive physiological decline driven by chronic inflammation, oxidative stress, immune dysfunction, and gut microbial dysbiosis, and fermented foods contain probiotics and bioactive metabolites that may beneficially influence these processes. This narrative review summarizes evidence on fermented foods and mechanisms associated with healthy aging, particularly gut microbiota composition, immune function, oxidative stress, and inflammation, while explicitly distinguishing findings from cell-based (in vitro) systems, animal (in vivo) models, and human participants. Each finding is labeled by its evidence tier so the strength and translational relevance of the data can be judged transparently. In vitro studies using cultured cells, including senescent fibroblasts, immune cells, and cancer cell lines, show that fermentation-derived metabolites can activate antioxidant, autophagic, and anti-inflammatory signaling pathways, and studies in rodent models, principally aged mice, show that fermented foods and their metabolites can improve mitochondrial function, reduce inflammatory markers, and reshape the gut microbiota. Human observational and interventional studies indicate that regular consumption of fermented foods is associated with increased gut microbial diversity, reduced circulating inflammatory markers, and, in some cohorts, longer leukocyte telomere length, although direct human evidence for many of the mechanisms identified in cell-based and animal work remains limited, a gap highlighted throughout the review. Taken together, fermented foods show potential as accessible dietary interventions for promoting healthy aging, but mechanistic detail is derived largely from cell-based and animal studies, whereas human data remain mostly observational or limited to biomarker-level endpoints, and confirmation through well-controlled human trials is still needed. The reviewed literature does not establish a minimum effective daily intake for any fermented food, and questions of portion size, variety, cultural/geographic availability, and safety of sustained daily consumption (e.g., sodium and biogenic amine content) remain priorities for future research.
Additional Links: PMID-43064202
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43064202,
year = {2026},
author = {Hazarika, P and Akhtar, I and Khan, MR},
title = {Fermented Foods Target Multiple Hallmarks of Aging to Promote Healthy Longevity.},
journal = {The Journal of nutrition},
volume = {},
number = {},
pages = {101950},
doi = {10.1016/j.tjnut.2026.101950},
pmid = {43064202},
issn = {1541-6100},
abstract = {Aging is associated with progressive physiological decline driven by chronic inflammation, oxidative stress, immune dysfunction, and gut microbial dysbiosis, and fermented foods contain probiotics and bioactive metabolites that may beneficially influence these processes. This narrative review summarizes evidence on fermented foods and mechanisms associated with healthy aging, particularly gut microbiota composition, immune function, oxidative stress, and inflammation, while explicitly distinguishing findings from cell-based (in vitro) systems, animal (in vivo) models, and human participants. Each finding is labeled by its evidence tier so the strength and translational relevance of the data can be judged transparently. In vitro studies using cultured cells, including senescent fibroblasts, immune cells, and cancer cell lines, show that fermentation-derived metabolites can activate antioxidant, autophagic, and anti-inflammatory signaling pathways, and studies in rodent models, principally aged mice, show that fermented foods and their metabolites can improve mitochondrial function, reduce inflammatory markers, and reshape the gut microbiota. Human observational and interventional studies indicate that regular consumption of fermented foods is associated with increased gut microbial diversity, reduced circulating inflammatory markers, and, in some cohorts, longer leukocyte telomere length, although direct human evidence for many of the mechanisms identified in cell-based and animal work remains limited, a gap highlighted throughout the review. Taken together, fermented foods show potential as accessible dietary interventions for promoting healthy aging, but mechanistic detail is derived largely from cell-based and animal studies, whereas human data remain mostly observational or limited to biomarker-level endpoints, and confirmation through well-controlled human trials is still needed. The reviewed literature does not establish a minimum effective daily intake for any fermented food, and questions of portion size, variety, cultural/geographic availability, and safety of sustained daily consumption (e.g., sodium and biogenic amine content) remain priorities for future research.},
}
RevDate: 2026-11-20
Effect of long-term oxygen exposure on anaerobic microbiome carrying out ex-situ biomethanation in a continuous trickle bed reactor.
Bioresource technology pii:S0960-8524(26)02386-2 [Epub ahead of print].
Biological methanation can convert industrial CO2 streams into renewable CH4 using H2. However, O2 can inhibit methanogenic archaea, and the long-term response of biofilm-based systems remains poorly understood. This study investigated the effects of long-term O2 exposure on hydrogenotrophic methanogenesis and the anaerobic microbiome in a thermophilic trickle-bed reactor operated for 217 days. Following O2-free enrichment, the biofilm was exposed sequentially to 1 % and 5 % O2 while process performance, vertical gas profiles, and microbial dynamics were monitored. Under O2-free conditions, H2 and CO2 conversions reached approximately 100 % and 95 %, respectively, with a CH4 production rate of 9.3 Nm[3] m[-3] d[-1]. During exposure to 1 % O2, O2 conversion averaged approximately 82 % and reached complete conversion late in the phase, while H2 and CO2 conversions averaged 77 % and 75 % and CH4 production averaged 6.9 Nm[3] m[-3] d[-1]. Increasing O2 to 5 % maintained high O2 conversion (89 %) but severely impaired biomethanation, with H2 and CO2 conversions frequently below 45 % and CH4 production falling to 3.1 Nm[3] m[-3] d[-1]. This decline coincided with a decrease in the relative abundance of Methanothermobacter to 30-48 %, although it remained dominant and increased relative abundances of the aerobic genera Thermoflavimicrobium, Chelativorans, and Mycobacterium across the biofilm. Multivariate analyses showed changes in microbial community composition associated with O2 exposure and declining CH4 production. Thus, long-term O2 exposure shifted the microbial community that sustained O2 conversion but with reduced methanogenic function.
Additional Links: PMID-43064212
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43064212,
year = {2026},
author = {Ali, R and Ashraf, MT and Yde, L},
title = {Effect of long-term oxygen exposure on anaerobic microbiome carrying out ex-situ biomethanation in a continuous trickle bed reactor.},
journal = {Bioresource technology},
volume = {},
number = {},
pages = {136304},
doi = {10.1016/j.biortech.2026.136304},
pmid = {43064212},
issn = {1873-2976},
abstract = {Biological methanation can convert industrial CO2 streams into renewable CH4 using H2. However, O2 can inhibit methanogenic archaea, and the long-term response of biofilm-based systems remains poorly understood. This study investigated the effects of long-term O2 exposure on hydrogenotrophic methanogenesis and the anaerobic microbiome in a thermophilic trickle-bed reactor operated for 217 days. Following O2-free enrichment, the biofilm was exposed sequentially to 1 % and 5 % O2 while process performance, vertical gas profiles, and microbial dynamics were monitored. Under O2-free conditions, H2 and CO2 conversions reached approximately 100 % and 95 %, respectively, with a CH4 production rate of 9.3 Nm[3] m[-3] d[-1]. During exposure to 1 % O2, O2 conversion averaged approximately 82 % and reached complete conversion late in the phase, while H2 and CO2 conversions averaged 77 % and 75 % and CH4 production averaged 6.9 Nm[3] m[-3] d[-1]. Increasing O2 to 5 % maintained high O2 conversion (89 %) but severely impaired biomethanation, with H2 and CO2 conversions frequently below 45 % and CH4 production falling to 3.1 Nm[3] m[-3] d[-1]. This decline coincided with a decrease in the relative abundance of Methanothermobacter to 30-48 %, although it remained dominant and increased relative abundances of the aerobic genera Thermoflavimicrobium, Chelativorans, and Mycobacterium across the biofilm. Multivariate analyses showed changes in microbial community composition associated with O2 exposure and declining CH4 production. Thus, long-term O2 exposure shifted the microbial community that sustained O2 conversion but with reduced methanogenic function.},
}
RevDate: 2026-11-20
Multiomics Approach to Regionally Profile Zinc-Driven Host-Gut Microbiome Interactions in the Intestinal Tract.
Cellular and molecular gastroenterology and hepatology pii:S2352-345X(26)00211-0 [Epub ahead of print].
BACKGROUND AND AIMS: Zinc (Zn) deficiency (ZnD) is a major risk factor for metabolic and inflammatory diseases associated with gut microbial alterations, including obesity, type 2 diabetes, and inflammatory bowel disease. Despite its importance, there are no established dietary recommendations for Zn supplementation in individuals with these conditions, except in cases of severe diarrhea in children. This gap stems from inconsistent outcomes in Zn supplementation trials, suggesting an incomplete understanding of Zn-mediated spatial regulation within the host-microbiome interface.
METHODS: Here, we employed a multi-omics approach to investigate Zn-driven host-gut microbial interactions along the intestinal tract of mice fed Zn-adequate (ZnA) or ZnD diets.
RESULTS: Radiotracing and metallomics analyses revealed region-specific Zn gradients across intestinal tissues and demonstrated reduced mucosal Zn levels in conventionalized compared with germ-free mice, highlighting an influence of microbial colonization on mucosal Zn availability. Transcriptomic analyses identified shared interferon-dominant immune activation in both the small intestine (SI) and the colon under ZnD conditions, accompanied by region-specific epithelial remodeling programs. In the SI, ZnD suppressed apical surface gene networks while inducing Paneth cell-associated antimicrobial responses. In contrast, ZnD colon exhibited suppression of apical junction and extracellular matrix (ECM) structural gene programs. Metagenomic profiling revealed reduced microbial diversity in the SI under ZnD, while the colon displayed enrichment of glycan-degrading taxa, including Hungatella hathewayi and Bacteroides ovatus, along with Clostridioides difficile, a glycan-responsive pathogen that benefits from microbial glycan degradation. Integrated host-microbe correlation and network analyses in the colon identified coordinated associations between ECM/cytoskeletal gene expression and glycosaminoglycan (GAG)-utilizing bacterial taxa. Functional annotation demonstrated enrichment of GAG-catabolic enzymes under ZnD conditions, with the strongest homology mapping to B. ovatus and H. hathewayi, and qPCR confirmed increased tissue-associated abundance of bacterial GAG-utilizing gene sequences alongside reduced host ECM gene expression.
CONCLUSIONS: Collectively, these findings demonstrate that Zn deficiency induces region-specific host epithelial and microbial adaptations, revealing a coordinated ECM-GAG-microbe axis in the colon and distinct epithelial remodeling programs along the intestinal tract.
Additional Links: PMID-43064302
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43064302,
year = {2026},
author = {S, S and Sb, M and A, G and Tl, T and Y, Y and A, L and Tb, A},
title = {Multiomics Approach to Regionally Profile Zinc-Driven Host-Gut Microbiome Interactions in the Intestinal Tract.},
journal = {Cellular and molecular gastroenterology and hepatology},
volume = {},
number = {},
pages = {101933},
doi = {10.1016/j.jcmgh.2026.101933},
pmid = {43064302},
issn = {2352-345X},
abstract = {BACKGROUND AND AIMS: Zinc (Zn) deficiency (ZnD) is a major risk factor for metabolic and inflammatory diseases associated with gut microbial alterations, including obesity, type 2 diabetes, and inflammatory bowel disease. Despite its importance, there are no established dietary recommendations for Zn supplementation in individuals with these conditions, except in cases of severe diarrhea in children. This gap stems from inconsistent outcomes in Zn supplementation trials, suggesting an incomplete understanding of Zn-mediated spatial regulation within the host-microbiome interface.
METHODS: Here, we employed a multi-omics approach to investigate Zn-driven host-gut microbial interactions along the intestinal tract of mice fed Zn-adequate (ZnA) or ZnD diets.
RESULTS: Radiotracing and metallomics analyses revealed region-specific Zn gradients across intestinal tissues and demonstrated reduced mucosal Zn levels in conventionalized compared with germ-free mice, highlighting an influence of microbial colonization on mucosal Zn availability. Transcriptomic analyses identified shared interferon-dominant immune activation in both the small intestine (SI) and the colon under ZnD conditions, accompanied by region-specific epithelial remodeling programs. In the SI, ZnD suppressed apical surface gene networks while inducing Paneth cell-associated antimicrobial responses. In contrast, ZnD colon exhibited suppression of apical junction and extracellular matrix (ECM) structural gene programs. Metagenomic profiling revealed reduced microbial diversity in the SI under ZnD, while the colon displayed enrichment of glycan-degrading taxa, including Hungatella hathewayi and Bacteroides ovatus, along with Clostridioides difficile, a glycan-responsive pathogen that benefits from microbial glycan degradation. Integrated host-microbe correlation and network analyses in the colon identified coordinated associations between ECM/cytoskeletal gene expression and glycosaminoglycan (GAG)-utilizing bacterial taxa. Functional annotation demonstrated enrichment of GAG-catabolic enzymes under ZnD conditions, with the strongest homology mapping to B. ovatus and H. hathewayi, and qPCR confirmed increased tissue-associated abundance of bacterial GAG-utilizing gene sequences alongside reduced host ECM gene expression.
CONCLUSIONS: Collectively, these findings demonstrate that Zn deficiency induces region-specific host epithelial and microbial adaptations, revealing a coordinated ECM-GAG-microbe axis in the colon and distinct epithelial remodeling programs along the intestinal tract.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Microbial ecology of marine rocky habitats: Current state and research trends.
Advances in marine biology, 105:315-337.
Rocky shores and shallow rocky reefs are foundational coastal ecosystems found across the globe. Microbial assemblages are fundamental for the ecology of these systems, but a synthesis spanning habitat types, taxa and research approaches is lacking. We systematically mapped the literature on microorganisms associated with coastal marine rocky habitats, identifying 136 studies (with one or more records each) published between 2005 and June 2026. Research increased markedly over the last six years, which accounted for 71 % of all studies. Most records originated from temperate regions, with China, the USA and Australia contributing more than one-third of all studies. Microbial research was concentrated on host-associated assemblages (68 % of records), particularly macroalgae, which accounted for 76 % of host-associated studies. Bacteria dominated the literature (82 % of records), whereas Archaea, fungi, microeukaryotes and especially viruses were rarely investigated. Amplicon sequencing was the most common analytical approach, with bacterial 16S rRNA gene sequencing comprising the majority of studies. Most records focused on taxonomic characterization of microbiota via field surveys, while functional assessments and direct experimental manipulations of microbiota were comparatively uncommon. Only 28 % of records examined responses of microbiota to environmental disturbances, with temperature-related stressors, nutrient enrichment and urbanization being the most frequently studied drivers. Collectively, these patterns reveal a rapidly expanding but predominantly descriptive field and highlight priorities for future research, including broader taxonomic coverage, increased functional and experimental approaches, and stronger integration of microorganisms into ecological studies of rocky coastal ecosystems.
Additional Links: PMID-43064424
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43064424,
year = {2026},
author = {Marzinelli, EM and Vadillo Gonzalez, S},
title = {Microbial ecology of marine rocky habitats: Current state and research trends.},
journal = {Advances in marine biology},
volume = {105},
number = {},
pages = {315-337},
doi = {10.1016/bs.amb.2026.08.006},
pmid = {43064424},
issn = {2162-5875},
mesh = {*Ecosystem ; *Microbiota ; Bacteria ; Seashore ; },
abstract = {Rocky shores and shallow rocky reefs are foundational coastal ecosystems found across the globe. Microbial assemblages are fundamental for the ecology of these systems, but a synthesis spanning habitat types, taxa and research approaches is lacking. We systematically mapped the literature on microorganisms associated with coastal marine rocky habitats, identifying 136 studies (with one or more records each) published between 2005 and June 2026. Research increased markedly over the last six years, which accounted for 71 % of all studies. Most records originated from temperate regions, with China, the USA and Australia contributing more than one-third of all studies. Microbial research was concentrated on host-associated assemblages (68 % of records), particularly macroalgae, which accounted for 76 % of host-associated studies. Bacteria dominated the literature (82 % of records), whereas Archaea, fungi, microeukaryotes and especially viruses were rarely investigated. Amplicon sequencing was the most common analytical approach, with bacterial 16S rRNA gene sequencing comprising the majority of studies. Most records focused on taxonomic characterization of microbiota via field surveys, while functional assessments and direct experimental manipulations of microbiota were comparatively uncommon. Only 28 % of records examined responses of microbiota to environmental disturbances, with temperature-related stressors, nutrient enrichment and urbanization being the most frequently studied drivers. Collectively, these patterns reveal a rapidly expanding but predominantly descriptive field and highlight priorities for future research, including broader taxonomic coverage, increased functional and experimental approaches, and stronger integration of microorganisms into ecological studies of rocky coastal ecosystems.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Ecosystem
*Microbiota
Bacteria
Seashore
RevDate: 2026-11-20
CmpDate: 2026-11-20
Shrubification Has Limited Effects on Prokaryotic Communities in Northern Permafrost Regions.
Environmental microbiology, 28(11):.
The northern landscape is greening due to climate change. Yet, little is known about the effect of increasingly more abundant erect shrubs on Arctic soil microbial communities, which play a crucial role in climate feedback. Soil samples were collected from soil pits with and without erect shrubs at a sub-Arctic (Umiujaq, Quebec) and Arctic (Bylot Island, Nunavut) site in Canada. These samples were analysed for carbon density, nitrogen density, bulk density and pH, while the soil microbiome was studied using 16S rRNA metabarcoding. Both alpha and beta diversity were lower at the Arctic site compared to the sub-Arctic site, while heterogeneous selection pressures had a greater influence on Arctic microbial community assembly processes. Additionally, soil depth and properties played a critical role in shaping the microbial communities, suggesting that both broad-scale geographic factors and small-scale environmental heterogeneity drive the microbiome composition and structure. Shrubs had a weak effect on microbial diversity, through their effect on soil pH. Moreover, the shrub effect varied with soil depth in the sub-Arctic, likely due to the podzolic soils there. However, additional research is needed to understand the functions of this diverse microbial community and its role in climate feedback as the Arctic changes.
Additional Links: PMID-43064502
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43064502,
year = {2026},
author = {Ola, A and Leroy, M and Jacquemot, L and Domine, F and Fortier, D and Comte, J},
title = {Shrubification Has Limited Effects on Prokaryotic Communities in Northern Permafrost Regions.},
journal = {Environmental microbiology},
volume = {28},
number = {11},
pages = {},
doi = {10.1111/1462-2920.70497},
pmid = {43064502},
issn = {1462-2920},
support = {#RGPIN-2018-03941//Natural Sciences and Engineering Research Council of Canada/ ; #RGPIN-2020-06874//Natural Sciences and Engineering Research Council of Canada/ ; //Sentinelle Nord, Université Laval/ ; #1042//Institut Polaire Français Paul Emile Victor/ ; },
mesh = {*Soil Microbiology ; *Permafrost/microbiology ; Arctic Regions ; RNA, Ribosomal, 16S/genetics ; *Microbiota ; *Bacteria/classification/genetics/isolation & purification ; Soil/chemistry ; Climate Change ; Quebec ; Hydrogen-Ion Concentration ; Nitrogen/analysis ; Carbon/analysis ; Nunavut ; Biodiversity ; *Archaea/classification/genetics/isolation & purification ; },
abstract = {The northern landscape is greening due to climate change. Yet, little is known about the effect of increasingly more abundant erect shrubs on Arctic soil microbial communities, which play a crucial role in climate feedback. Soil samples were collected from soil pits with and without erect shrubs at a sub-Arctic (Umiujaq, Quebec) and Arctic (Bylot Island, Nunavut) site in Canada. These samples were analysed for carbon density, nitrogen density, bulk density and pH, while the soil microbiome was studied using 16S rRNA metabarcoding. Both alpha and beta diversity were lower at the Arctic site compared to the sub-Arctic site, while heterogeneous selection pressures had a greater influence on Arctic microbial community assembly processes. Additionally, soil depth and properties played a critical role in shaping the microbial communities, suggesting that both broad-scale geographic factors and small-scale environmental heterogeneity drive the microbiome composition and structure. Shrubs had a weak effect on microbial diversity, through their effect on soil pH. Moreover, the shrub effect varied with soil depth in the sub-Arctic, likely due to the podzolic soils there. However, additional research is needed to understand the functions of this diverse microbial community and its role in climate feedback as the Arctic changes.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Soil Microbiology
*Permafrost/microbiology
Arctic Regions
RNA, Ribosomal, 16S/genetics
*Microbiota
*Bacteria/classification/genetics/isolation & purification
Soil/chemistry
Climate Change
Quebec
Hydrogen-Ion Concentration
Nitrogen/analysis
Carbon/analysis
Nunavut
Biodiversity
*Archaea/classification/genetics/isolation & purification
RevDate: 2026-11-20
Inside the gut microbiome of manatees.
Nature microbiology [Epub ahead of print].
Additional Links: PMID-43064805
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43064805,
year = {2026},
author = {},
title = {Inside the gut microbiome of manatees.},
journal = {Nature microbiology},
volume = {},
number = {},
pages = {},
pmid = {43064805},
issn = {2058-5276},
}
RevDate: 2026-11-21
CmpDate: 2026-11-21
Adaptive Bayesian transfer learning under compositional generalized linear mixed model for microbiome data analysis.
BMC medical research methodology, 26(1):.
BACKGROUND: With the development of high-throughput sequencing technologies, microbiome data play an increasingly important role in pathological analysis and disease prediction. However, microbiome data are typically characterized by high dimensionality, small sample sizes, and compositional constraints, which present challenges to conventional statistical methods, particularly in studies of specific diseases with limited sample sizes.
METHODS: Motivated by these challenges, this paper develops an adaptive Bayesian transfer learning framework built upon the Bayesian Compositional Generalized Linear Mixed Model (BCGLMM). The proposed framework integrates a power-prior-based adaptive Bayesian transfer learning with BCGLMM, which enables information borrowing from a related source dataset while accounting for compositional constraints, phylogenetic relatedness among taxa, and dependence among samples in high-dimensional microbiome data. By adopting an adaptive transfer parameter, the framework can adjust the contribution of source information according to the compatibility between the source and target datasets, thereby improving robustness and reducing the risk of negative transfer.
RESULTS: Systematic simulation studies show that the proposed Bayesian transfer learning methods generally achieve better predictive performance than target-only, pooled, and existing transfer-learning competitors, especially when the target sample size is limited and related source data are available. Compared with the fixed-transfer method, Adaptive BTL-CGLMM maintains more stable performance under increasing source-target discrepancy, different dimensions, varying sample sizes, and heterogeneous covariance structures. Real gut microbiome applications, including body mass index (BMI) prediction, type 2 diabetes (T2D) diagnosis, and colorectal cancer (CRC) diagnosis, further demonstrate that the proposed methods improve prediction by borrowing useful auxiliary information from related source datasets. The microbial taxa identified by Adaptive BTL-CGLMM are also consistent with existing biological findings, supporting the interpretability of the proposed framework.
CONCLUSION: This study provides an adaptive Bayesian transfer learning framework for high-dimensional microbiome data analysis with limited target sample sizes. By enabling knowledge transfer under compositional constraints, the proposed method improves predictive performance and robustness across varying data settings, thereby enhancing phenotype prediction and disease diagnosis in small-sample microbiome studies.
Additional Links: PMID-43064939
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43064939,
year = {2026},
author = {Luo, X and Hu, Q},
title = {Adaptive Bayesian transfer learning under compositional generalized linear mixed model for microbiome data analysis.},
journal = {BMC medical research methodology},
volume = {26},
number = {1},
pages = {},
pmid = {43064939},
issn = {1471-2288},
support = {Grant ZR2022MA065//Shandong Provincial Natural Science Foundation/ ; Grant ZR2022MA065//Shandong Provincial Natural Science Foundation/ ; },
mesh = {Bayes Theorem ; Humans ; *Microbiota/genetics ; Linear Models ; Computer Simulation ; Algorithms ; Adaptive Algorithms ; },
abstract = {BACKGROUND: With the development of high-throughput sequencing technologies, microbiome data play an increasingly important role in pathological analysis and disease prediction. However, microbiome data are typically characterized by high dimensionality, small sample sizes, and compositional constraints, which present challenges to conventional statistical methods, particularly in studies of specific diseases with limited sample sizes.
METHODS: Motivated by these challenges, this paper develops an adaptive Bayesian transfer learning framework built upon the Bayesian Compositional Generalized Linear Mixed Model (BCGLMM). The proposed framework integrates a power-prior-based adaptive Bayesian transfer learning with BCGLMM, which enables information borrowing from a related source dataset while accounting for compositional constraints, phylogenetic relatedness among taxa, and dependence among samples in high-dimensional microbiome data. By adopting an adaptive transfer parameter, the framework can adjust the contribution of source information according to the compatibility between the source and target datasets, thereby improving robustness and reducing the risk of negative transfer.
RESULTS: Systematic simulation studies show that the proposed Bayesian transfer learning methods generally achieve better predictive performance than target-only, pooled, and existing transfer-learning competitors, especially when the target sample size is limited and related source data are available. Compared with the fixed-transfer method, Adaptive BTL-CGLMM maintains more stable performance under increasing source-target discrepancy, different dimensions, varying sample sizes, and heterogeneous covariance structures. Real gut microbiome applications, including body mass index (BMI) prediction, type 2 diabetes (T2D) diagnosis, and colorectal cancer (CRC) diagnosis, further demonstrate that the proposed methods improve prediction by borrowing useful auxiliary information from related source datasets. The microbial taxa identified by Adaptive BTL-CGLMM are also consistent with existing biological findings, supporting the interpretability of the proposed framework.
CONCLUSION: This study provides an adaptive Bayesian transfer learning framework for high-dimensional microbiome data analysis with limited target sample sizes. By enabling knowledge transfer under compositional constraints, the proposed method improves predictive performance and robustness across varying data settings, thereby enhancing phenotype prediction and disease diagnosis in small-sample microbiome studies.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Bayes Theorem
Humans
*Microbiota/genetics
Linear Models
Computer Simulation
Algorithms
Adaptive Algorithms
RevDate: 2026-11-21
CmpDate: 2026-11-21
The gut microbiota: a key modulator of radiotherapy efficacy and toxicity in colorectal cancer.
Journal of translational medicine, 24(1):.
The gut microbiota plays a critical role in modulating both the efficacy and toxicity of radiotherapy in patients with colorectal cancer (CRC). This review synthesizes current evidence on the bidirectional interaction between the gut microbiome and radiotherapy, highlighting the mechanisms through which microbial communities influence radiosensitivity and treatment-related adverse effects. Specific microbiota-derived metabolites, such as short-chain fatty acids and methylglyoxal, can enhance the radiotherapeutic response by exacerbating DNA damage, promoting immunogenic cell death, and activating antitumor immunity. Conversely, dysbiosis may contribute to radioresistance and exacerbate radiation-induced enteritis by impairing intestinal barrier function and amplifying inflammatory responses. Therapeutic strategies targeting the gut microbiome-including probiotics, prebiotics, antibiotics, and fecal microbiota transplantation-show promise in improving radiotherapy outcomes and mitigating toxicity. However, its clinical application remains limited by issues of safety, variability in individual microbiome composition, and lack of standardized protocols. Further high-quality clinical trials are essential to validate these interventions and advance personalized microbial modulation approaches in CRC radiotherapy.
Additional Links: PMID-43065020
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43065020,
year = {2026},
author = {He, X and Yu, Y and Wang, N and Ma, S and Zhang, Y and Fang, Z and Yang, Y and Zhang, W and Yu, G},
title = {The gut microbiota: a key modulator of radiotherapy efficacy and toxicity in colorectal cancer.},
journal = {Journal of translational medicine},
volume = {24},
number = {1},
pages = {},
pmid = {43065020},
issn = {1479-5876},
mesh = {Humans ; *Colorectal Neoplasms/radiotherapy/microbiology ; *Gastrointestinal Microbiome/radiation effects ; Treatment Outcome ; Animals ; Fecal Microbiota Transplantation ; },
abstract = {The gut microbiota plays a critical role in modulating both the efficacy and toxicity of radiotherapy in patients with colorectal cancer (CRC). This review synthesizes current evidence on the bidirectional interaction between the gut microbiome and radiotherapy, highlighting the mechanisms through which microbial communities influence radiosensitivity and treatment-related adverse effects. Specific microbiota-derived metabolites, such as short-chain fatty acids and methylglyoxal, can enhance the radiotherapeutic response by exacerbating DNA damage, promoting immunogenic cell death, and activating antitumor immunity. Conversely, dysbiosis may contribute to radioresistance and exacerbate radiation-induced enteritis by impairing intestinal barrier function and amplifying inflammatory responses. Therapeutic strategies targeting the gut microbiome-including probiotics, prebiotics, antibiotics, and fecal microbiota transplantation-show promise in improving radiotherapy outcomes and mitigating toxicity. However, its clinical application remains limited by issues of safety, variability in individual microbiome composition, and lack of standardized protocols. Further high-quality clinical trials are essential to validate these interventions and advance personalized microbial modulation approaches in CRC radiotherapy.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Colorectal Neoplasms/radiotherapy/microbiology
*Gastrointestinal Microbiome/radiation effects
Treatment Outcome
Animals
Fecal Microbiota Transplantation
RevDate: 2026-11-19
CmpDate: 2026-11-19
Galactooligosaccharides drive dose-dependent improvements in child gut microbiome, metabolome and barrier function ex vivo.
Frontiers in nutrition, 13:1874394.
BACKGROUND: Galactooligosaccharides (GOS) are well-established prebiotic fibers, yet dose-response relationships and functional effects on children's microbiota remain incompletely characterized.
METHODS: Using the predictive ex vivo SIFR[®] technology platform (systemic intestinal fermentation research), this study assessed the dose-dependent effects of GOS (1.25, 2.5 and 5 g/day equivalents) on the gut microbiome of children from two different age groups (3-6 years and 6-12 years, n = 6 × 2). Shifts in microbial composition were evaluated via shallow shotgun metagenomic sequencing coupled with flow cytometry, metabolite production was evaluated through GC-FID and LC-MS/MS, while effects on epithelial barrier integrity were studied by measuring transepithelial electrical resistance (TEER) in a Caco-2/THP-1 co-culture model.
RESULTS: GOS induced pronounced, dose-dependent bifidogenic effects and significantly increased other beneficial microbial taxa, including butyrate-producing Lachnospiraceae and Ruminococcaceae members, in both age groups. These compositional shifts were accompanied by elevated SCFA levels (acetate, propionate, butyrate), with significant effects already observed at the lowest dose (1.25 g/day), while gas formation increased proportionally less, resulting in a lower gas-to-SCFA ratio. Untargeted metabolomics revealed stimulation of additional microbial metabolites, including N-acetylated amino acids, agmatine and polyamines along with tryptophan-derived indoles and p-hydroxyphenyllactic acid, many of which were already significantly increased at lower GOS doses. Importantly, fermented GOS markedly supported gut barrier integrity, a hallmark of gut health, reflected by increased TEER values under both normal and LPS-induced inflammatory conditions, with significant improvements evident from the lowest dose onward. Overall, the effects on microbiome composition, metabolite production and gut barrier integrity were highly comparable between younger and older children.
CONCLUSIONS: Ex vivo GOS supplementation drove consistent, dose-dependent improvements in the child gut microbiome, microbial metabolic activity and gut barrier function. The efficacy already observed at low doses highlights GOS as a promising nutritional strategy to potentially support gut health in children aged 3-12 years.
Additional Links: PMID-43054846
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43054846,
year = {2026},
author = {De Beul, E and Vu, LD and De Buck, V and Van den Abbeele, P and van Hengel, IAJ and Looijesteijn, E and Delsing, DJ},
title = {Galactooligosaccharides drive dose-dependent improvements in child gut microbiome, metabolome and barrier function ex vivo.},
journal = {Frontiers in nutrition},
volume = {13},
number = {},
pages = {1874394},
pmid = {43054846},
issn = {2296-861X},
abstract = {BACKGROUND: Galactooligosaccharides (GOS) are well-established prebiotic fibers, yet dose-response relationships and functional effects on children's microbiota remain incompletely characterized.
METHODS: Using the predictive ex vivo SIFR[®] technology platform (systemic intestinal fermentation research), this study assessed the dose-dependent effects of GOS (1.25, 2.5 and 5 g/day equivalents) on the gut microbiome of children from two different age groups (3-6 years and 6-12 years, n = 6 × 2). Shifts in microbial composition were evaluated via shallow shotgun metagenomic sequencing coupled with flow cytometry, metabolite production was evaluated through GC-FID and LC-MS/MS, while effects on epithelial barrier integrity were studied by measuring transepithelial electrical resistance (TEER) in a Caco-2/THP-1 co-culture model.
RESULTS: GOS induced pronounced, dose-dependent bifidogenic effects and significantly increased other beneficial microbial taxa, including butyrate-producing Lachnospiraceae and Ruminococcaceae members, in both age groups. These compositional shifts were accompanied by elevated SCFA levels (acetate, propionate, butyrate), with significant effects already observed at the lowest dose (1.25 g/day), while gas formation increased proportionally less, resulting in a lower gas-to-SCFA ratio. Untargeted metabolomics revealed stimulation of additional microbial metabolites, including N-acetylated amino acids, agmatine and polyamines along with tryptophan-derived indoles and p-hydroxyphenyllactic acid, many of which were already significantly increased at lower GOS doses. Importantly, fermented GOS markedly supported gut barrier integrity, a hallmark of gut health, reflected by increased TEER values under both normal and LPS-induced inflammatory conditions, with significant improvements evident from the lowest dose onward. Overall, the effects on microbiome composition, metabolite production and gut barrier integrity were highly comparable between younger and older children.
CONCLUSIONS: Ex vivo GOS supplementation drove consistent, dose-dependent improvements in the child gut microbiome, microbial metabolic activity and gut barrier function. The efficacy already observed at low doses highlights GOS as a promising nutritional strategy to potentially support gut health in children aged 3-12 years.},
}
RevDate: 2026-11-20
A decade-scale audit of microbiome AI-readiness.
A systematic, PRISMA-guided review led by our consortium screened 23,781 human microbiome papers and procured 2896 studies published from 2012 to 2025 that were then scored by reviewers into four Biological Host-Associated AI-Ready Metadata (BHAM) tiers. Only 5.9% of studies deposited sequence data with per-sample host disease status, age, and sex, and 63.1% shared no reusable sequence data, so that 85.5% of roughly 720,000 samples cannot be reused for cross-cohort or artificial intelligence (AI) analyses without contacting the authors. Sequence deposition improved modestly over time, whereas per-sample annotation did not. Journals, repositories, and researchers should require structured, machine-readable metadata at submission, supported by AI-assisted curation.
Additional Links: PMID-43054892
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43054892,
year = {2026},
author = {Degregori, S and Huang, I and Fetcinko, LH and Martel, H and Kisselev, D and Gu, H and Kobobel, DG and Song, E and Reyes, AG and Suy, MT and Nguyen, K and Hampton, AJ and Anderson, J and Prakash, M and Bohrer, J and Franco, NM and Vudatha, R and Sofia, C and Lu, W and Zepeda, NA and Balkanli, EM and Xu, L and Li, Y and Sicat, C and Sinha, A and Sicat, A and Fan, Y and Tran, K and Yang, V and Xie, Y and Hall, Z and Khadye, S and Li, K and Malleboyina, S and Weng, Y and Iter, M and Pessemier, B and Kirkland, J and Patel, L and Ambre, M and Ackermann, G and González, A and McDonald, D and Birmingham, A and Ventura, EF and Wright, S and Kelliher, J and , and Mehta, S and Gilbert, J and Mungall, CJ and Dorrestein, PC and Suzuki, TA and Eloe-Fadrosh, EA and Knight, R},
title = {A decade-scale audit of microbiome AI-readiness.},
journal = {iMeta},
volume = {},
number = {},
pages = {e70192},
pmid = {43054892},
issn = {2770-596X},
support = {F30 AG094275/AG/NIA NIH HHS/United States ; R35 GM160076/GM/NIGMS NIH HHS/United States ; T32 GM007198/GM/NIGMS NIH HHS/United States ; },
abstract = {A systematic, PRISMA-guided review led by our consortium screened 23,781 human microbiome papers and procured 2896 studies published from 2012 to 2025 that were then scored by reviewers into four Biological Host-Associated AI-Ready Metadata (BHAM) tiers. Only 5.9% of studies deposited sequence data with per-sample host disease status, age, and sex, and 63.1% shared no reusable sequence data, so that 85.5% of roughly 720,000 samples cannot be reused for cross-cohort or artificial intelligence (AI) analyses without contacting the authors. Sequence deposition improved modestly over time, whereas per-sample annotation did not. Journals, repositories, and researchers should require structured, machine-readable metadata at submission, supported by AI-assisted curation.},
}
RevDate: 2026-11-19
CmpDate: 2026-11-19
Classical and mediterranean-modified ketogenic diets distinctly shape the gut microbiota composition and function in scopolamine-induced cognitive impairment model.
Frontiers in microbiology, 17:1968751.
BACKGROUND: Mild cognitive impairment (MCI) is associated with impaired cerebral glucose metabolism, and ketogenic diets may influence cognitive impairment (CI) via the gut-brain axis. We investigated whether classical ketogenic (KD) and Mediterranean-modified ketogenic diet (MMKD) differentially affect gut microbiome composition and function, as well as cognitive performance, in a rat model of scopolamine-induced CI.
METHODS: Twenty-eight male Wistar rats were assigned to a cognitively normal control group (CN), a scopolamine-induced CI group (SCOP) on standard diet, and two scopolamine-treated groups receiving either a classical KD (KD; 84% fat, 16% protein) or a MMKD (60% fat, predominantly olive oil, 30% protein, 10% carbohydrate, resveratrol, and inulin-supplemented) for 9 weeks. Spatial and recognition memory were assessed using the Morris Water Maze and Novel Object Recognition Test. Caecal microbiome composition and function were profiled by shotgun metagenomic sequencing. Short-chain fatty acid (SCFA) analysis was conducted from caecal contents of rats. Brain and hippocampal brain derived neurotrophic factor (BDNF) and phosphorylated cyclic AMP response element-binding (p-CREB) protein levels were evaluated by Western blotting.
RESULTS: MMKD significantly improved spatial memory relative to other groups. MMKD had higher alpha diversity in the gut microbiome compared to the KD group. KD showed the most distinct gut microbiome profile, marked by enrichment of Bacteroides and Parabacteroides species and reduced carbohydrate and amino acid metabolism. MMKD was characterized by enrichment of lactic acid bacteria with elevated coenzyme A and pyrimidine biosynthesis. Moreover, MMKD was associated with higher SCFA levels compared to the KD group. No significant differences in brain or hippocampal BDNF or p-CREB protein levels were observed among groups.
CONCLUSION: These findings show that KD and MMKD produce distinct gut microbiome compositional and functional signatures, with MMKD associated with higher microbial diversity, SCFA levels, and spatial learning performance.
Additional Links: PMID-43054893
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43054893,
year = {2026},
author = {Ayten, Ş and Koc, F and Patangia, D and Stanton, C and Ross, RP and Kayabaşı, B and Dincer, S and Saglam, ASY and Bilici, S},
title = {Classical and mediterranean-modified ketogenic diets distinctly shape the gut microbiota composition and function in scopolamine-induced cognitive impairment model.},
journal = {Frontiers in microbiology},
volume = {17},
number = {},
pages = {1968751},
pmid = {43054893},
issn = {1664-302X},
abstract = {BACKGROUND: Mild cognitive impairment (MCI) is associated with impaired cerebral glucose metabolism, and ketogenic diets may influence cognitive impairment (CI) via the gut-brain axis. We investigated whether classical ketogenic (KD) and Mediterranean-modified ketogenic diet (MMKD) differentially affect gut microbiome composition and function, as well as cognitive performance, in a rat model of scopolamine-induced CI.
METHODS: Twenty-eight male Wistar rats were assigned to a cognitively normal control group (CN), a scopolamine-induced CI group (SCOP) on standard diet, and two scopolamine-treated groups receiving either a classical KD (KD; 84% fat, 16% protein) or a MMKD (60% fat, predominantly olive oil, 30% protein, 10% carbohydrate, resveratrol, and inulin-supplemented) for 9 weeks. Spatial and recognition memory were assessed using the Morris Water Maze and Novel Object Recognition Test. Caecal microbiome composition and function were profiled by shotgun metagenomic sequencing. Short-chain fatty acid (SCFA) analysis was conducted from caecal contents of rats. Brain and hippocampal brain derived neurotrophic factor (BDNF) and phosphorylated cyclic AMP response element-binding (p-CREB) protein levels were evaluated by Western blotting.
RESULTS: MMKD significantly improved spatial memory relative to other groups. MMKD had higher alpha diversity in the gut microbiome compared to the KD group. KD showed the most distinct gut microbiome profile, marked by enrichment of Bacteroides and Parabacteroides species and reduced carbohydrate and amino acid metabolism. MMKD was characterized by enrichment of lactic acid bacteria with elevated coenzyme A and pyrimidine biosynthesis. Moreover, MMKD was associated with higher SCFA levels compared to the KD group. No significant differences in brain or hippocampal BDNF or p-CREB protein levels were observed among groups.
CONCLUSION: These findings show that KD and MMKD produce distinct gut microbiome compositional and functional signatures, with MMKD associated with higher microbial diversity, SCFA levels, and spatial learning performance.},
}
RevDate: 2026-11-19
CmpDate: 2026-11-19
Gut microbiota responses to aerobic exercise training are intensity-dependent and associated with individual improvements in V . O 2 max.
Frontiers in microbiology, 17:1981808.
BACKGROUND: Exercise intensity is a key determinant of physiological adaptations to training, yet its influence on the gut microbiota remains poorly understood. Furthermore, considerable interindividual variability in aerobic training adaptations exists, but factors associated with this variability are still unclear. We investigated how six weeks of cycling in the moderate, heavy, and severe exercise intensity domains influenced V . O 2 max and the gut microbiota in healthy adults.
METHODS: Sixty-five healthy young adults were randomized to one of five cycling intervention groups according to exercise intensity domains (MOD: n = 11; HVY1: n = 10; HVY2: n = 13; HIIT: n = 11; SIT: n = 12), or a non-intervention control group (CON: n = 8). For analysis, groups were combined at the domain level into moderate (MOD: n = 11), heavy (HVY; HVY1 + HVY2: n = 23), and severe (SVR; HIIT + SIT: n = 23). All groups except SIT were work matched. Participants performed 3 training sessions weekly for 6 weeks. Stool samples, serum, and a 3-day dietary food log were collected before (PRE) and after (POST) the 6-week intervention.
RESULTS: HVY and SVR exercise significantly increased V . O 2 max and gut microbiota alpha diversity, whereas changes in the MOD group were not statistically significant. Participants with larger improvements in V . O 2 max (responders) exhibited distinct gut microbiota profiles differing from those with limited improvements (non-responders), and proxy markers of gut permeability and inflammation further distinguished non-responders. Holdemanella was consistently associated with non-response and was the primary discriminating feature in a decision-tree classification model.
CONCLUSION: Six weeks of HVY and SVR intensity cycling was associated with improvements in V . O 2 max and detectable changes in the gut microbiota under the conditions of this intervention; the dose-response relationship and any physiological threshold remain to be determined. Distinct gut microbiota profiles were associated with the magnitude of improvement in V . O 2 max across intensity domains, raising the possibility that the gut microbiota contributes to interindividual differences in aerobic training response.
Additional Links: PMID-43054902
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43054902,
year = {2026},
author = {Sales, KM and Schlechte, J and Inglis, EC and Wang, W and Cho, NA and Lowry, DE and MacInnis, MJ and Murias, JM and Reimer, RA},
title = {Gut microbiota responses to aerobic exercise training are intensity-dependent and associated with individual improvements in V . O 2 max.},
journal = {Frontiers in microbiology},
volume = {17},
number = {},
pages = {1981808},
pmid = {43054902},
issn = {1664-302X},
abstract = {BACKGROUND: Exercise intensity is a key determinant of physiological adaptations to training, yet its influence on the gut microbiota remains poorly understood. Furthermore, considerable interindividual variability in aerobic training adaptations exists, but factors associated with this variability are still unclear. We investigated how six weeks of cycling in the moderate, heavy, and severe exercise intensity domains influenced V . O 2 max and the gut microbiota in healthy adults.
METHODS: Sixty-five healthy young adults were randomized to one of five cycling intervention groups according to exercise intensity domains (MOD: n = 11; HVY1: n = 10; HVY2: n = 13; HIIT: n = 11; SIT: n = 12), or a non-intervention control group (CON: n = 8). For analysis, groups were combined at the domain level into moderate (MOD: n = 11), heavy (HVY; HVY1 + HVY2: n = 23), and severe (SVR; HIIT + SIT: n = 23). All groups except SIT were work matched. Participants performed 3 training sessions weekly for 6 weeks. Stool samples, serum, and a 3-day dietary food log were collected before (PRE) and after (POST) the 6-week intervention.
RESULTS: HVY and SVR exercise significantly increased V . O 2 max and gut microbiota alpha diversity, whereas changes in the MOD group were not statistically significant. Participants with larger improvements in V . O 2 max (responders) exhibited distinct gut microbiota profiles differing from those with limited improvements (non-responders), and proxy markers of gut permeability and inflammation further distinguished non-responders. Holdemanella was consistently associated with non-response and was the primary discriminating feature in a decision-tree classification model.
CONCLUSION: Six weeks of HVY and SVR intensity cycling was associated with improvements in V . O 2 max and detectable changes in the gut microbiota under the conditions of this intervention; the dose-response relationship and any physiological threshold remain to be determined. Distinct gut microbiota profiles were associated with the magnitude of improvement in V . O 2 max across intensity domains, raising the possibility that the gut microbiota contributes to interindividual differences in aerobic training response.},
}
RevDate: 2026-11-19
Microbial β-glucuronidase is associated with variations in clozapine serum levels in patients with treatment-resistant schizophrenia.
Journal of psychopharmacology (Oxford, England) [Epub ahead of print].
BACKGROUND: Clozapine is the most effective treatment for people with treatment-resistant schizophrenia (TRS). However, clozapine blood levels vary up to 15-fold across patients, and known determinants (cytochrome P450 modulation, smoking, demographics) explain only part of this variability. Identifying additional factors could help lower toxicity risk, reduce reliance on intensive therapeutic drug monitoring, and widen access to an effective treatment. We evaluated whether gut microbial β-glucuronidase was associated with clozapine serum concentration-to-dose (C/D) ratio, hypothesising that intestinal bacterial deconjugation of N-glucuronidated clozapine enables its re-absorption through the enterohepatic circulation.
METHODS: We conducted a secondary analysis of a cross-sectional cohort of adults with TRS on stable clozapine treatment who provided paired blood and stool samples (N = 46). Shotgun metagenomic data were processed to quantify microbial β-glucuronidase (KEGG ortholog K01195). Ordinary least squares regression tested the association between β-glucuronidase abundance and clozapine C/D ratio, unadjusted and adjusted for sex, smoking, ethnicity, stool type, constipation, diet, body mass index, age, total antipsychotic dose, and blood-to-stool sample interval.
RESULTS: Microbial β-glucuronidase was positively associated with clozapine C/D ratio in the unadjusted model (β = 0.145, 95% CI [0.001, 0.288]; p = 0.048, adjusted R[2] = 0.07). This association strengthened after adjustment (β = 0.236, 95% CI [0.084, 0.388], p = 0.004, adjusted R[2] = 0.25, full covariate model), corresponding to a 26.65% higher C/D ratio per unit increase. β-glucuronidase was not associated with gastrointestinal symptoms (p = 0.235, unadjusted).
CONCLUSIONS: These findings provide the first evidence that a specific gut microbial enzyme can modulate clozapine exposure in patients. If confirmed in independent cohorts, these findings can pave the way for microbiome-based precision dosing in psychiatry.
Additional Links: PMID-43055085
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43055085,
year = {2026},
author = {Vasileva, SS and Eyles, D and Gratten, J and Siskind, D and Baker, A and McCutcheon, R and McGuire, P and Burnet, PWJ and Lennox, BR and Minichino, A},
title = {Microbial β-glucuronidase is associated with variations in clozapine serum levels in patients with treatment-resistant schizophrenia.},
journal = {Journal of psychopharmacology (Oxford, England)},
volume = {},
number = {},
pages = {2698811261504421},
doi = {10.1177/02698811261504421},
pmid = {43055085},
issn = {1461-7285},
abstract = {BACKGROUND: Clozapine is the most effective treatment for people with treatment-resistant schizophrenia (TRS). However, clozapine blood levels vary up to 15-fold across patients, and known determinants (cytochrome P450 modulation, smoking, demographics) explain only part of this variability. Identifying additional factors could help lower toxicity risk, reduce reliance on intensive therapeutic drug monitoring, and widen access to an effective treatment. We evaluated whether gut microbial β-glucuronidase was associated with clozapine serum concentration-to-dose (C/D) ratio, hypothesising that intestinal bacterial deconjugation of N-glucuronidated clozapine enables its re-absorption through the enterohepatic circulation.
METHODS: We conducted a secondary analysis of a cross-sectional cohort of adults with TRS on stable clozapine treatment who provided paired blood and stool samples (N = 46). Shotgun metagenomic data were processed to quantify microbial β-glucuronidase (KEGG ortholog K01195). Ordinary least squares regression tested the association between β-glucuronidase abundance and clozapine C/D ratio, unadjusted and adjusted for sex, smoking, ethnicity, stool type, constipation, diet, body mass index, age, total antipsychotic dose, and blood-to-stool sample interval.
RESULTS: Microbial β-glucuronidase was positively associated with clozapine C/D ratio in the unadjusted model (β = 0.145, 95% CI [0.001, 0.288]; p = 0.048, adjusted R[2] = 0.07). This association strengthened after adjustment (β = 0.236, 95% CI [0.084, 0.388], p = 0.004, adjusted R[2] = 0.25, full covariate model), corresponding to a 26.65% higher C/D ratio per unit increase. β-glucuronidase was not associated with gastrointestinal symptoms (p = 0.235, unadjusted).
CONCLUSIONS: These findings provide the first evidence that a specific gut microbial enzyme can modulate clozapine exposure in patients. If confirmed in independent cohorts, these findings can pave the way for microbiome-based precision dosing in psychiatry.},
}
RevDate: 2026-11-19
CmpDate: 2026-11-19
Fecal microbiota transplantation in cancer immunotherapy: targeting the Gut-Tumor Axis.
Gut microbes, 18(1):2765047.
Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, but resistance and immune-related toxicities continue to limit their benefit. Fecal microbiota transplantation (FMT) may enhance ICI efficacy and alleviate treatment-related intestinal toxicity, yet clinical responses remain inconsistent, and microbiome remodeling does not reliably predict benefit. Moreover, clinical, ecological, and mechanistic evidence remains fragmented and has not been critically integrated. This review therefore evaluates the current clinical evidence for FMT in cancer immunotherapy and examines how donor-recipient interactions, microbial engraftment and function, host immunity, and tumor context jointly shape efficacy and toxicity. We organize these mechanisms within the Gut-Tumor Axis, encompassing microbial metabolites and cellular components, cross-organ immune signaling, and intratumoral microbiota. Finally, we discuss how multi-omics and computational modeling may enable more predictable and precise microbiome interventions.
Additional Links: PMID-43055220
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43055220,
year = {2026},
author = {Yu, Y and Xu, C and Hua, Y and Yang, F and Xie, S and Zhong, L and Wang, J and Zhang, W and Wang, Y and Li, H and Chen, K and Zhou, Z and Xia, S},
title = {Fecal microbiota transplantation in cancer immunotherapy: targeting the Gut-Tumor Axis.},
journal = {Gut microbes},
volume = {18},
number = {1},
pages = {2765047},
doi = {10.1080/19490976.2026.2765047},
pmid = {43055220},
issn = {1949-0984},
mesh = {*Fecal Microbiota Transplantation/methods ; Humans ; *Immunotherapy/methods ; *Neoplasms/therapy/immunology/microbiology ; *Gastrointestinal Microbiome ; Animals ; Immune Checkpoint Inhibitors/therapeutic use ; },
abstract = {Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, but resistance and immune-related toxicities continue to limit their benefit. Fecal microbiota transplantation (FMT) may enhance ICI efficacy and alleviate treatment-related intestinal toxicity, yet clinical responses remain inconsistent, and microbiome remodeling does not reliably predict benefit. Moreover, clinical, ecological, and mechanistic evidence remains fragmented and has not been critically integrated. This review therefore evaluates the current clinical evidence for FMT in cancer immunotherapy and examines how donor-recipient interactions, microbial engraftment and function, host immunity, and tumor context jointly shape efficacy and toxicity. We organize these mechanisms within the Gut-Tumor Axis, encompassing microbial metabolites and cellular components, cross-organ immune signaling, and intratumoral microbiota. Finally, we discuss how multi-omics and computational modeling may enable more predictable and precise microbiome interventions.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Fecal Microbiota Transplantation/methods
Humans
*Immunotherapy/methods
*Neoplasms/therapy/immunology/microbiology
*Gastrointestinal Microbiome
Animals
Immune Checkpoint Inhibitors/therapeutic use
RevDate: 2026-11-19
Effects of fine soils from former bauxite mines on phytopathogenic and biological control agent fungal strains.
Microbiology spectrum [Epub ahead of print].
UNLABELLED: Soil samples collected at 20 and 50 m around the entrances of three former bauxite mines in the Puglia region, Southern Italy, at San Giovanni Rotondo, Otranto, and Spinazzola, were characterized by pollutant total concentration (PTC), considering rare earth elements (REEs), toxic metals (TMs), and PTCREEs+TMs, Nemerow integrated risk index, and the modified contamination degree index. Samples were tested at 1% in potato dextrose agar (PDA) and as liquid cultures in half-strength potato dextrose broth (½PDB) against Fusarium oxysporum f. sp. lycopersici (FOL), Sclerotinia minor (SM), Verticillium dahliae (VD), and Trichoderma harzianum (TH). Sampling locality and distance strongly influenced the biological effects of soil samples on fungal strains. The PDA medium amended with soil samples affected fungal radial growth, reduced FOL sporulation (23.53%-62.75%), enhanced TH (5.4%-9.3%) and VD (27.5%-41.37%) conidia production, and showed a slight effect (-2.00% to 4.2%) on SM microsclerotia formation. In ½PDB liquid cultures, almost all soil samples affected biomass production, decreased VD (85.02%-90.86%) and TH (20.01%-70.23%) conidia production, and increased FOL (35.13%-88.16%) sporulation. The SM strain failed to produce microsclerotia in any of the tested liquid media. Soil samples in the liquid media also affected the TH antagonistic activity mediated by secondary metabolites. The Pearson correlation coefficient linked the biological effects to PTCREEs and PTCREEs+TMs. The data recommend more frequent soil surveys to assess the impact of REEs on biota, especially at sites of naturalistic, geological, or tourist interest and sites of urban/suburban development.
IMPORTANCE: Toxic metals (TMs) and rare earth elements (REEs) can be essential or beneficial. Still, they can also become toxic to living organisms and pose a serious threat to global health, food security, and agricultural production. This study tests the effects of "naturally" contaminated sources of pollutants (TMs and RREs) in former bauxite mines on the biological parameters of three phytopathogenic fungi and one biological control agent (BCA) useful as indicators. The work also reveals the biological effects of naturally polluted soil on soilborne fungi, as well as a possible ecological implication of REE elements in former bauxite mines. Soil pollutants, REE in particular, could affect growth, dispersal, and ecological interactions of the microbiome, rhizosphere, symbionts, plant growth-promoting rhizobacteria, mycorrhizal fungi, endophytic bacteria, actinomycetes, nematodes, protozoans, soilborne agents of plant disease, and BCAs, as well as their development and ability to cause plant disease, plant protection, and human health.
Additional Links: PMID-43055368
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43055368,
year = {2026},
author = {Bruno, GL and Tommasi, F and Pirra, S and Tucci, F and Gjata, I and Brouziotis, AA and Micheletti, F and Fanelli, G and Bottalico, A},
title = {Effects of fine soils from former bauxite mines on phytopathogenic and biological control agent fungal strains.},
journal = {Microbiology spectrum},
volume = {},
number = {},
pages = {e0376025},
doi = {10.1128/spectrum.03760-25},
pmid = {43055368},
issn = {2165-0497},
abstract = {UNLABELLED: Soil samples collected at 20 and 50 m around the entrances of three former bauxite mines in the Puglia region, Southern Italy, at San Giovanni Rotondo, Otranto, and Spinazzola, were characterized by pollutant total concentration (PTC), considering rare earth elements (REEs), toxic metals (TMs), and PTCREEs+TMs, Nemerow integrated risk index, and the modified contamination degree index. Samples were tested at 1% in potato dextrose agar (PDA) and as liquid cultures in half-strength potato dextrose broth (½PDB) against Fusarium oxysporum f. sp. lycopersici (FOL), Sclerotinia minor (SM), Verticillium dahliae (VD), and Trichoderma harzianum (TH). Sampling locality and distance strongly influenced the biological effects of soil samples on fungal strains. The PDA medium amended with soil samples affected fungal radial growth, reduced FOL sporulation (23.53%-62.75%), enhanced TH (5.4%-9.3%) and VD (27.5%-41.37%) conidia production, and showed a slight effect (-2.00% to 4.2%) on SM microsclerotia formation. In ½PDB liquid cultures, almost all soil samples affected biomass production, decreased VD (85.02%-90.86%) and TH (20.01%-70.23%) conidia production, and increased FOL (35.13%-88.16%) sporulation. The SM strain failed to produce microsclerotia in any of the tested liquid media. Soil samples in the liquid media also affected the TH antagonistic activity mediated by secondary metabolites. The Pearson correlation coefficient linked the biological effects to PTCREEs and PTCREEs+TMs. The data recommend more frequent soil surveys to assess the impact of REEs on biota, especially at sites of naturalistic, geological, or tourist interest and sites of urban/suburban development.
IMPORTANCE: Toxic metals (TMs) and rare earth elements (REEs) can be essential or beneficial. Still, they can also become toxic to living organisms and pose a serious threat to global health, food security, and agricultural production. This study tests the effects of "naturally" contaminated sources of pollutants (TMs and RREs) in former bauxite mines on the biological parameters of three phytopathogenic fungi and one biological control agent (BCA) useful as indicators. The work also reveals the biological effects of naturally polluted soil on soilborne fungi, as well as a possible ecological implication of REE elements in former bauxite mines. Soil pollutants, REE in particular, could affect growth, dispersal, and ecological interactions of the microbiome, rhizosphere, symbionts, plant growth-promoting rhizobacteria, mycorrhizal fungi, endophytic bacteria, actinomycetes, nematodes, protozoans, soilborne agents of plant disease, and BCAs, as well as their development and ability to cause plant disease, plant protection, and human health.},
}
RevDate: 2026-11-19
CmpDate: 2026-11-19
Deep longitudinal phenotyping of a single individual enables host-microbiome metabolic modeling over 3.6 years.
Gut microbes, 18(1):2757368.
This study examines a single subject (LS) experiencing severe episodic colonic inflammation and associated gut microbiome dysbiosis. Metagenomic sequencing of LS's stool samples at 51 time points over 3.6 years provided a time series of gut microbial species' relative abundances, from which we generated time-point specific microbiome models. Flux balance analysis was used to predict metabolic phenotypes across the time series. The microbial abundances and predicted fluxes were compared with clinical inflammation biomarkers [serum C-reactive protein (CRP); stool lactoferrin, calprotectin, lysozyme, and secretory immunoglobulin A]. Each of these 51 microbiome models were integrated with a time-point specific male whole-body metabolic model personalized based on LS's weight, blood glucose, and cholesterol. A healthy average (HeAve) community model from 34 individuals provided a reference. Our models predicted methane overproduction from high Methanobrevibacter smithii levels, coinciding with peak CRP and calprotectin. We found that Escherichia coli plays a central role in shaping the predicted metabolome and may promote inflammation through trimethylamine N-oxide and formaldehyde production, out-competing Desulfovibrio piger and Akkermansia muciniphila via active methyl and sulfur cycles. At a later time point, LS experienced a major shift in gut Proteobacteria ecology: E. coli, over-abundant at 675 × HeAve, dropped nearly 80-fold in one month, while Morganella morganii rose by nearly eight times, which coincided with a spike in LS's lactoferrin and lysozyme, a rise in species including Klebsiella pneumoniae and Faecalibacterium prausnitzii, a change in predicted metabolic profile, and increased alpha diversity. We also noted a correlation between postulated inflammation periods and predicted lithocholic acid levels. This work extends two previous studies of 7 and 27 of these time points. Our analysis demonstrates the value of pairing multi-omics time-series data with systems biology approaches in an n-of-1 design, resolving how microbiome composition dynamics shape host-microbiome metabolism and inflammation.
Additional Links: PMID-43055535
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43055535,
year = {2026},
author = {Sheehy, A and Martinelli, F and Fang, X and Smarr, L and Palsson, BO and Knight, R and Thiele, I},
title = {Deep longitudinal phenotyping of a single individual enables host-microbiome metabolic modeling over 3.6 years.},
journal = {Gut microbes},
volume = {18},
number = {1},
pages = {2757368},
doi = {10.1080/19490976.2026.2757368},
pmid = {43055535},
issn = {1949-0984},
mesh = {Humans ; Male ; Feces/microbiology ; *Gastrointestinal Microbiome ; Phenotype ; Longitudinal Studies ; *Bacteria/classification/genetics/isolation & purification/metabolism ; Dysbiosis/microbiology/metabolism ; Metabolome ; Biomarkers ; *Host Microbial Interactions ; Multiomics ; Inflammation/microbiology ; C-Reactive Protein ; Metagenomics ; },
abstract = {This study examines a single subject (LS) experiencing severe episodic colonic inflammation and associated gut microbiome dysbiosis. Metagenomic sequencing of LS's stool samples at 51 time points over 3.6 years provided a time series of gut microbial species' relative abundances, from which we generated time-point specific microbiome models. Flux balance analysis was used to predict metabolic phenotypes across the time series. The microbial abundances and predicted fluxes were compared with clinical inflammation biomarkers [serum C-reactive protein (CRP); stool lactoferrin, calprotectin, lysozyme, and secretory immunoglobulin A]. Each of these 51 microbiome models were integrated with a time-point specific male whole-body metabolic model personalized based on LS's weight, blood glucose, and cholesterol. A healthy average (HeAve) community model from 34 individuals provided a reference. Our models predicted methane overproduction from high Methanobrevibacter smithii levels, coinciding with peak CRP and calprotectin. We found that Escherichia coli plays a central role in shaping the predicted metabolome and may promote inflammation through trimethylamine N-oxide and formaldehyde production, out-competing Desulfovibrio piger and Akkermansia muciniphila via active methyl and sulfur cycles. At a later time point, LS experienced a major shift in gut Proteobacteria ecology: E. coli, over-abundant at 675 × HeAve, dropped nearly 80-fold in one month, while Morganella morganii rose by nearly eight times, which coincided with a spike in LS's lactoferrin and lysozyme, a rise in species including Klebsiella pneumoniae and Faecalibacterium prausnitzii, a change in predicted metabolic profile, and increased alpha diversity. We also noted a correlation between postulated inflammation periods and predicted lithocholic acid levels. This work extends two previous studies of 7 and 27 of these time points. Our analysis demonstrates the value of pairing multi-omics time-series data with systems biology approaches in an n-of-1 design, resolving how microbiome composition dynamics shape host-microbiome metabolism and inflammation.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
Male
Feces/microbiology
*Gastrointestinal Microbiome
Phenotype
Longitudinal Studies
*Bacteria/classification/genetics/isolation & purification/metabolism
Dysbiosis/microbiology/metabolism
Metabolome
Biomarkers
*Host Microbial Interactions
Multiomics
Inflammation/microbiology
C-Reactive Protein
Metagenomics
RevDate: 2026-11-19
Microbiome-Mediated Modulation of the Tumor Microenvironment and Immunotherapeutic Responses.
Immunological investigations [Epub ahead of print].
Increasing research suggests the influence of microbial communities within tumors on disease progression, therapeutic responses, and clinical outcomes. The tumor microbiome is a complex niche comprising bacterial, viral, and fungal components that vary across cancer types and influence cancer progression. Tissue-specific microbial signatures suggest niche-specific roles, and their heterogeneity further complicates this landscape, emphasizing the need for high-resolution profiling by multi-omics and imaging approaches to understand the contributions of microbes to tumor behavior and unravel host-microbe interactions. From a therapeutic perspective, modulating the microbiome via probiotics, engineered bacteria/phages, or selective antibiotics is being explored to enhance the efficacy of immunotherapy. Nevertheless, significant challenges persist in our comprehension of microbial causality, overcoming delivery barriers, and developing personalized microbiome interventions. Tumor-associated microbial signatures are being investigated as candidate biomarkers for early detection, prognosis, and treatment response, although clinical validation remains limited.
Additional Links: PMID-43055536
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43055536,
year = {2026},
author = {Atoom, AM and Allela, OQB and Priyadarshini Nayak, P and Arora, V and Singla, S and Athab, ZH and Eshmetov, R and Sadikova, S},
title = {Microbiome-Mediated Modulation of the Tumor Microenvironment and Immunotherapeutic Responses.},
journal = {Immunological investigations},
volume = {},
number = {},
pages = {1-44},
doi = {10.1080/08820139.2026.2757128},
pmid = {43055536},
issn = {1532-4311},
abstract = {Increasing research suggests the influence of microbial communities within tumors on disease progression, therapeutic responses, and clinical outcomes. The tumor microbiome is a complex niche comprising bacterial, viral, and fungal components that vary across cancer types and influence cancer progression. Tissue-specific microbial signatures suggest niche-specific roles, and their heterogeneity further complicates this landscape, emphasizing the need for high-resolution profiling by multi-omics and imaging approaches to understand the contributions of microbes to tumor behavior and unravel host-microbe interactions. From a therapeutic perspective, modulating the microbiome via probiotics, engineered bacteria/phages, or selective antibiotics is being explored to enhance the efficacy of immunotherapy. Nevertheless, significant challenges persist in our comprehension of microbial causality, overcoming delivery barriers, and developing personalized microbiome interventions. Tumor-associated microbial signatures are being investigated as candidate biomarkers for early detection, prognosis, and treatment response, although clinical validation remains limited.},
}
RevDate: 2026-11-19
Plant pathogenic continuum in the microbiome era.
FEMS microbiology reviews pii:9103339 [Epub ahead of print].
Plant pathology has traditionally relied on a binary distinction between pathogens and non-pathogens, or between harmful and beneficial microorganisms. However, this distinction is becoming increasingly difficult to maintain in the microbiome era. For many plant-associated microorganisms, pathogenicity is not a fixed property but varies along a gradient depending on host physiology, microbial strain, environmental conditions, resident microbiota, and time. This review discusses a plant pathogenicity continuum as a framework for interpreting this fluidity. Within this continuum, we discuss four interconnected positions: true or near-deterministic pathogens, context-dependent pathogens, opportunistic pathogens, and pathobiome- or dysbiosis-associated disease states. These positions should not be treated as rigid categories, but as reference points that help compare how strongly disease depends on the host, environment and microbiome interactions. We also discuss the strain-level problem in plant pathology, because species or pathovar-level detection often does not capture real differences in virulence and host range. Finally, we consider the diagnostic implications of this continuum, especially where pathogen detection alone is not sufficient. This continuum-based view may help plant pathology move from naming pathogens toward interpreting disease states.
Additional Links: PMID-43055730
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43055730,
year = {2026},
author = {Rosić, I and Berić, T and Stanković, S and Nikolić, I},
title = {Plant pathogenic continuum in the microbiome era.},
journal = {FEMS microbiology reviews},
volume = {},
number = {},
pages = {},
doi = {10.1093/femsre/fuag062},
pmid = {43055730},
issn = {1574-6976},
abstract = {Plant pathology has traditionally relied on a binary distinction between pathogens and non-pathogens, or between harmful and beneficial microorganisms. However, this distinction is becoming increasingly difficult to maintain in the microbiome era. For many plant-associated microorganisms, pathogenicity is not a fixed property but varies along a gradient depending on host physiology, microbial strain, environmental conditions, resident microbiota, and time. This review discusses a plant pathogenicity continuum as a framework for interpreting this fluidity. Within this continuum, we discuss four interconnected positions: true or near-deterministic pathogens, context-dependent pathogens, opportunistic pathogens, and pathobiome- or dysbiosis-associated disease states. These positions should not be treated as rigid categories, but as reference points that help compare how strongly disease depends on the host, environment and microbiome interactions. We also discuss the strain-level problem in plant pathology, because species or pathovar-level detection often does not capture real differences in virulence and host range. Finally, we consider the diagnostic implications of this continuum, especially where pathogen detection alone is not sufficient. This continuum-based view may help plant pathology move from naming pathogens toward interpreting disease states.},
}
RevDate: 2026-11-19
Synbiotics Reduce Hypercholesterolemia and Aortic Inflammation Via Modulation of Cholesterol Metabolism.
Probiotics and antimicrobial proteins [Epub ahead of print].
Synbiotics have emerged as a potential intervention to alleviate high-fat diet (HFD)-induced metabolic and cardiovascular dysfunction. Here, we evaluated a novel synbiotic formulation in HFD-fed ApoE[-]/[-] mice for its effects on lipid metabolism, intestinal and systemic T-cell immunity, and gut microbiome composition. ApoE[-]/[-] mice were fed a HFD and treated with either vehicle or synbiotics for 4 weeks. Serum LDL cholesterol levels and hepatic lipid accumulation and cholesterol content were assessed. Expression of cholesterol metabolism genes was analyzed in the liver and in the small intestine. Flow cytometry was used to examine T-cell populations in mesenteric lymph nodes and spleen. Gut microbiome composition was profiled by shotgun sequencing, and short-chain fatty acid (SCFA) levels were quantified in serum and stool as well as aortic inflammation was evaluated. Synbiotic treatment significantly reduced LDL cholesterol and hepatic lipid accumulation without altering body or organ weights. In the intestine, synbiotics attenuated HFD-induced dysregulation of cholesterol metabolism genes and maintained hepatic cholesterol levels comparable to standard chow-fed mice. Immunologically, synbiotic-fed mice showed reduced Th17 cells in mesenteric lymph nodes and increased cytotoxic T cells in the spleen, indicating immune reprogramming. Despite HFD-induced dysbiosis, synbiotic treatment preserved SCFA-producing taxa, including Lactobacillus johnsonii, Bacteroides fragilis, and Eubacterium spp., and significantly increased fecal butyrate levels. Notably, synbiotic-treated mice showed a complete absence of aortic inflammation, in contrast to vehicle-treated HFD controls. In conclusion, synbiotic intervention ameliorates diet-induced cardiometabolic dysfunction in HFD-fed ApoE[-]/[-] mice by modulating intestinal cholesterol metabolism, restoring microbiota-derived metabolite production, and reshaping T-cell responses. These findings support synbiotics as a promising strategy to counter diet-driven cardiometabolic dysfunction.
Additional Links: PMID-43055905
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43055905,
year = {2026},
author = {Palani Kumar, MK and Szmigiel, D and Motiram Halami, P and Serva Peddha, M and Geisberger, S and Rauch, A and Anders, W and Karlik, A and Bartolomaeus, TUP and Löber, U and Wilck, N and Kempa, S and Haghikia, A and Forslund, SK and Markó, L and Przybyl, L},
title = {Synbiotics Reduce Hypercholesterolemia and Aortic Inflammation Via Modulation of Cholesterol Metabolism.},
journal = {Probiotics and antimicrobial proteins},
volume = {},
number = {},
pages = {},
pmid = {43055905},
issn = {1867-1314},
abstract = {Synbiotics have emerged as a potential intervention to alleviate high-fat diet (HFD)-induced metabolic and cardiovascular dysfunction. Here, we evaluated a novel synbiotic formulation in HFD-fed ApoE[-]/[-] mice for its effects on lipid metabolism, intestinal and systemic T-cell immunity, and gut microbiome composition. ApoE[-]/[-] mice were fed a HFD and treated with either vehicle or synbiotics for 4 weeks. Serum LDL cholesterol levels and hepatic lipid accumulation and cholesterol content were assessed. Expression of cholesterol metabolism genes was analyzed in the liver and in the small intestine. Flow cytometry was used to examine T-cell populations in mesenteric lymph nodes and spleen. Gut microbiome composition was profiled by shotgun sequencing, and short-chain fatty acid (SCFA) levels were quantified in serum and stool as well as aortic inflammation was evaluated. Synbiotic treatment significantly reduced LDL cholesterol and hepatic lipid accumulation without altering body or organ weights. In the intestine, synbiotics attenuated HFD-induced dysregulation of cholesterol metabolism genes and maintained hepatic cholesterol levels comparable to standard chow-fed mice. Immunologically, synbiotic-fed mice showed reduced Th17 cells in mesenteric lymph nodes and increased cytotoxic T cells in the spleen, indicating immune reprogramming. Despite HFD-induced dysbiosis, synbiotic treatment preserved SCFA-producing taxa, including Lactobacillus johnsonii, Bacteroides fragilis, and Eubacterium spp., and significantly increased fecal butyrate levels. Notably, synbiotic-treated mice showed a complete absence of aortic inflammation, in contrast to vehicle-treated HFD controls. In conclusion, synbiotic intervention ameliorates diet-induced cardiometabolic dysfunction in HFD-fed ApoE[-]/[-] mice by modulating intestinal cholesterol metabolism, restoring microbiota-derived metabolite production, and reshaping T-cell responses. These findings support synbiotics as a promising strategy to counter diet-driven cardiometabolic dysfunction.},
}
RevDate: 2026-11-19
Maternal prenatal gut microbiome and domain-specific neurodevelopment in early childhood: associations and exploratory prediction.
Science China. Life sciences [Epub ahead of print].
The potential of the maternal prenatal gut microbiome for prediction of domain-specific neurodevelopment in children has not been fully appreciated. We sought to explore the associations and predictive capacity of the maternal prenatal gut microbiome in relation to children's domain-specific neurodevelopment. Leveraging a prospective birth cohort, we performed both 16S rRNA gene amplicon sequencing and shotgun metagenomic sequencing for pregnant women's fecal samples. The domain-specific neurodevelopment in children was evaluated utilizing the Ages and Stages Questionnaire (ASQ). We used the prenatal gut microbiome at the phylum, genus, species, and pathway levels in combination with multiple machine learning models, including random forest, extreme gradient boosting (XGBoost), light gradient-boosting machine (LightGBM), least absolute shrinkage and selection operator (LASSO) logistic regression, and ridge logistic regression, individually and in conjunction with conventional risk factors to predict children's neurodevelopment. We found that the gut microbiome features, individually or integrated with conventional risk factors, improved the predictive performance of machine learning models for children's neurodevelopment across five subdomains, achieving area under the receiver operating characteristic curves (AUROCs) up to 0.88. Compared with AUROCs of 0.70-0.76 for communication, 0.70-0.72 for gross motor, 0.71-0.77 for fine motor, 0.68-0.77 for problem solving, and 0.57-0.62 for personal-social development using conventional risk factors alone, the combined models achieved AUROCs of 0.79-0.83, 0.71-0.80, 0.82-0.84, 0.79-0.88, and 0.59-0.64, respectively. The highest area under the precision-recall curves (AUPRCs) were 0.63, 0.50, 0.63, 0.60, and 0.39 for communication, gross motor, fine motor, problem solving, and personal-social development, respectively, compared with prevalence-matched AUPRC baselines of 0.12, 0.14, 0.12, 0.12, and 0.17. However, performance gains varied across algorithms and feature configurations. Maternal prenatal gut microbial features were associated with domain-specific neurodevelopment and showed exploratory predictive signals in selected internally validated models. Independent external cohorts and age-specific longitudinal validation are required before these features can be considered clinically useful biomarkers or used to inform early-identification or intervention strategies.
Additional Links: PMID-43055924
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43055924,
year = {2026},
author = {Wei, H and Jin, B and Xu, Y and Zhao, X and Ning, J and Gao, B and Zhang, M and Tun, HM and Xia, Y},
title = {Maternal prenatal gut microbiome and domain-specific neurodevelopment in early childhood: associations and exploratory prediction.},
journal = {Science China. Life sciences},
volume = {},
number = {},
pages = {},
pmid = {43055924},
issn = {1869-1889},
abstract = {The potential of the maternal prenatal gut microbiome for prediction of domain-specific neurodevelopment in children has not been fully appreciated. We sought to explore the associations and predictive capacity of the maternal prenatal gut microbiome in relation to children's domain-specific neurodevelopment. Leveraging a prospective birth cohort, we performed both 16S rRNA gene amplicon sequencing and shotgun metagenomic sequencing for pregnant women's fecal samples. The domain-specific neurodevelopment in children was evaluated utilizing the Ages and Stages Questionnaire (ASQ). We used the prenatal gut microbiome at the phylum, genus, species, and pathway levels in combination with multiple machine learning models, including random forest, extreme gradient boosting (XGBoost), light gradient-boosting machine (LightGBM), least absolute shrinkage and selection operator (LASSO) logistic regression, and ridge logistic regression, individually and in conjunction with conventional risk factors to predict children's neurodevelopment. We found that the gut microbiome features, individually or integrated with conventional risk factors, improved the predictive performance of machine learning models for children's neurodevelopment across five subdomains, achieving area under the receiver operating characteristic curves (AUROCs) up to 0.88. Compared with AUROCs of 0.70-0.76 for communication, 0.70-0.72 for gross motor, 0.71-0.77 for fine motor, 0.68-0.77 for problem solving, and 0.57-0.62 for personal-social development using conventional risk factors alone, the combined models achieved AUROCs of 0.79-0.83, 0.71-0.80, 0.82-0.84, 0.79-0.88, and 0.59-0.64, respectively. The highest area under the precision-recall curves (AUPRCs) were 0.63, 0.50, 0.63, 0.60, and 0.39 for communication, gross motor, fine motor, problem solving, and personal-social development, respectively, compared with prevalence-matched AUPRC baselines of 0.12, 0.14, 0.12, 0.12, and 0.17. However, performance gains varied across algorithms and feature configurations. Maternal prenatal gut microbial features were associated with domain-specific neurodevelopment and showed exploratory predictive signals in selected internally validated models. Independent external cohorts and age-specific longitudinal validation are required before these features can be considered clinically useful biomarkers or used to inform early-identification or intervention strategies.},
}
RevDate: 2026-11-19
Gut microbiome functional genomics and PBPK modeling: a systems framework for precision therapeutics.
Folia microbiologica [Epub ahead of print].
The gut microbiome is increasingly recognized as an important determinant of interindividual variability in the disposition and response to pharmaceuticals, nutraceuticals, and dietary bioactives. Conventional microbiome profiling based primarily on taxonomic composition provides limited mechanistic insight into these effects, whereas functional genomics and multi-omics approaches enable characterization of microbial genes, enzymes, pathways, and metabolites involved in xenobiotic biotransformation. This review examines the integration of gut microbiome functional genomics with physiologically based pharmacokinetic (PBPK) modeling as a systems framework for precision therapeutics. Particular emphasis is placed on translating microbial gene-enzyme-metabolite relationships and experimentally characterized biotransformation kinetics into quantitative PBPK parameters. Metagenomics, metatranscriptomics, metaproteomics, and metabolomics provide complementary information for resolving microbial metabolic potential and activity, while genome-scale and community metabolic models can identify candidate pathways for xenobiotic transformation and metabolite production. Microbiome-aware PBPK approaches may incorporate microbial biotransformation, metabolite formation, gastrointestinal transit, absorption, and temporal functional variability. Whether these additions improve exposure predictions requires evaluation against conventional PBPK models using independent pharmacokinetic datasets.Artificial intelligence and machine learning may further support functional feature identification and hybrid PBPK modeling, provided that predictions remain biologically interpretable and experimentally validated. Despite its potential, clinical translation is constrained by limited standardized kinetic data, microbiome variability, incomplete functional annotation, and insufficient prospective validation. Integrating validated microbial functional information with mechanistic PBPK modeling may ultimately provide a quantitative basis for microbiome-informed prediction of drug and nutraceutical exposure and advance individualized therapeutic strategies.
Additional Links: PMID-43056040
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43056040,
year = {2026},
author = {Jeyavelkumaran, R and Saravanan, MD and Keerthivasan, N},
title = {Gut microbiome functional genomics and PBPK modeling: a systems framework for precision therapeutics.},
journal = {Folia microbiologica},
volume = {},
number = {},
pages = {},
pmid = {43056040},
issn = {1874-9356},
abstract = {The gut microbiome is increasingly recognized as an important determinant of interindividual variability in the disposition and response to pharmaceuticals, nutraceuticals, and dietary bioactives. Conventional microbiome profiling based primarily on taxonomic composition provides limited mechanistic insight into these effects, whereas functional genomics and multi-omics approaches enable characterization of microbial genes, enzymes, pathways, and metabolites involved in xenobiotic biotransformation. This review examines the integration of gut microbiome functional genomics with physiologically based pharmacokinetic (PBPK) modeling as a systems framework for precision therapeutics. Particular emphasis is placed on translating microbial gene-enzyme-metabolite relationships and experimentally characterized biotransformation kinetics into quantitative PBPK parameters. Metagenomics, metatranscriptomics, metaproteomics, and metabolomics provide complementary information for resolving microbial metabolic potential and activity, while genome-scale and community metabolic models can identify candidate pathways for xenobiotic transformation and metabolite production. Microbiome-aware PBPK approaches may incorporate microbial biotransformation, metabolite formation, gastrointestinal transit, absorption, and temporal functional variability. Whether these additions improve exposure predictions requires evaluation against conventional PBPK models using independent pharmacokinetic datasets.Artificial intelligence and machine learning may further support functional feature identification and hybrid PBPK modeling, provided that predictions remain biologically interpretable and experimentally validated. Despite its potential, clinical translation is constrained by limited standardized kinetic data, microbiome variability, incomplete functional annotation, and insufficient prospective validation. Integrating validated microbial functional information with mechanistic PBPK modeling may ultimately provide a quantitative basis for microbiome-informed prediction of drug and nutraceutical exposure and advance individualized therapeutic strategies.},
}
RevDate: 2026-11-19
A novel gut microbiome-derived Tenebrionidae bacteriophage for biocontrol of Salmonella Typhimurium: in vitro characterization and in vivo evaluation in zebrafish.
Folia microbiologica [Epub ahead of print].
The global rise in antibiotic resistance has heightened interest in alternative biocontrol strategies, including bacteriophages and their endolysins. In this study, a new lytic bacteriophage, VB-STMS-SemU (hereafter SemU), was isolated from the gut microbiome of Opatroides punctulatus. It was purified using Salmonella Typhimurium as a host. Results showed that SemU exhibits siphovirus-like morphology, with an icosahedral capsid and a long, non-contractile tail. The host range includes Salmonella Typhimurium, Salmonella Enteritidis, and Klebsiella pneumoniae. Kinetic analysis indicated an MOI of 1, an adsorption time of 17 min, a latent period of 70 min, and a burst size of 192 virions per cell. The phage-derived protein extract degraded 17% of the cell wall and was more effective than the whole phage at eradicating biofilms. No cytotoxicity was observed in eukaryotic cells. In zebrafish, about 10% of the phage was absorbed within 3 h, and no neutralizing antibodies were detected. Although an initial MOI of 1 was insufficient due to physiological barriers, increasing it to 10 significantly decreased intestinal bacterial loads. Phage titers peaked on day 3 and dropped to undetectable levels by day 7. SemU is a promising candidate for treating enteric infections.
Additional Links: PMID-43056041
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43056041,
year = {2026},
author = {Kheirkhahan, A and Abolmaali, S and Golestaninasab, M and Darvish Alipour Astaneh, S},
title = {A novel gut microbiome-derived Tenebrionidae bacteriophage for biocontrol of Salmonella Typhimurium: in vitro characterization and in vivo evaluation in zebrafish.},
journal = {Folia microbiologica},
volume = {},
number = {},
pages = {},
pmid = {43056041},
issn = {1874-9356},
support = {226/1404T14041086//Semnan University/ ; },
abstract = {The global rise in antibiotic resistance has heightened interest in alternative biocontrol strategies, including bacteriophages and their endolysins. In this study, a new lytic bacteriophage, VB-STMS-SemU (hereafter SemU), was isolated from the gut microbiome of Opatroides punctulatus. It was purified using Salmonella Typhimurium as a host. Results showed that SemU exhibits siphovirus-like morphology, with an icosahedral capsid and a long, non-contractile tail. The host range includes Salmonella Typhimurium, Salmonella Enteritidis, and Klebsiella pneumoniae. Kinetic analysis indicated an MOI of 1, an adsorption time of 17 min, a latent period of 70 min, and a burst size of 192 virions per cell. The phage-derived protein extract degraded 17% of the cell wall and was more effective than the whole phage at eradicating biofilms. No cytotoxicity was observed in eukaryotic cells. In zebrafish, about 10% of the phage was absorbed within 3 h, and no neutralizing antibodies were detected. Although an initial MOI of 1 was insufficient due to physiological barriers, increasing it to 10 significantly decreased intestinal bacterial loads. Phage titers peaked on day 3 and dropped to undetectable levels by day 7. SemU is a promising candidate for treating enteric infections.},
}
RevDate: 2026-11-19
Microbiome-derived phenylethylamine impairs diabetic wound healing via TAAR1-mediated NETosis.
Cell reports, 45(12):118337 pii:S2211-1247(26)01416-6 [Epub ahead of print].
Impaired wound repair is a major complication of diabetes, yet how microbiota-derived metabolites sustain inflammation remains unclear. By integrating metabolomic and microbiome profiling of individuals with type 2 diabetes, we identify phenylethylamine as an elevated microbiota-associated metabolite. In mouse cutaneous and oral wounds, phenylethylamine promotes neutrophil extracellular trap formation and delays wound healing. Mechanistically, phenylethylamine signals through trace amine-associated receptor 1 on neutrophils, engaging β-arrestin-extracellular signal-regulated kinase-reactive oxygen species signaling. Microbiota depletion lowers circulating phenylethylamine, whereas Enterococcus faecalis recolonization increases its concentration and delays repair, supporting a microbial contribution to phenylethylamine exposure. Local delivery of a receptor antagonist in a thermosensitive hydrogel reduces neutrophil extracellular traps and improves cutaneous and oral healing in diabetic mice. These findings provide preclinical support for local TAAR1 blockade as a potential approach to improving diabetic wound repair.
Additional Links: PMID-43056233
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43056233,
year = {2026},
author = {Tang, Z and Chen, R and Lv, X and Zhang, Y and Li, M and Yin, W and Huang, Q and Lai, H and Zhao, L and Shi, J},
title = {Microbiome-derived phenylethylamine impairs diabetic wound healing via TAAR1-mediated NETosis.},
journal = {Cell reports},
volume = {45},
number = {12},
pages = {118337},
doi = {10.1016/j.celrep.2026.118337},
pmid = {43056233},
issn = {2211-1247},
abstract = {Impaired wound repair is a major complication of diabetes, yet how microbiota-derived metabolites sustain inflammation remains unclear. By integrating metabolomic and microbiome profiling of individuals with type 2 diabetes, we identify phenylethylamine as an elevated microbiota-associated metabolite. In mouse cutaneous and oral wounds, phenylethylamine promotes neutrophil extracellular trap formation and delays wound healing. Mechanistically, phenylethylamine signals through trace amine-associated receptor 1 on neutrophils, engaging β-arrestin-extracellular signal-regulated kinase-reactive oxygen species signaling. Microbiota depletion lowers circulating phenylethylamine, whereas Enterococcus faecalis recolonization increases its concentration and delays repair, supporting a microbial contribution to phenylethylamine exposure. Local delivery of a receptor antagonist in a thermosensitive hydrogel reduces neutrophil extracellular traps and improves cutaneous and oral healing in diabetic mice. These findings provide preclinical support for local TAAR1 blockade as a potential approach to improving diabetic wound repair.},
}
RevDate: 2026-11-19
CmpDate: 2026-11-19
Gut Holdemania filiformis raises brain isoallopregnanolone in progesterone-treated female mice.
Gut microbes, 18(1):2765085.
Neuroactive 5α-steroids modulate γ-aminobutyric acid type A (GABAA) receptor signaling and are of growing therapeutic interest: allopregnanolone (3α,5α) is a positive allosteric modulator, whereas its 3β-epimer isoallopregnanolone antagonizes this action and is itself in clinical development. Their formation has been attributed to host enzymes in the liver, gastrointestinal tract, and central nervous system, whereas a contribution from any individual gut bacterium has not been demonstrated. Steroid 5α-reduction is an unusual microbial activity: among sequenced bacterial genomes, only 18 encode a recognizable steroid 5α-reductase. All available Holdemania genomes encode one of these (BaiJ-like, type 2), forming a clade distinct from the characterized Clostridium scindens BaiJ (type 1), together with a 3β-hydroxysteroid oxidoreductase. We therefore asked whether colonization with a single defined bacterium can measurably add to the host 5α-steroid pool. Consistent with this gene pair, anaerobic H. filiformis cultures converted progesterone principally to isoallopregnanolone, accumulating the intermediate 5α-dihydroprogesterone under sub-optimal conditions. In antibiotic-treated female C57BL/6 mice receiving oral progesterone, colonization with H. filiformis significantly increased isoallopregnanolone in cecal contents and brain, whereas hepatic allopregnanolone and isoallopregnanolone were unchanged. Brain isoallopregnanolone rose only in mice given both progesterone and H. filiformis, and [3,4-[13]C2]progesterone tracing showed that the brain pool derived from the orally administered substrate rather than from endogenous progesterone. These findings identify Holdemania as a gut microbial source of isoallopregnanolone acting alongside host intestinal, hepatic, and cerebral steroidogenesis, and nominate H. filiformis as a candidate for microbiome-based modulation of host neuroactive 5α-steroid levels.
Additional Links: PMID-43056384
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43056384,
year = {2026},
author = {Brandon-Mong, GJ and Chou, CH and Hsiao, TH and Wu, TY and Wang, PH and Gicana, RG and Huang, CT and Wu, GL and Li, YC and Tu, YA and Chang, YY and Lai, YL and Li, PT and Chen, HY and Chen, MJ and Chiang, YR},
title = {Gut Holdemania filiformis raises brain isoallopregnanolone in progesterone-treated female mice.},
journal = {Gut microbes},
volume = {18},
number = {1},
pages = {2765085},
doi = {10.1080/19490976.2026.2765085},
pmid = {43056384},
issn = {1949-0984},
mesh = {Animals ; Female ; *Pregnanolone/metabolism/analogs & derivatives ; Mice ; *Brain/metabolism ; *Progesterone/metabolism/administration & dosage ; Mice, Inbred C57BL ; *Gastrointestinal Microbiome ; *Bacillota/metabolism/genetics ; },
abstract = {Neuroactive 5α-steroids modulate γ-aminobutyric acid type A (GABAA) receptor signaling and are of growing therapeutic interest: allopregnanolone (3α,5α) is a positive allosteric modulator, whereas its 3β-epimer isoallopregnanolone antagonizes this action and is itself in clinical development. Their formation has been attributed to host enzymes in the liver, gastrointestinal tract, and central nervous system, whereas a contribution from any individual gut bacterium has not been demonstrated. Steroid 5α-reduction is an unusual microbial activity: among sequenced bacterial genomes, only 18 encode a recognizable steroid 5α-reductase. All available Holdemania genomes encode one of these (BaiJ-like, type 2), forming a clade distinct from the characterized Clostridium scindens BaiJ (type 1), together with a 3β-hydroxysteroid oxidoreductase. We therefore asked whether colonization with a single defined bacterium can measurably add to the host 5α-steroid pool. Consistent with this gene pair, anaerobic H. filiformis cultures converted progesterone principally to isoallopregnanolone, accumulating the intermediate 5α-dihydroprogesterone under sub-optimal conditions. In antibiotic-treated female C57BL/6 mice receiving oral progesterone, colonization with H. filiformis significantly increased isoallopregnanolone in cecal contents and brain, whereas hepatic allopregnanolone and isoallopregnanolone were unchanged. Brain isoallopregnanolone rose only in mice given both progesterone and H. filiformis, and [3,4-[13]C2]progesterone tracing showed that the brain pool derived from the orally administered substrate rather than from endogenous progesterone. These findings identify Holdemania as a gut microbial source of isoallopregnanolone acting alongside host intestinal, hepatic, and cerebral steroidogenesis, and nominate H. filiformis as a candidate for microbiome-based modulation of host neuroactive 5α-steroid levels.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
Female
*Pregnanolone/metabolism/analogs & derivatives
Mice
*Brain/metabolism
*Progesterone/metabolism/administration & dosage
Mice, Inbred C57BL
*Gastrointestinal Microbiome
*Bacillota/metabolism/genetics
RevDate: 2026-11-19
Gut Microbiota and Neuroendocrine Neoplasms: Emerging Insights into the Gut-Metabolome-Immune Axis.
Neuroendocrinology pii:9103444 [Epub ahead of print].
BACKGROUND: Neuroendocrine neoplasms (NENs) are heterogeneous tumors with increasing incidence and substantial clinical variability. Emerging evidence suggests that the gut microbiota may influence NEN biology through immune, metabolic, and tumor microenvironment interactions. However, the underlying mechanisms remain poorly understood Methods: This narrative review synthesizes evidence on microbiota alterations across NEN subtypes, integrating microbiome profiling, intratumoral microbiome studies, multi-omics analyses, and Mendelian randomization (MR) investigations exploring potential causal associations and mediating pathways.
RESULTS: Patients with NENs consistently exhibit gut microbial dysbiosis, although signatures vary by tumor site. Evidence of an intratumoral microbiome in NENs suggests that bacteria may be integrated into the tumor microenvironment, potentially influencing immune regulation and tumor behavior. Multi-omics studies further demonstrate systemic metabolic alterations, including dysregulated tryptophan metabolism, altered circulating organic acids, and increased microbial-derived uremic toxins associated with metastatic disease. Mendelian randomization analyses support potential bidirectional causal relationships between gut microbiota and gastroenteropancreatic NENs, with evidence of immune- and metabolite-mediated effects. Importantly, microbiota involvement appears heterogeneous across NENs subtypes, reflecting tissue-specific ecological and hormonal contexts. Chronic inflammation may further link dysbiosis and tumorigenesis, contributing to a shared pathogenic continuum.
CONCLUSIONS: The gut microbiota is emerging as a potential area of interest in NEN biology, with possible links to interconnected microbial, metabolic, and immune pathways. Although the underlying mechanisms and causal relationships remain to be established, current evidence suggests potential interactions between the host-microbiome axis and tumor development and progression. Further studies are needed to clarify these relationships and assess the potential of microbiota-based biomarkers and therapeutic strategies in NENs.
Additional Links: PMID-43056438
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43056438,
year = {2026},
author = {La Salvia, A and Modica, R and Spada, F and Rossi, RE},
title = {Gut Microbiota and Neuroendocrine Neoplasms: Emerging Insights into the Gut-Metabolome-Immune Axis.},
journal = {Neuroendocrinology},
volume = {},
number = {},
pages = {},
doi = {10.1159/nen/advag018},
pmid = {43056438},
issn = {1423-0194},
abstract = {BACKGROUND: Neuroendocrine neoplasms (NENs) are heterogeneous tumors with increasing incidence and substantial clinical variability. Emerging evidence suggests that the gut microbiota may influence NEN biology through immune, metabolic, and tumor microenvironment interactions. However, the underlying mechanisms remain poorly understood Methods: This narrative review synthesizes evidence on microbiota alterations across NEN subtypes, integrating microbiome profiling, intratumoral microbiome studies, multi-omics analyses, and Mendelian randomization (MR) investigations exploring potential causal associations and mediating pathways.
RESULTS: Patients with NENs consistently exhibit gut microbial dysbiosis, although signatures vary by tumor site. Evidence of an intratumoral microbiome in NENs suggests that bacteria may be integrated into the tumor microenvironment, potentially influencing immune regulation and tumor behavior. Multi-omics studies further demonstrate systemic metabolic alterations, including dysregulated tryptophan metabolism, altered circulating organic acids, and increased microbial-derived uremic toxins associated with metastatic disease. Mendelian randomization analyses support potential bidirectional causal relationships between gut microbiota and gastroenteropancreatic NENs, with evidence of immune- and metabolite-mediated effects. Importantly, microbiota involvement appears heterogeneous across NENs subtypes, reflecting tissue-specific ecological and hormonal contexts. Chronic inflammation may further link dysbiosis and tumorigenesis, contributing to a shared pathogenic continuum.
CONCLUSIONS: The gut microbiota is emerging as a potential area of interest in NEN biology, with possible links to interconnected microbial, metabolic, and immune pathways. Although the underlying mechanisms and causal relationships remain to be established, current evidence suggests potential interactions between the host-microbiome axis and tumor development and progression. Further studies are needed to clarify these relationships and assess the potential of microbiota-based biomarkers and therapeutic strategies in NENs.},
}
RevDate: 2026-11-19
Microbiome testing in clinical practice: promise, limitation and the need for evidence.
The New Zealand medical journal, 139(1646):10-12.
Additional Links: PMID-43056623
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43056623,
year = {2026},
author = {Permain, J and Purcell, R},
title = {Microbiome testing in clinical practice: promise, limitation and the need for evidence.},
journal = {The New Zealand medical journal},
volume = {139},
number = {1646},
pages = {10-12},
doi = {10.26635/6965.1646e},
pmid = {43056623},
issn = {1175-8716},
}
RevDate: 2026-11-20
Correction to: Microbial interactions from a new perspective: reinforcement learning reveals new insights into microbiome evolution.
Bioinformatics (Oxford, England), 42(11):.
Additional Links: PMID-43056740
Full Text:
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43056740,
year = {2026},
author = {},
title = {Correction to: Microbial interactions from a new perspective: reinforcement learning reveals new insights into microbiome evolution.},
journal = {Bioinformatics (Oxford, England)},
volume = {42},
number = {11},
pages = {},
doi = {10.1093/bioinformatics/btag820},
pmid = {43056740},
issn = {1367-4811},
}
RevDate: 2026-11-19
Probiotic supplementation is associated with distinct gut microbiota development in extremely preterm infants: A pre- and post-implementation cohort study.
Clinical nutrition (Edinburgh, Scotland), 67:106841 pii:S0261-5614(26)00268-2 [Epub ahead of print].
Probiotics are used in preterm infants to reduce necrotizing enterocolitis (NEC), potentially through modulation of the gut microbiota. We investigated the effects of multi-strain probiotic supplementation (ProPrems®) on microbiota development in extremely preterm infants (<28 weeks). Pre- and post-implementation cohorts from four neonatal intensive care units were included. Fecal samples collected during the first 4 weeks of life were analyzed using IS-pro microbiota profiling and targeted quantitative PCR. 243 infants and 777 fecal samples were studied. NEC incidence was significantly lower in probiotic-exposed infants (2% vs 11%, p = 0.007). Probiotic exposure was the strongest of the tested influencing factors of microbial beta-diversity (adj.R[2] 4.1%, p = 0.001) and was associated with increased probiotic-associated taxa, reduced potentially pathogenic taxa, and a more connected microbial network. Antibiotic exposure and invasive ventilation reduced quantities of B. longum subsp. infantis. These findings show probiotics alter early gut microbiota development, which provides plausible mechanistic insights into how they may protect against NEC.
Additional Links: PMID-43056779
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43056779,
year = {2026},
author = {van Wesemael, AJ and de Kroon, RR and Li, S and Frerichs, NM and Bos, MP and Budding, AE and de Jonge, WJ and de Boode, WP and Hulzebos, CV and van den Akker, CHP and van Kaam, AH and Niemarkt, HJ and de Meij, TG and , },
title = {Probiotic supplementation is associated with distinct gut microbiota development in extremely preterm infants: A pre- and post-implementation cohort study.},
journal = {Clinical nutrition (Edinburgh, Scotland)},
volume = {67},
number = {},
pages = {106841},
doi = {10.1016/j.clnu.2026.106841},
pmid = {43056779},
issn = {1532-1983},
abstract = {Probiotics are used in preterm infants to reduce necrotizing enterocolitis (NEC), potentially through modulation of the gut microbiota. We investigated the effects of multi-strain probiotic supplementation (ProPrems®) on microbiota development in extremely preterm infants (<28 weeks). Pre- and post-implementation cohorts from four neonatal intensive care units were included. Fecal samples collected during the first 4 weeks of life were analyzed using IS-pro microbiota profiling and targeted quantitative PCR. 243 infants and 777 fecal samples were studied. NEC incidence was significantly lower in probiotic-exposed infants (2% vs 11%, p = 0.007). Probiotic exposure was the strongest of the tested influencing factors of microbial beta-diversity (adj.R[2] 4.1%, p = 0.001) and was associated with increased probiotic-associated taxa, reduced potentially pathogenic taxa, and a more connected microbial network. Antibiotic exposure and invasive ventilation reduced quantities of B. longum subsp. infantis. These findings show probiotics alter early gut microbiota development, which provides plausible mechanistic insights into how they may protect against NEC.},
}
RevDate: 2026-11-19
Chemical composition analysis of instant oil tea and its effect on metabolic disorders in high-fat /high-sucrose diet-fed mice.
Food chemistry, 533(Pt 4):152170 pii:S0308-8146(26)04330-X [Epub ahead of print].
This study aimed to characterize the chemical components of instant oil tea (IOT) and explore its ameliorative effects on glucose and lipid metabolism in high-fat /high-sucrose (HFS) diet mice. A total of 16 bioactive compounds were identified in IOT by LC-MS/MS, including phenolic acids, catechins, proanthocyanidins, ellagitannin, and flavonoids. Gallic acid and 3 representative catechins were quantified by HPLC. GC-MS analysis revealed that IOT also contain various volatile components, such as zingiberene, β-sesquiphellandrene, and γ-muurolene. IOT significantly reduced the liver index, as well as the serum levels of TC, TG, LDL-C, LPS, and blood glucose, while increasing the HDL-C level. The the colonic expression of ZO-1 and Occludin genes was obviously increased in the IOT group. Gut microbiome analysis showed that IOT significantly decreased the abundance of harmful bacteria, including Intestinimonas, Oscillibacter, Ruminiclostridium, Ruminiclostridium_9, Lachnospiraceae_NK4A136_group, and Blautia. These findings provided new insights into the metabolic abnormalities regulatory effect of IOT.
Additional Links: PMID-43056814
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43056814,
year = {2026},
author = {Mo, L and Liu, X and Lin, W and Liang, M and Wang, N and Wang, Q and Yang, Y and Li, J},
title = {Chemical composition analysis of instant oil tea and its effect on metabolic disorders in high-fat /high-sucrose diet-fed mice.},
journal = {Food chemistry},
volume = {533},
number = {Pt 4},
pages = {152170},
doi = {10.1016/j.foodchem.2026.152170},
pmid = {43056814},
issn = {1873-7072},
abstract = {This study aimed to characterize the chemical components of instant oil tea (IOT) and explore its ameliorative effects on glucose and lipid metabolism in high-fat /high-sucrose (HFS) diet mice. A total of 16 bioactive compounds were identified in IOT by LC-MS/MS, including phenolic acids, catechins, proanthocyanidins, ellagitannin, and flavonoids. Gallic acid and 3 representative catechins were quantified by HPLC. GC-MS analysis revealed that IOT also contain various volatile components, such as zingiberene, β-sesquiphellandrene, and γ-muurolene. IOT significantly reduced the liver index, as well as the serum levels of TC, TG, LDL-C, LPS, and blood glucose, while increasing the HDL-C level. The the colonic expression of ZO-1 and Occludin genes was obviously increased in the IOT group. Gut microbiome analysis showed that IOT significantly decreased the abundance of harmful bacteria, including Intestinimonas, Oscillibacter, Ruminiclostridium, Ruminiclostridium_9, Lachnospiraceae_NK4A136_group, and Blautia. These findings provided new insights into the metabolic abnormalities regulatory effect of IOT.},
}
RevDate: 2026-11-19
Integrated microbiomic and metabolomic analysis reveals key microbes, metabolites, and pathways affecting semen quality in drakes.
Poultry science, 106(1):108123 pii:S0032-5791(26)01760-8 [Epub ahead of print].
Semen quality is one of the important indicators for evaluating the reproductive capacity of drakes. Currently, semen quality is one of the main factors limiting the development of artificial insemination technology in ducks. Multiple studies have shown that seminal microorganisms are important factors affecting duck semen quality via metabolites, but the specific mechanisms remain unclear. Therefore, this study used 340-day-old Nonghua drakes as experimental subjects. After routine semen quality evaluation of the 86 drakes, we found large individual differences in semen quality. Then, 8 drakes with the highest and lowest SQF were divided into high semen quality (HSQ) and low semen quality (LSQ) groups. The semen quality evaluation results showed that sperm viability, sperm motility, sperm concentration, and SQF of drakes in the HSQ group were significantly higher than those in the LSQ group (P < 0.05). The results of semen untargeted metabolomics in the HSQ and LSQ groups showed that a total of 1934 common metabolites were identified in both groups, among which 54 were differential metabolites between the groups. Functional analysis results showed that 8 differential metabolites were enriched in KEGG pathways closely related to sperm energy metabolism, antioxidant protection, and signal transduction. 16S rRNA sequencing results showed that the relative abundances of Bacillus, Methyloversatilis, and Turicibacter in the semen of the HSQ group were significantly lower than those in the LSQ group (P < 0.05). In contrast, the relative abundances of Gallibacterium, Lactobacillus, Mycoplasma, and Pseudomonas in the semen of HSQ drakes were significantly higher than those in the LSQ group (P < 0.05). The combined analysis of the microbiome and metabolome showed that key microbes (Lactobacillus and Methyloversatilis) and a key metabolite (3-Hydroxybutanoic acid and uridine 5'-monophosphate) are factors affecting sperm concentration, sperm viability, SQF, and sperm motility in drake semen. Their effects may be related to the butanoate metabolism and pyrimidine metabolism pathways. These results provide important insights for further understanding the regulatory mechanisms of drake semen quality.
Additional Links: PMID-43056955
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43056955,
year = {2026},
author = {Xie, H and Hu, X and Li, J and Liu, H and Hu, S and Hu, J and He, H and Li, L and Wang, J},
title = {Integrated microbiomic and metabolomic analysis reveals key microbes, metabolites, and pathways affecting semen quality in drakes.},
journal = {Poultry science},
volume = {106},
number = {1},
pages = {108123},
doi = {10.1016/j.psj.2026.108123},
pmid = {43056955},
issn = {1525-3171},
abstract = {Semen quality is one of the important indicators for evaluating the reproductive capacity of drakes. Currently, semen quality is one of the main factors limiting the development of artificial insemination technology in ducks. Multiple studies have shown that seminal microorganisms are important factors affecting duck semen quality via metabolites, but the specific mechanisms remain unclear. Therefore, this study used 340-day-old Nonghua drakes as experimental subjects. After routine semen quality evaluation of the 86 drakes, we found large individual differences in semen quality. Then, 8 drakes with the highest and lowest SQF were divided into high semen quality (HSQ) and low semen quality (LSQ) groups. The semen quality evaluation results showed that sperm viability, sperm motility, sperm concentration, and SQF of drakes in the HSQ group were significantly higher than those in the LSQ group (P < 0.05). The results of semen untargeted metabolomics in the HSQ and LSQ groups showed that a total of 1934 common metabolites were identified in both groups, among which 54 were differential metabolites between the groups. Functional analysis results showed that 8 differential metabolites were enriched in KEGG pathways closely related to sperm energy metabolism, antioxidant protection, and signal transduction. 16S rRNA sequencing results showed that the relative abundances of Bacillus, Methyloversatilis, and Turicibacter in the semen of the HSQ group were significantly lower than those in the LSQ group (P < 0.05). In contrast, the relative abundances of Gallibacterium, Lactobacillus, Mycoplasma, and Pseudomonas in the semen of HSQ drakes were significantly higher than those in the LSQ group (P < 0.05). The combined analysis of the microbiome and metabolome showed that key microbes (Lactobacillus and Methyloversatilis) and a key metabolite (3-Hydroxybutanoic acid and uridine 5'-monophosphate) are factors affecting sperm concentration, sperm viability, SQF, and sperm motility in drake semen. Their effects may be related to the butanoate metabolism and pyrimidine metabolism pathways. These results provide important insights for further understanding the regulatory mechanisms of drake semen quality.},
}
RevDate: 2026-11-19
Applications of 16S rRNA gene sequencing for profiling the poultry litter microbiome- an industry perspective.
Poultry science, 106(1):108117 pii:S0032-5791(26)01754-2 [Epub ahead of print].
Poultry litter is a dynamic polymicrobial habitat with implications for bird health, food safety, and environmental integrity. Amplicon sequencing of the 16S rRNA gene has emerged as the dominant approach for characterizing poultry-associated microbial communities, offering a scalable and reproducible framework for exploring litter microbial ecology. Complementary to biosurveillance and the expansion of foundational knowledge, 16S-based profiling holds substantial translational value in an industry setting. Microbiome data can inform the identification and mechanistic characterization of pre-, pro-, post-, and synbiotic intervention candidates, including elucidating indirect modes of action mediated through shifts in the native microbial community or litter environment. Profiling efforts also facilitate the discovery of indicator organisms, enteric pathogens, keystone taxa, and core microbiome members whose presence and relative abundance may signal broader community dynamics and guide targeted intervention strategies. When litter is profiled alongside adjacent matrices such as soil, dust, and aerosols, comparative analyses can illuminate microbial passage and shared community members across compartments, informing sanitation and biosecurity practices. Overlaying microbial composition with physicochemical parameters may improve understanding of acidifier performance, ammonia mitigation, and litter fertilizer value. Additionally, 16S datasets provide a framework for the development of targeted molecular assays for routine monitoring and decision-making. This review highlights practical applications of 16S sequencing-based poultry litter microbiome profiling from an industry perspective, demonstrating how microbiome-informed approaches can be leveraged to develop targeted, data-driven intervention strategies.
Additional Links: PMID-43056961
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43056961,
year = {2026},
author = {Hale, B and Gajurel, G and Arnold, C and Priddle, C and Olson, EG and Ricke, SC},
title = {Applications of 16S rRNA gene sequencing for profiling the poultry litter microbiome- an industry perspective.},
journal = {Poultry science},
volume = {106},
number = {1},
pages = {108117},
doi = {10.1016/j.psj.2026.108117},
pmid = {43056961},
issn = {1525-3171},
abstract = {Poultry litter is a dynamic polymicrobial habitat with implications for bird health, food safety, and environmental integrity. Amplicon sequencing of the 16S rRNA gene has emerged as the dominant approach for characterizing poultry-associated microbial communities, offering a scalable and reproducible framework for exploring litter microbial ecology. Complementary to biosurveillance and the expansion of foundational knowledge, 16S-based profiling holds substantial translational value in an industry setting. Microbiome data can inform the identification and mechanistic characterization of pre-, pro-, post-, and synbiotic intervention candidates, including elucidating indirect modes of action mediated through shifts in the native microbial community or litter environment. Profiling efforts also facilitate the discovery of indicator organisms, enteric pathogens, keystone taxa, and core microbiome members whose presence and relative abundance may signal broader community dynamics and guide targeted intervention strategies. When litter is profiled alongside adjacent matrices such as soil, dust, and aerosols, comparative analyses can illuminate microbial passage and shared community members across compartments, informing sanitation and biosecurity practices. Overlaying microbial composition with physicochemical parameters may improve understanding of acidifier performance, ammonia mitigation, and litter fertilizer value. Additionally, 16S datasets provide a framework for the development of targeted molecular assays for routine monitoring and decision-making. This review highlights practical applications of 16S sequencing-based poultry litter microbiome profiling from an industry perspective, demonstrating how microbiome-informed approaches can be leveraged to develop targeted, data-driven intervention strategies.},
}
RevDate: 2026-11-19
Population-scale identification of gut commensals that antagonize antibiotic-resistant pathogens.
Cell host & microbe pii:S1931-3128(26)00444-0 [Epub ahead of print].
Antimicrobial resistance poses a global threat, yet microbiome-encoded defenses against antibiotic resistance gene (ARG)-associated pathogens remain poorly defined. Here, we analyze 12,238 human gut metagenomes and prioritize 159 commensal species ("coexcluders") that show inverse associations with ARG-associated pathogenic taxa. These taxa carry low ARG burdens and encode candidate antimicrobial peptide repertoires. For Faecalibacterium prausnitzii, deep learning-guided mining of 2,053 genomes reveals 6,737 peptides prevalent in the human gut that inversely associate with ARG-associated pathogens. In antibiotic-perturbed mice, F. prausnitzii reduces the resistance burden and restores ecological stability, with peptide enrichment. These peptides show preferential activity against antibiotic-resistant E. coli derivatives while sparing commensals, which is consistent with a kill-the-winner dynamic. Anaerobic coculture reveals resistance-dependent peptide induction, linking the resistance phenotype to competitive suppression. This work establishes a scalable, resistance-guided framework that links population-level ecological signatures to strain-resolved microbial and molecular candidates, providing a basis for mechanistic and therapeutic development.
Additional Links: PMID-43057237
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43057237,
year = {2026},
author = {Zhang, Q and Chen, B and Zhang, Z and Ni, Y and Xu, N and Qiu, D and Lu, T and Du, H and Gillings, M and Peñuelas, J and Zhu, G and Zhu, L and Zhu, YG and Qian, H},
title = {Population-scale identification of gut commensals that antagonize antibiotic-resistant pathogens.},
journal = {Cell host & microbe},
volume = {},
number = {},
pages = {},
doi = {10.1016/j.chom.2026.10.010},
pmid = {43057237},
issn = {1934-6069},
abstract = {Antimicrobial resistance poses a global threat, yet microbiome-encoded defenses against antibiotic resistance gene (ARG)-associated pathogens remain poorly defined. Here, we analyze 12,238 human gut metagenomes and prioritize 159 commensal species ("coexcluders") that show inverse associations with ARG-associated pathogenic taxa. These taxa carry low ARG burdens and encode candidate antimicrobial peptide repertoires. For Faecalibacterium prausnitzii, deep learning-guided mining of 2,053 genomes reveals 6,737 peptides prevalent in the human gut that inversely associate with ARG-associated pathogens. In antibiotic-perturbed mice, F. prausnitzii reduces the resistance burden and restores ecological stability, with peptide enrichment. These peptides show preferential activity against antibiotic-resistant E. coli derivatives while sparing commensals, which is consistent with a kill-the-winner dynamic. Anaerobic coculture reveals resistance-dependent peptide induction, linking the resistance phenotype to competitive suppression. This work establishes a scalable, resistance-guided framework that links population-level ecological signatures to strain-resolved microbial and molecular candidates, providing a basis for mechanistic and therapeutic development.},
}
RevDate: 2026-11-19
Genome-resolved multi-omics reveals microbiome reorganization and carbon-flow regulation driven by functional bioaugmentation in thermophilic anaerobic digestion.
Bioresource technology pii:S0960-8524(26)02378-3 [Epub ahead of print].
Bioaugmentation has emerged as a promising strategy for manipulating complex microbial ecosystems. However, the ecological mechanisms determining whether introduced microorganisms can functionally integrate into indigenous communities remain poorly understood. Here, genome-resolved metagenomics and metabolomics were combined to investigate how B. thermoamylovorans Y25 influenced microbial succession and ecosystem-level carbon transformation. Y25 successfully established within the thermophilic anaerobic microbiome and promoted a 12.69% (472.00 ± 27.69 NmL g[-1] VS, p < 0.05) increase in cumulative methane yield without compromising reactor stability. This improvement occurred without significant changes in methanogenesis-related genes. Instead, Y25 bioaugmentation induced pronounced shifts in microorganisms associated with hydrolysis and fermentation and enhanced pathways related to substrate transport and intermediate carbon metabolism, accompanied by coordinated metabolite changes. These findings support a transition from strain-centered bioaugmentation strategies toward an ecosystem-level perspective, highlighting that successful microbial engineering depends on ecological integration and functional coordination within indigenous microbial networks.
Additional Links: PMID-43057540
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43057540,
year = {2026},
author = {Zhang, S and Zhang, L and Xiao, M and Hu, Z and Wang, N and Shi, J and Xie, B and Shi, J and Ge, J and Yan, W and Liu, L},
title = {Genome-resolved multi-omics reveals microbiome reorganization and carbon-flow regulation driven by functional bioaugmentation in thermophilic anaerobic digestion.},
journal = {Bioresource technology},
volume = {},
number = {},
pages = {136296},
doi = {10.1016/j.biortech.2026.136296},
pmid = {43057540},
issn = {1873-2976},
abstract = {Bioaugmentation has emerged as a promising strategy for manipulating complex microbial ecosystems. However, the ecological mechanisms determining whether introduced microorganisms can functionally integrate into indigenous communities remain poorly understood. Here, genome-resolved metagenomics and metabolomics were combined to investigate how B. thermoamylovorans Y25 influenced microbial succession and ecosystem-level carbon transformation. Y25 successfully established within the thermophilic anaerobic microbiome and promoted a 12.69% (472.00 ± 27.69 NmL g[-1] VS, p < 0.05) increase in cumulative methane yield without compromising reactor stability. This improvement occurred without significant changes in methanogenesis-related genes. Instead, Y25 bioaugmentation induced pronounced shifts in microorganisms associated with hydrolysis and fermentation and enhanced pathways related to substrate transport and intermediate carbon metabolism, accompanied by coordinated metabolite changes. These findings support a transition from strain-centered bioaugmentation strategies toward an ecosystem-level perspective, highlighting that successful microbial engineering depends on ecological integration and functional coordination within indigenous microbial networks.},
}
RevDate: 2026-11-19
CmpDate: 2026-11-19
Insulin resistance and hepatic steatosis.
Best practice & research. Clinical gastroenterology, 84:102150.
Insulin resistance promotes hepatic steatosis by increasing fatty acid delivery from adipose tissue and favoring hepatic de novo lipogenesis. Hepatic triglyceride accumulation occurs when lipid acquisition exceeds disposal through oxidation and very-low-density lipoprotein secretion. These disposal pathways may initially increase, but their adaptation can become inadequate during sustained metabolic stress. Lipid intermediates, endoplasmic reticulum stress, mitochondrial dysfunction, and inflammatory signaling can then impair insulin action and contribute to hepatocellular injury. Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses steatosis and metabolic dysfunction-associated steatohepatitis (MASH), with variable progression to fibrosis, cirrhosis, and hepatocellular carcinoma. Genetic variants, including PNPLA3 and TM6SF2, modify hepatic lipid handling and disease susceptibility, while HSD17B13 illustrates that susceptibility to steatosis and progressive liver injury can differ. The gut microbiome and intestinal barrier provide additional links between nutrient metabolism and hepatic inflammation, although their causal and therapeutic relevance in humans remains incompletely defined. This narrative review examines the mechanisms connecting insulin resistance with hepatic steatosis, the factors that modify progression, and the evidence for metabolic and liver-directed therapies. Sustained weight loss and selected pharmacological treatments improve liver fat or histological outcomes, but durable clinical benefit, treatment selection, and noninvasive monitoring remain priorities for research.
Additional Links: PMID-43057752
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43057752,
year = {2026},
author = {Tomovic, A and Bakovic, N and Pantic, I and Baljosevic, N and Rankovic, I and Milovanovic, T},
title = {Insulin resistance and hepatic steatosis.},
journal = {Best practice & research. Clinical gastroenterology},
volume = {84},
number = {},
pages = {102150},
doi = {10.1016/j.bpg.2026.102150},
pmid = {43057752},
issn = {1532-1916},
mesh = {Humans ; *Insulin Resistance ; *Fatty Liver/metabolism/therapy/genetics/physiopathology ; *Liver/metabolism/pathology ; Animals ; Disease Progression ; Genetic Predisposition to Disease ; Lipid Metabolism ; Gastrointestinal Microbiome ; Phospholipases A2, Calcium-Independent ; },
abstract = {Insulin resistance promotes hepatic steatosis by increasing fatty acid delivery from adipose tissue and favoring hepatic de novo lipogenesis. Hepatic triglyceride accumulation occurs when lipid acquisition exceeds disposal through oxidation and very-low-density lipoprotein secretion. These disposal pathways may initially increase, but their adaptation can become inadequate during sustained metabolic stress. Lipid intermediates, endoplasmic reticulum stress, mitochondrial dysfunction, and inflammatory signaling can then impair insulin action and contribute to hepatocellular injury. Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses steatosis and metabolic dysfunction-associated steatohepatitis (MASH), with variable progression to fibrosis, cirrhosis, and hepatocellular carcinoma. Genetic variants, including PNPLA3 and TM6SF2, modify hepatic lipid handling and disease susceptibility, while HSD17B13 illustrates that susceptibility to steatosis and progressive liver injury can differ. The gut microbiome and intestinal barrier provide additional links between nutrient metabolism and hepatic inflammation, although their causal and therapeutic relevance in humans remains incompletely defined. This narrative review examines the mechanisms connecting insulin resistance with hepatic steatosis, the factors that modify progression, and the evidence for metabolic and liver-directed therapies. Sustained weight loss and selected pharmacological treatments improve liver fat or histological outcomes, but durable clinical benefit, treatment selection, and noninvasive monitoring remain priorities for research.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Insulin Resistance
*Fatty Liver/metabolism/therapy/genetics/physiopathology
*Liver/metabolism/pathology
Animals
Disease Progression
Genetic Predisposition to Disease
Lipid Metabolism
Gastrointestinal Microbiome
Phospholipases A2, Calcium-Independent
RevDate: 2026-11-19
CmpDate: 2026-11-19
Temporal strain-resolved metagenomics associates IBD dysbiosis with gastrointestinal inflammation.
Nature communications, 17(1):.
The gut microbiome in inflammatory bowel disease (IBD) is enriched in proinflammatory bacteria, yet defining a consistent dysbiotic signature is challenging, due to substantial variation between individuals and over time. We performed a high-resolution meta-analysis of 4,839 public metagenomes to disentangle the effects of IBD subtypes, inflammation, temporal, and individual variability. After accounting for temporal variation, we show that IBD-associated dysbiosis was characterized primarily by relative depletion of commensal bacteria rather than expansion of disease-associated taxa, together with increased microbiome variability both within and between individuals. Although 30% of species were IBD-associated, only 73% of these associations remained consistent across all timepoints. IBD-associated bacteria showed reduced persistence within hosts, increased strain loss and diminished strain engraftment. 8% of commensal species displayed strain-level associations with IBD that were independent of species-level changes, suggesting distinct ecological strategies for persistence. Finally, defining an inflammatory index, we demonstrated that inflammation explains much of the observed variation in microbial composition and abundance. Together, our findings indicate that inflammation associates and likely contributes to loss of commensals, thereby limiting microbiome recovery and resilience.
Additional Links: PMID-43058101
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43058101,
year = {2026},
author = {Ansorge, R and Romano, S and Frioux, C and Korcsmáros, T and Yoou, M and Juge, N and Sidorczuk, K and Hildebrand, F},
title = {Temporal strain-resolved metagenomics associates IBD dysbiosis with gastrointestinal inflammation.},
journal = {Nature communications},
volume = {17},
number = {1},
pages = {},
pmid = {43058101},
issn = {2041-1723},
support = {erc-stg-948219//EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council)/ ; BB/X011054/1//RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)/ ; BBX011089/1//RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)/ ; },
mesh = {*Dysbiosis/microbiology ; *Inflammatory Bowel Diseases/microbiology ; *Metagenomics/methods ; Humans ; *Gastrointestinal Microbiome/genetics ; Bacteria/genetics/classification/isolation & purification ; Metagenome ; Inflammation/microbiology ; Animals ; },
abstract = {The gut microbiome in inflammatory bowel disease (IBD) is enriched in proinflammatory bacteria, yet defining a consistent dysbiotic signature is challenging, due to substantial variation between individuals and over time. We performed a high-resolution meta-analysis of 4,839 public metagenomes to disentangle the effects of IBD subtypes, inflammation, temporal, and individual variability. After accounting for temporal variation, we show that IBD-associated dysbiosis was characterized primarily by relative depletion of commensal bacteria rather than expansion of disease-associated taxa, together with increased microbiome variability both within and between individuals. Although 30% of species were IBD-associated, only 73% of these associations remained consistent across all timepoints. IBD-associated bacteria showed reduced persistence within hosts, increased strain loss and diminished strain engraftment. 8% of commensal species displayed strain-level associations with IBD that were independent of species-level changes, suggesting distinct ecological strategies for persistence. Finally, defining an inflammatory index, we demonstrated that inflammation explains much of the observed variation in microbial composition and abundance. Together, our findings indicate that inflammation associates and likely contributes to loss of commensals, thereby limiting microbiome recovery and resilience.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Dysbiosis/microbiology
*Inflammatory Bowel Diseases/microbiology
*Metagenomics/methods
Humans
*Gastrointestinal Microbiome/genetics
Bacteria/genetics/classification/isolation & purification
Metagenome
Inflammation/microbiology
Animals
RevDate: 2026-11-19
CmpDate: 2026-11-19
Bacterial Communities Associated with Angiostrongylus cantonensis Third-Stage Larvae Vary Across Different Intermediate Host Species.
Microbial ecology, 89(1):.
Host-associated microbiomes are critical to animal biology, yet those of helminthic parasites are poorly understood. We investigated the microbiome of third-stage larvae (L3) of the rat lungworm, Angiostrongylus cantonensis, isolated from two invasive slug intermediate host species in Hawai'i, Laevicaulis alte and Parmarion martensi. Using partial 16 S rRNA gene sequencing, we compared parasite microbiomes with those of their slug hosts. The nematodes harbored a distinct microbiome that overlapped with, but differed compositionally from, the slug microbiomes. Angiostrongylus cantonensis L3 microbiomes also differed between larvae isolated from the two slug species. Predictions of parasite microbiome functional capability identified 480 microbial gene pathways that varied in abundance between the parasite-isolate populations, including pathways related to amino acid and B-vitamin synthesis. These findings suggest that A. cantonensis L3 maintains a selective, partially host-derived, microbiome that also may have a role in nutrient provisioning for the parasite. This study provides novel insights into parasite-microbiome ecology, with implications for understanding host-parasite interactions and transmission dynamics.
Additional Links: PMID-43058289
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43058289,
year = {2026},
author = {Griffin, CD and Ezenwa, VO and Gottdenker, NL and Cowie, RH},
title = {Bacterial Communities Associated with Angiostrongylus cantonensis Third-Stage Larvae Vary Across Different Intermediate Host Species.},
journal = {Microbial ecology},
volume = {89},
number = {1},
pages = {},
pmid = {43058289},
issn = {1432-184X},
support = {2410205//National Science Foundation, United States/ ; },
mesh = {Animals ; *Angiostrongylus cantonensis/microbiology/growth & development ; Larva/microbiology ; *Microbiota ; *Gastropoda/parasitology/microbiology ; *Bacteria/classification/genetics/isolation & purification ; Host-Parasite Interactions ; Hawaii ; RNA, Ribosomal, 16S/genetics ; },
abstract = {Host-associated microbiomes are critical to animal biology, yet those of helminthic parasites are poorly understood. We investigated the microbiome of third-stage larvae (L3) of the rat lungworm, Angiostrongylus cantonensis, isolated from two invasive slug intermediate host species in Hawai'i, Laevicaulis alte and Parmarion martensi. Using partial 16 S rRNA gene sequencing, we compared parasite microbiomes with those of their slug hosts. The nematodes harbored a distinct microbiome that overlapped with, but differed compositionally from, the slug microbiomes. Angiostrongylus cantonensis L3 microbiomes also differed between larvae isolated from the two slug species. Predictions of parasite microbiome functional capability identified 480 microbial gene pathways that varied in abundance between the parasite-isolate populations, including pathways related to amino acid and B-vitamin synthesis. These findings suggest that A. cantonensis L3 maintains a selective, partially host-derived, microbiome that also may have a role in nutrient provisioning for the parasite. This study provides novel insights into parasite-microbiome ecology, with implications for understanding host-parasite interactions and transmission dynamics.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
*Angiostrongylus cantonensis/microbiology/growth & development
Larva/microbiology
*Microbiota
*Gastropoda/parasitology/microbiology
*Bacteria/classification/genetics/isolation & purification
Host-Parasite Interactions
Hawaii
RNA, Ribosomal, 16S/genetics
RevDate: 2026-11-19
CmpDate: 2026-11-19
Rhizosphere microbiome assembly of the pioneer fern Dicranopteris dichotoma and the effects of multifunctional plant growth-promoting rhizobacteria on rapeseed.
World journal of microbiology & biotechnology, 42(12):.
The red soil regions of southern China are characterized by acidity and severe nutrient deficiency, where the pioneer fern Dicranopteris dichotoma thrives. Its rhizosphere may harbor stress-adapted plant growth-promoting rhizobacteria (PGPR). The study compared rhizosphere and non-rhizosphere soil microbial communities, screened culturable rhizobacteria for plant growth-promoting (PGP) traits, and evaluated selected multifunctional strains on rapeseed (Brassica napus L.) seedlings. High‑throughput sequencing and culturing were combined to analyze community structure. Isolates were screened for phosphate solubilization, potassium mobilization, putative nitrogen fixation, IAA, and siderophore production; and evaluated their growth-promoting effects using pot experiments. Rhizosphere soil showed low nutrients but high enzyme activities: available P was higher (P < 0.05), while organic matter, total N, and available K were lower (P < 0.01). Sucrase, urease, acid phosphatase, and cellulase were significantly elevated (P < 0.01). Bacterial alpha diversity was higher in the rhizosphere (P < 0.05), and bacterial community structure showed a separation trend (PERMANOVA, R[2] = 0.617, P = 0.10), whereas fungal communities did not differ significantly. The rhizosphere was enriched with beneficial bacteria such as Actinobacteriota, Bacillota, and genera Bacillus, Rhodanobacter, Jatrophihabitans, Devosia and the fungal genu Nigrospora. Among 90 isolates, 38 displayed PGP traits, and five strains (MQRB23, MQRB29, MQRB62, MQRB70, and MQRB86) possessed all five traits. All ten multifunctional strains significantly promoted rape growth; MQRB62 (Burkholderia sp.) was most effective, increasing plant fresh and dry weights by 92.6% and 109.7% (P < 0.001), outperforming a commercial microbial agent. These isolates therefore represent candidate PGPR with preliminary biofertilizer potential, pending validation of their biosafety and performance in red soil.
Additional Links: PMID-43058314
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43058314,
year = {2026},
author = {He, F and Zeng, J and Zhong, Y and Li, X and Cheng, Y and Huang, W and Wang, Y},
title = {Rhizosphere microbiome assembly of the pioneer fern Dicranopteris dichotoma and the effects of multifunctional plant growth-promoting rhizobacteria on rapeseed.},
journal = {World journal of microbiology & biotechnology},
volume = {42},
number = {12},
pages = {},
pmid = {43058314},
issn = {1573-0972},
support = {YC2024-s688//Postgraduate Innovations Project of Jiangxi Province/ ; GJJ2401211//Science and Technology Research Project of Jiangxi Provincial Department of Education/ ; },
mesh = {*Rhizosphere ; Soil Microbiology ; *Bacteria/classification/isolation & purification/genetics/metabolism ; *Brassica napus/microbiology/growth & development ; *Ferns/microbiology ; *Microbiota ; Soil/chemistry ; Fungi/classification/isolation & purification/genetics ; Plant Roots/microbiology/growth & development ; China ; Siderophores/metabolism ; Nitrogen Fixation ; Seedlings/microbiology/growth & development ; Phosphates/metabolism ; Plant Development ; Indoleacetic Acids/metabolism ; },
abstract = {The red soil regions of southern China are characterized by acidity and severe nutrient deficiency, where the pioneer fern Dicranopteris dichotoma thrives. Its rhizosphere may harbor stress-adapted plant growth-promoting rhizobacteria (PGPR). The study compared rhizosphere and non-rhizosphere soil microbial communities, screened culturable rhizobacteria for plant growth-promoting (PGP) traits, and evaluated selected multifunctional strains on rapeseed (Brassica napus L.) seedlings. High‑throughput sequencing and culturing were combined to analyze community structure. Isolates were screened for phosphate solubilization, potassium mobilization, putative nitrogen fixation, IAA, and siderophore production; and evaluated their growth-promoting effects using pot experiments. Rhizosphere soil showed low nutrients but high enzyme activities: available P was higher (P < 0.05), while organic matter, total N, and available K were lower (P < 0.01). Sucrase, urease, acid phosphatase, and cellulase were significantly elevated (P < 0.01). Bacterial alpha diversity was higher in the rhizosphere (P < 0.05), and bacterial community structure showed a separation trend (PERMANOVA, R[2] = 0.617, P = 0.10), whereas fungal communities did not differ significantly. The rhizosphere was enriched with beneficial bacteria such as Actinobacteriota, Bacillota, and genera Bacillus, Rhodanobacter, Jatrophihabitans, Devosia and the fungal genu Nigrospora. Among 90 isolates, 38 displayed PGP traits, and five strains (MQRB23, MQRB29, MQRB62, MQRB70, and MQRB86) possessed all five traits. All ten multifunctional strains significantly promoted rape growth; MQRB62 (Burkholderia sp.) was most effective, increasing plant fresh and dry weights by 92.6% and 109.7% (P < 0.001), outperforming a commercial microbial agent. These isolates therefore represent candidate PGPR with preliminary biofertilizer potential, pending validation of their biosafety and performance in red soil.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Rhizosphere
Soil Microbiology
*Bacteria/classification/isolation & purification/genetics/metabolism
*Brassica napus/microbiology/growth & development
*Ferns/microbiology
*Microbiota
Soil/chemistry
Fungi/classification/isolation & purification/genetics
Plant Roots/microbiology/growth & development
China
Siderophores/metabolism
Nitrogen Fixation
Seedlings/microbiology/growth & development
Phosphates/metabolism
Plant Development
Indoleacetic Acids/metabolism
RevDate: 2026-11-20
CmpDate: 2026-11-20
Gut microbiome and immunotherapy in advanced non-small cell lung cancer: a prospective cohort study.
BMC cancer, 26(1):.
BACKGROUND: The gut microbiome (GM) is increasingly recognized as a determinant of immune checkpoint inhibitor (ICI) efficacy in non-small cell lung cancer (NSCLC). However, most available evidence originates from Western, Bacteroides-dominant populations. Understanding GM characteristics in diverse ecological and dietary settings is crucial for global biomarker development.
METHODS: This is a prospective, observational study conducted at a tertiary cancer hospital. 50 adults with advanced NSCLC initiating PD-1/PD-L1 inhibitor-based therapy (with or without chemotherapy) between March 2024 and January 2025 were enrolled. Eligibility required ECOG performance status 0-2 and absence of concurrent antibiotics or probiotics. Paired stool samples were collected at baseline (T0) and first radiologic evaluation (T1, approximately 8-12 weeks). The aim was to characterize baseline and early-on-treatment gut microbiome composition and diversity in Indian patients with advanced NSCLC receiving ICI therapy and to explore associations with clinical outcomes between Responders (CR/PR/SD) vs. Non-Responders (PD).
RESULTS: Among 50 enrolled patients (median age, 56 years; 52% male; 84% adenocarcinoma), 38 were responders and 12 nonresponders. The gut microbiome was Prevotella-dominant (P. copri ≈ 40% relative abundance). No significant differences in α-diversity (Shannon P = .47; Simpson P = .66) or β-diversity (PERMANOVA R²<0.03, P > .2) were observed. Nominal enrichment of Bacteroides sp. AM16 15, Holdemanella biformis, and Phocaeicola salanitronis was seen in responders, whereas Escherichia coli and other Proteobacteria were higher in some non-responders. Akkermansia muciniphila and Faecalibacterium prausnitzii showed no significant association with response.
CONCLUSIONS: This first Indian NSCLC microbiome study establishes a Prevotella-rich regional baseline and underscores that microbiome-immunotherapy associations observed in Western cohorts may not be universal. Population-specific, functionally oriented, multi-omic studies are warranted to guide globally translatable microbiome-based interventions.
TRIAL REGISTRATION: The study was registered with Clinical Trial Registry of India (CTRI, 2024/03/081240) before starting enrolment in the study.
Additional Links: PMID-43058555
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43058555,
year = {2026},
author = {Kapoor, A and Chaudhary, M and Gupta, A and Sansar, B and Mishra, BK and Pal, A and Thakur, P and Kallapura, G and Josphine, I and Singh, A and Upadhyay, A and Sisodia, N and Singh, N and Shukla, S and Bajpai, V and Noronha, V and Prabhash, K},
title = {Gut microbiome and immunotherapy in advanced non-small cell lung cancer: a prospective cohort study.},
journal = {BMC cancer},
volume = {26},
number = {1},
pages = {},
pmid = {43058555},
issn = {1471-2407},
mesh = {Humans ; *Carcinoma, Non-Small-Cell Lung/drug therapy/microbiology/therapy/pathology/immunology ; *Lung Neoplasms/drug therapy/microbiology/pathology/therapy/immunology ; Male ; Prospective Studies ; Female ; *Gastrointestinal Microbiome/drug effects/immunology ; Middle Aged ; *Immunotherapy/methods ; Aged ; *Immune Checkpoint Inhibitors/therapeutic use ; Adult ; },
abstract = {BACKGROUND: The gut microbiome (GM) is increasingly recognized as a determinant of immune checkpoint inhibitor (ICI) efficacy in non-small cell lung cancer (NSCLC). However, most available evidence originates from Western, Bacteroides-dominant populations. Understanding GM characteristics in diverse ecological and dietary settings is crucial for global biomarker development.
METHODS: This is a prospective, observational study conducted at a tertiary cancer hospital. 50 adults with advanced NSCLC initiating PD-1/PD-L1 inhibitor-based therapy (with or without chemotherapy) between March 2024 and January 2025 were enrolled. Eligibility required ECOG performance status 0-2 and absence of concurrent antibiotics or probiotics. Paired stool samples were collected at baseline (T0) and first radiologic evaluation (T1, approximately 8-12 weeks). The aim was to characterize baseline and early-on-treatment gut microbiome composition and diversity in Indian patients with advanced NSCLC receiving ICI therapy and to explore associations with clinical outcomes between Responders (CR/PR/SD) vs. Non-Responders (PD).
RESULTS: Among 50 enrolled patients (median age, 56 years; 52% male; 84% adenocarcinoma), 38 were responders and 12 nonresponders. The gut microbiome was Prevotella-dominant (P. copri ≈ 40% relative abundance). No significant differences in α-diversity (Shannon P = .47; Simpson P = .66) or β-diversity (PERMANOVA R²<0.03, P > .2) were observed. Nominal enrichment of Bacteroides sp. AM16 15, Holdemanella biformis, and Phocaeicola salanitronis was seen in responders, whereas Escherichia coli and other Proteobacteria were higher in some non-responders. Akkermansia muciniphila and Faecalibacterium prausnitzii showed no significant association with response.
CONCLUSIONS: This first Indian NSCLC microbiome study establishes a Prevotella-rich regional baseline and underscores that microbiome-immunotherapy associations observed in Western cohorts may not be universal. Population-specific, functionally oriented, multi-omic studies are warranted to guide globally translatable microbiome-based interventions.
TRIAL REGISTRATION: The study was registered with Clinical Trial Registry of India (CTRI, 2024/03/081240) before starting enrolment in the study.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Carcinoma, Non-Small-Cell Lung/drug therapy/microbiology/therapy/pathology/immunology
*Lung Neoplasms/drug therapy/microbiology/pathology/therapy/immunology
Male
Prospective Studies
Female
*Gastrointestinal Microbiome/drug effects/immunology
Middle Aged
*Immunotherapy/methods
Aged
*Immune Checkpoint Inhibitors/therapeutic use
Adult
RevDate: 2026-11-20
CmpDate: 2026-11-20
Decoding the sand fly-Leishmania interaction: from biological insights to disease control.
Parasites & vectors, 19(1):.
Leishmaniasis persists as a major yet under-controlled vector-borne disease, maintained by a highly specialized and dynamic interaction between Leishmania parasites and their sand fly vectors. Understanding how vector competence emerges from the integration of molecular, immunological, and microbiome-driven processes is critical for identifying novel intervention points to reduce disease incidence. We share our perspective on this multilayered biological dialogue shaped by molecular interactions, innate immune signaling, and microbiota ecology. Rather than a non-reactive host, the sand fly regulates digestion, immunity, and the resident microbial gut communities. In parallel, Leishmania deploys virulence strategies that can manipulate gut physiology, immune responses, and even vector behavior to ensure its survival and transmission. The outcomes depend on timing and, eventually, species-specific compatibility. We further explore how antiviral defenses, bacterial symbionts, and metabolic context intersect with parasite development, revealing layers of complexity that extend beyond basic parasite-vector models. We point out new opportunities for intervention, ranging from transmission-blocking approaches to microbiome-based control that can disrupt disease transmission at its source.
Additional Links: PMID-43058871
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43058871,
year = {2026},
author = {Telleria, EL and Fonseca, VW and Tempone, AJ and Traub-Cseko, YM},
title = {Decoding the sand fly-Leishmania interaction: from biological insights to disease control.},
journal = {Parasites & vectors},
volume = {19},
number = {1},
pages = {},
pmid = {43058871},
issn = {1756-3305},
mesh = {Animals ; *Psychodidae/parasitology/immunology/microbiology/physiology ; *Leishmania/physiology/pathogenicity ; *Host-Parasite Interactions ; *Insect Vectors/parasitology/immunology/microbiology ; *Leishmaniasis/prevention & control/transmission/parasitology ; Humans ; Microbiota ; Immunity, Innate ; },
abstract = {Leishmaniasis persists as a major yet under-controlled vector-borne disease, maintained by a highly specialized and dynamic interaction between Leishmania parasites and their sand fly vectors. Understanding how vector competence emerges from the integration of molecular, immunological, and microbiome-driven processes is critical for identifying novel intervention points to reduce disease incidence. We share our perspective on this multilayered biological dialogue shaped by molecular interactions, innate immune signaling, and microbiota ecology. Rather than a non-reactive host, the sand fly regulates digestion, immunity, and the resident microbial gut communities. In parallel, Leishmania deploys virulence strategies that can manipulate gut physiology, immune responses, and even vector behavior to ensure its survival and transmission. The outcomes depend on timing and, eventually, species-specific compatibility. We further explore how antiviral defenses, bacterial symbionts, and metabolic context intersect with parasite development, revealing layers of complexity that extend beyond basic parasite-vector models. We point out new opportunities for intervention, ranging from transmission-blocking approaches to microbiome-based control that can disrupt disease transmission at its source.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
*Psychodidae/parasitology/immunology/microbiology/physiology
*Leishmania/physiology/pathogenicity
*Host-Parasite Interactions
*Insect Vectors/parasitology/immunology/microbiology
*Leishmaniasis/prevention & control/transmission/parasitology
Humans
Microbiota
Immunity, Innate
RevDate: 2026-11-19
CmpDate: 2026-11-20
Bacterial and fungal diversity in Anopheles larval habitats with different productivities.
Parasites & vectors, 19(1):.
BACKGROUND: Anopheles gambiae mosquitoes develop in diverse aquatic habitats, where microbial communities influence oviposition, larval growth, and survival. This study characterized bacterial and fungal communities across Anopheles larval habitats of differing productivity in southern Ghana.
METHODS: Larval densities were monitored bi-weekly over 6 months. Water and larval samples were collected for bacterial (16S rRNA gene) and fungal (ITS) amplicon sequencing. Based on the consistency of Anopheles larval presence throughout the monitoring period, habitats were classified as high-productive (larvae present at every visit), low-productive (intermittent larval presence), or non-productive (larvae consistently absent).
RESULTS: The study revealed that distinct microbial signatures were associated with habitat productivity. Linear discriminant analysis identified Paraclostridium bifermentans and Bacillus spp. as indicator taxa for high-productive habitats, while Acinetobacter variabilis and Lactococcus garvieae were associated with low-productive habitats. For fungi, Cladosporium halotolerans and Aspergillus penicillioides were the primary discriminant taxa associated with high-productive habitats, while Candida tropicalis and Pichia kudriavzevii characterized low-productive habitats. Beta-diversity analyses revealed significant differences in bacterial communities between productive and non-productive habitats (PERMANOVA, p = 0.006), whereas fungal communities showed no significant separation.
CONCLUSIONS: These findings highlight an association between microbial assemblages and larval-habitat suitability and underscore the potential of microbiota-informed strategies to enhance vector surveillance and targeted larval control.
Additional Links: PMID-43058881
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43058881,
year = {2026},
author = {Forson, AO and Afrane, YA and Sraku, IK and Akorli, J and Gyamfi, J and Perkins, DJ and Hurwitz, I},
title = {Bacterial and fungal diversity in Anopheles larval habitats with different productivities.},
journal = {Parasites & vectors},
volume = {19},
number = {1},
pages = {},
pmid = {43058881},
issn = {1756-3305},
support = {D43 TW010543/TW/FIC NIH HHS/United States ; R01 AI130473/AI/NIAID NIH HHS/United States ; D43 TW011513, R03AI186018/NH/NIH HHS/United States ; R01AI130473, D43TW005884/NH/NIH HHS/United States ; D43 TW005884/TW/FIC NIH HHS/United States ; D43 TW011513/TW/FIC NIH HHS/United States ; R03 AI186018/AI/NIAID NIH HHS/United States ; },
mesh = {Animals ; *Anopheles/microbiology ; Larva/microbiology ; *Bacteria/classification/genetics/isolation & purification ; *Fungi/classification/genetics/isolation & purification ; RNA, Ribosomal, 16S/genetics ; *Ecosystem ; Ghana ; *Biodiversity ; Microbiota ; },
abstract = {BACKGROUND: Anopheles gambiae mosquitoes develop in diverse aquatic habitats, where microbial communities influence oviposition, larval growth, and survival. This study characterized bacterial and fungal communities across Anopheles larval habitats of differing productivity in southern Ghana.
METHODS: Larval densities were monitored bi-weekly over 6 months. Water and larval samples were collected for bacterial (16S rRNA gene) and fungal (ITS) amplicon sequencing. Based on the consistency of Anopheles larval presence throughout the monitoring period, habitats were classified as high-productive (larvae present at every visit), low-productive (intermittent larval presence), or non-productive (larvae consistently absent).
RESULTS: The study revealed that distinct microbial signatures were associated with habitat productivity. Linear discriminant analysis identified Paraclostridium bifermentans and Bacillus spp. as indicator taxa for high-productive habitats, while Acinetobacter variabilis and Lactococcus garvieae were associated with low-productive habitats. For fungi, Cladosporium halotolerans and Aspergillus penicillioides were the primary discriminant taxa associated with high-productive habitats, while Candida tropicalis and Pichia kudriavzevii characterized low-productive habitats. Beta-diversity analyses revealed significant differences in bacterial communities between productive and non-productive habitats (PERMANOVA, p = 0.006), whereas fungal communities showed no significant separation.
CONCLUSIONS: These findings highlight an association between microbial assemblages and larval-habitat suitability and underscore the potential of microbiota-informed strategies to enhance vector surveillance and targeted larval control.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
*Anopheles/microbiology
Larva/microbiology
*Bacteria/classification/genetics/isolation & purification
*Fungi/classification/genetics/isolation & purification
RNA, Ribosomal, 16S/genetics
*Ecosystem
Ghana
*Biodiversity
Microbiota
RevDate: 2026-11-19
CmpDate: 2026-11-20
Distinct gut viral communities across life stages in dairy cattle.
Microbiome, 14(1):.
BACKGROUND: Ruminant gut microbial communities influence host health, productivity, and methane emissions, yet viral communities across life stages remain uncharacterized. Whilst bacteriophages shape microbial communities in many ecosystems, their role across dairy cattle life stages is unknown. We characterized DNA viral community composition, diversity, and ecology in cows belonging to four life stages: calf, heifer, dry adult, and lactating adult.
RESULTS: Using hybrid Illumina and Oxford Nanopore sequencing, we assembled 30,321 viral operational taxonomic units from fecal samples, including 1338 complete genomes (92% representing novel genera). Viral communities showed distinct life-stage stratification. Calves harbored low-diversity communities (Shannon index: 2.49 vs >6.58 in adults). They also showed a higher proportion of temperate phages (49% vs <24% in adults), though this difference was not statistically significant given the small calf sample (n = 3). Adult viromes showed 50-fold higher community evenness than calves. Viral and bacterial diversity were inversely correlated (Spearman's rho = -0.69), with viral diversity peaking during the drying-off period when bacterial diversity was lowest. Dry cows showed the highest viral loads (3.61% of microbial DNA vs 1.52% in lactating cows) and elevated virus-host ratios, coinciding with increased positive selection on viral genes. Twenty-six vOTUs targeting the methanogen Methanobrevibacter were detected in adults but not calves, paralleling a 757-fold higher relative abundance of Methanobrevibacter in adults. Additionally, we identified viruses carrying putative auxiliary metabolic genes involved in methane metabolism pathways.
CONCLUSIONS: The dairy cattle gut virome is extensive, almost entirely novel, and clearly stratified by life stage-characterised here across calves, heifers, dry adults, and lactating adults for the first time. Viral and bacterial diversity showed a significant inverse relationship that was most pronounced around drying-off, and viruses targeting the methanogen Methanobrevibacter were present in adults but absent from calves. Although cross-sectional, the data establish life stage as a key variable in the ruminant gut virome and identify methanogen-infecting phages as a candidate for reducing enteric methane emissions. Video Abstract.
Additional Links: PMID-43058911
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43058911,
year = {2026},
author = {Cook, R and Blanchard, AM and Marsh, C and Ponsero, AJ and Reynolds, J and Adriaenssens, EM and Hudson, C and Hobman, JL and Stekel, DJ and Jones, MA and Millard, AD},
title = {Distinct gut viral communities across life stages in dairy cattle.},
journal = {Microbiome},
volume = {14},
number = {1},
pages = {},
pmid = {43058911},
issn = {2049-2618},
mesh = {Animals ; Cattle/virology ; *Gastrointestinal Microbiome/genetics ; Female ; Feces/virology/microbiology ; *Virome ; Bacteriophages/genetics/classification/isolation & purification ; Bacteria/classification/genetics ; Lactation ; Life Cycle Stages ; },
abstract = {BACKGROUND: Ruminant gut microbial communities influence host health, productivity, and methane emissions, yet viral communities across life stages remain uncharacterized. Whilst bacteriophages shape microbial communities in many ecosystems, their role across dairy cattle life stages is unknown. We characterized DNA viral community composition, diversity, and ecology in cows belonging to four life stages: calf, heifer, dry adult, and lactating adult.
RESULTS: Using hybrid Illumina and Oxford Nanopore sequencing, we assembled 30,321 viral operational taxonomic units from fecal samples, including 1338 complete genomes (92% representing novel genera). Viral communities showed distinct life-stage stratification. Calves harbored low-diversity communities (Shannon index: 2.49 vs >6.58 in adults). They also showed a higher proportion of temperate phages (49% vs <24% in adults), though this difference was not statistically significant given the small calf sample (n = 3). Adult viromes showed 50-fold higher community evenness than calves. Viral and bacterial diversity were inversely correlated (Spearman's rho = -0.69), with viral diversity peaking during the drying-off period when bacterial diversity was lowest. Dry cows showed the highest viral loads (3.61% of microbial DNA vs 1.52% in lactating cows) and elevated virus-host ratios, coinciding with increased positive selection on viral genes. Twenty-six vOTUs targeting the methanogen Methanobrevibacter were detected in adults but not calves, paralleling a 757-fold higher relative abundance of Methanobrevibacter in adults. Additionally, we identified viruses carrying putative auxiliary metabolic genes involved in methane metabolism pathways.
CONCLUSIONS: The dairy cattle gut virome is extensive, almost entirely novel, and clearly stratified by life stage-characterised here across calves, heifers, dry adults, and lactating adults for the first time. Viral and bacterial diversity showed a significant inverse relationship that was most pronounced around drying-off, and viruses targeting the methanogen Methanobrevibacter were present in adults but absent from calves. Although cross-sectional, the data establish life stage as a key variable in the ruminant gut virome and identify methanogen-infecting phages as a candidate for reducing enteric methane emissions. Video Abstract.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
Cattle/virology
*Gastrointestinal Microbiome/genetics
Female
Feces/virology/microbiology
*Virome
Bacteriophages/genetics/classification/isolation & purification
Bacteria/classification/genetics
Lactation
Life Cycle Stages
RevDate: 2026-11-20
CmpDate: 2026-11-20
Modeling the human vaginal microbiome and its protection against pathogens using the replicator framework for invasion.
Microbiome, 14(1):.
BACKGROUND: The human vaginal microbiota plays a central role in reproductive and urogenital health, protecting against infections including bacterial vaginosis (BV), yeast infections, HIV, and urinary tract infections. However, the ecological mechanisms linking microbial community structure to clinical indicators such as Nugent scores remain poorly understood. Although machine-learning approaches can accurately predict BV from microbiota profiles, they provide limited biological insight into the mechanisms linking community structure to clinical outcomes.
RESULTS: We introduce a locally adapted mechanistic framework based on replicator dynamics to link vaginal microbiota composition to Nugent score and identify key ecological interactions underlying healthy, intermediate, and BV-positive states. We quantified both the contributions of individual taxa and the nonlinear effects arising from pairwise interactions, using a taxonomic representation that retained four vaginally relevant Lactobacillus species separately while grouping the remaining taxa at broader taxonomic units. Applied to microbiota data from a previously published cohort of 394 North American women, the model predicted BV status with 94% accuracy, matching machine-learning benchmarks while providing an interpretable ecological description of BV-associated community reorganization.
CONCLUSIONS: This framework provides a biologically interpretable link between vaginal microbiota composition and clinical outcomes, revealing ecological mechanisms underlying BV. Beyond BV, our results demonstrate the broader potential of replicator-based ecological formalisms for modeling microbiota-invader dynamics across host-associated microbial systems. Video Abstract.
Additional Links: PMID-43058922
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43058922,
year = {2026},
author = {Freire, TFA and Garcia-Romero, M and Gjini, E},
title = {Modeling the human vaginal microbiome and its protection against pathogens using the replicator framework for invasion.},
journal = {Microbiome},
volume = {14},
number = {1},
pages = {},
pmid = {43058922},
issn = {2049-2618},
support = {2022.03060.PTDC//Fundação para a Ciência e a Tecnologia/ ; 2022.03060.PTDC//Fundação para a Ciência e a Tecnologia/ ; 2022.03060.PTDC//Fundação para a Ciência e a Tecnologia/ ; },
mesh = {Female ; Humans ; *Vagina/microbiology ; *Microbiota ; *Vaginosis, Bacterial/microbiology ; Lactobacillus/isolation & purification/classification/genetics ; Machine Learning ; },
abstract = {BACKGROUND: The human vaginal microbiota plays a central role in reproductive and urogenital health, protecting against infections including bacterial vaginosis (BV), yeast infections, HIV, and urinary tract infections. However, the ecological mechanisms linking microbial community structure to clinical indicators such as Nugent scores remain poorly understood. Although machine-learning approaches can accurately predict BV from microbiota profiles, they provide limited biological insight into the mechanisms linking community structure to clinical outcomes.
RESULTS: We introduce a locally adapted mechanistic framework based on replicator dynamics to link vaginal microbiota composition to Nugent score and identify key ecological interactions underlying healthy, intermediate, and BV-positive states. We quantified both the contributions of individual taxa and the nonlinear effects arising from pairwise interactions, using a taxonomic representation that retained four vaginally relevant Lactobacillus species separately while grouping the remaining taxa at broader taxonomic units. Applied to microbiota data from a previously published cohort of 394 North American women, the model predicted BV status with 94% accuracy, matching machine-learning benchmarks while providing an interpretable ecological description of BV-associated community reorganization.
CONCLUSIONS: This framework provides a biologically interpretable link between vaginal microbiota composition and clinical outcomes, revealing ecological mechanisms underlying BV. Beyond BV, our results demonstrate the broader potential of replicator-based ecological formalisms for modeling microbiota-invader dynamics across host-associated microbial systems. Video Abstract.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Female
Humans
*Vagina/microbiology
*Microbiota
*Vaginosis, Bacterial/microbiology
Lactobacillus/isolation & purification/classification/genetics
Machine Learning
RevDate: 2026-11-19
CmpDate: 2026-11-20
Structure and function of the peatland prokaryotic microbiome.
Environmental microbiome, 21(1):.
Peatlands are vital long-term carbon sinks but also sources of trace greenhouse gases, with the balance largely governed by microbial processes. However, the structure and function of peatland microbial communities are currently poorly characterised beyond the local scale, limiting our understanding of their response to climate change. Here, we present a large-scale analysis of the peatland prokaryotic microbiome by leveraging a curated dataset of 109 publicly available metagenomes from 20 near-natural peatland sites worldwide. Despite limitations in the publicly available data, including geographic coverage and sampling depth, our analysis indicates that dominant vegetation and peatland type are the strongest predictors of peatland microbiome taxonomy and function. We show that obligate hydrogenotrophic methanogens of the family Bog-38, previously reported to be prevalent in diverse high methane-flux habitats, are abundant in northern peatlands but occur only at low abundance in tropical peatlands, suggesting a limited contribution to methane cycling in these ecosystems. In contrast to northern peatlands, the tropical peatland microbiome exhibits a broad metabolic potential for multiple key peatland biogeochemical processes, including methanogenesis and denitrification, across all depths. Intriguingly, we observe an impaired potential for complete denitrification in a significant proportion of the northern fen metagenomes, with potential implications for nitrous oxide emissions as a greenhouse gas. Overall, our study uncovers large-scale patterns and ecological drivers of the peatland prokaryotic microbiome based on existing metagenomic data, enhancing our understanding of its response to climate change and highlighting major data gaps for future research.
Additional Links: PMID-43058933
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43058933,
year = {2026},
author = {Cheung, SMK and Pancost, RD and Vreeken, M and Gallego-Sala, AV and Bryce, C},
title = {Structure and function of the peatland prokaryotic microbiome.},
journal = {Environmental microbiome},
volume = {21},
number = {1},
pages = {},
pmid = {43058933},
issn = {2524-6372},
support = {EP/X023214/1//UKRI Advanced Research Grant/ ; NE/S007504/1//NERC GW4+ Doctoral Training Partnership/ ; 865403/ERC_/European Research Council/International ; },
abstract = {Peatlands are vital long-term carbon sinks but also sources of trace greenhouse gases, with the balance largely governed by microbial processes. However, the structure and function of peatland microbial communities are currently poorly characterised beyond the local scale, limiting our understanding of their response to climate change. Here, we present a large-scale analysis of the peatland prokaryotic microbiome by leveraging a curated dataset of 109 publicly available metagenomes from 20 near-natural peatland sites worldwide. Despite limitations in the publicly available data, including geographic coverage and sampling depth, our analysis indicates that dominant vegetation and peatland type are the strongest predictors of peatland microbiome taxonomy and function. We show that obligate hydrogenotrophic methanogens of the family Bog-38, previously reported to be prevalent in diverse high methane-flux habitats, are abundant in northern peatlands but occur only at low abundance in tropical peatlands, suggesting a limited contribution to methane cycling in these ecosystems. In contrast to northern peatlands, the tropical peatland microbiome exhibits a broad metabolic potential for multiple key peatland biogeochemical processes, including methanogenesis and denitrification, across all depths. Intriguingly, we observe an impaired potential for complete denitrification in a significant proportion of the northern fen metagenomes, with potential implications for nitrous oxide emissions as a greenhouse gas. Overall, our study uncovers large-scale patterns and ecological drivers of the peatland prokaryotic microbiome based on existing metagenomic data, enhancing our understanding of its response to climate change and highlighting major data gaps for future research.},
}
RevDate: 2026-11-19
CmpDate: 2026-11-20
Algal diet and habitat structure jointly shape growth, behavior, and gut microbiota in Tripneustes gratilla.
Animal microbiome, 8(1):.
INTRODUCTION: Differences in food sources significantly affect the behavior, gut microbiota, and physiology of marine organisms. This study aimed to examine the effects of different algal diets and habitat conditions (presence/absence of coral reef structures) on the growth, gonadal development, digestive enzyme activity, feeding behavior, and gut microbiota of Tripneustes gratilla.
RESULTS: Sea urchins fed mixed brown algae showed the highest weight gain rates and test diameter growth, with SL-c and SL groups significantly outperforming single-species brown algae treatments (P < 0.05). In contrast, green algae treatments resulted in the lowest growth performance. Gonad index was significantly higher in red algae treatments than in green algae treatments (P < 0.05), and coral structure further enhanced gonad index in specific groups (e.g., E-c and K-c). Wet gut index varied with diet, with brown algae promoting higher gut index under non-structure conditions. A positive correlation between gonad weight and wet gut weight was observed across all diet groups, with the strongest relationship in the brown algae group (Spearman r = 0.4501, P < 0.01), and weaker correlations in the red (r = 0.3746, P < 0.05) and green (r = 0.2531, P < 0.05) groups. Digestive enzyme activity differed significantly among diets: brown algae increased pepsin and lipase activities (P < 0.05), whereas red and green algae resulted in higher amylase activity (P < 0.05). Feeding and foraging exhibited pronounced diel rhythms, peaking at midnight and declining at noon, with no significant effects of habitat structure (P > 0.05), whereas habitat use varied among diet groups and increased significantly at night under structured conditions. Gut microbial diversity and composition were strongly associated with diet. Brown algae treatments exhibited higher alpha diversity, and PCoA revealed clear clustering by diet. At the phylum level, Bacteroidota and Proteobacteria dominated across treatments, while relative abundances of Spirochaetota, Firmicutes, and Fusobacteriota varied among diets. Functional prediction indicated significant differences in KEGG pathways (P < 0.05), with enhanced carbohydrate and amino acid metabolism in brown and green algae groups, and enrichment of glycan metabolism and antimicrobial resistance pathways in the red algae group.
CONCLUSIONS: This study demonstrated that algal diet and habitat structure jointly influence the physiological performance, behavior, and gut microecology of T. gratilla, offering theoretical support for optimized aquaculture practices and reef-based ecological management.
Additional Links: PMID-43058934
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43058934,
year = {2026},
author = {Zhao, X and Guo, Y and Zhang, A and Li, C and Qin, C and Wang, X and Ma, Z and Yu, G},
title = {Algal diet and habitat structure jointly shape growth, behavior, and gut microbiota in Tripneustes gratilla.},
journal = {Animal microbiome},
volume = {8},
number = {1},
pages = {},
pmid = {43058934},
issn = {2524-4671},
support = {2023B1515250004//Guangdong Basic and Applied Basic Research Foundation/ ; 32160863//National Natural Science Foundation of China/ ; 2023XK01//South Sea Fisheries Research Institute, Chinese Academy of Fishery Sciences/ ; SKJC-2022-PTDX-014//Sanya Yazhou Bay Science and Technology City/ ; 2024YFD2401801//the National Key Research and Development Program of China/ ; },
abstract = {INTRODUCTION: Differences in food sources significantly affect the behavior, gut microbiota, and physiology of marine organisms. This study aimed to examine the effects of different algal diets and habitat conditions (presence/absence of coral reef structures) on the growth, gonadal development, digestive enzyme activity, feeding behavior, and gut microbiota of Tripneustes gratilla.
RESULTS: Sea urchins fed mixed brown algae showed the highest weight gain rates and test diameter growth, with SL-c and SL groups significantly outperforming single-species brown algae treatments (P < 0.05). In contrast, green algae treatments resulted in the lowest growth performance. Gonad index was significantly higher in red algae treatments than in green algae treatments (P < 0.05), and coral structure further enhanced gonad index in specific groups (e.g., E-c and K-c). Wet gut index varied with diet, with brown algae promoting higher gut index under non-structure conditions. A positive correlation between gonad weight and wet gut weight was observed across all diet groups, with the strongest relationship in the brown algae group (Spearman r = 0.4501, P < 0.01), and weaker correlations in the red (r = 0.3746, P < 0.05) and green (r = 0.2531, P < 0.05) groups. Digestive enzyme activity differed significantly among diets: brown algae increased pepsin and lipase activities (P < 0.05), whereas red and green algae resulted in higher amylase activity (P < 0.05). Feeding and foraging exhibited pronounced diel rhythms, peaking at midnight and declining at noon, with no significant effects of habitat structure (P > 0.05), whereas habitat use varied among diet groups and increased significantly at night under structured conditions. Gut microbial diversity and composition were strongly associated with diet. Brown algae treatments exhibited higher alpha diversity, and PCoA revealed clear clustering by diet. At the phylum level, Bacteroidota and Proteobacteria dominated across treatments, while relative abundances of Spirochaetota, Firmicutes, and Fusobacteriota varied among diets. Functional prediction indicated significant differences in KEGG pathways (P < 0.05), with enhanced carbohydrate and amino acid metabolism in brown and green algae groups, and enrichment of glycan metabolism and antimicrobial resistance pathways in the red algae group.
CONCLUSIONS: This study demonstrated that algal diet and habitat structure jointly influence the physiological performance, behavior, and gut microecology of T. gratilla, offering theoretical support for optimized aquaculture practices and reef-based ecological management.},
}
RevDate: 2026-11-20
A microbial metabolite reframes the gut-kidney axis in calcium oxalate nephropathy[†].
The Journal of pathology [Epub ahead of print].
Kidney stone disease has long been viewed primarily as a disorder of urinary supersaturation, with therapeutic strategies focusing on reducing urinary oxalate and preventing crystal formation. Increasing evidence, however, suggests that renal epithelial injury, immune responses, and the gut microbiota are integral components of disease pathogenesis. In their recent article, published in The Journal of Pathology, Li, Chen, Lin, Jian et al provide compelling evidence that microbiota-derived tryptophan metabolism constitutes an important regulator of calcium oxalate nephropathy. Through integrated metagenomic and metabolomic analyses of patients with calcium oxalate stones, followed by mechanistic validation in experimental models, the authors identify indole-3-propionic acid (IPA) as a key microbial metabolite depleted in stone formers. They further demonstrate that IPA protects against renal crystal deposition by activating aryl hydrocarbon receptor (AhR) signaling, inducing suppressor of cytokine signaling 3 (SOCS3), suppressing STAT1 activation, and ultimately limiting tubular epithelial apoptosis. Beyond identifying a candidate therapeutic metabolite, this study shifts the current paradigm from considering the gut microbiota solely as a regulator of intestinal oxalate metabolism to recognizing microbial metabolites as active mediators of renal injury and repair. These findings broaden our understanding of the gut-kidney axis and provide a framework for developing microbiome-based therapeutic strategies targeting host signaling pathways in nephrolithiasis. © 2026 The Pathological Society of Great Britain and Ireland.
Additional Links: PMID-43058974
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43058974,
year = {2026},
author = {Abdelhalim, KA},
title = {A microbial metabolite reframes the gut-kidney axis in calcium oxalate nephropathy[†].},
journal = {The Journal of pathology},
volume = {},
number = {},
pages = {},
doi = {10.1002/path.70158},
pmid = {43058974},
issn = {1096-9896},
abstract = {Kidney stone disease has long been viewed primarily as a disorder of urinary supersaturation, with therapeutic strategies focusing on reducing urinary oxalate and preventing crystal formation. Increasing evidence, however, suggests that renal epithelial injury, immune responses, and the gut microbiota are integral components of disease pathogenesis. In their recent article, published in The Journal of Pathology, Li, Chen, Lin, Jian et al provide compelling evidence that microbiota-derived tryptophan metabolism constitutes an important regulator of calcium oxalate nephropathy. Through integrated metagenomic and metabolomic analyses of patients with calcium oxalate stones, followed by mechanistic validation in experimental models, the authors identify indole-3-propionic acid (IPA) as a key microbial metabolite depleted in stone formers. They further demonstrate that IPA protects against renal crystal deposition by activating aryl hydrocarbon receptor (AhR) signaling, inducing suppressor of cytokine signaling 3 (SOCS3), suppressing STAT1 activation, and ultimately limiting tubular epithelial apoptosis. Beyond identifying a candidate therapeutic metabolite, this study shifts the current paradigm from considering the gut microbiota solely as a regulator of intestinal oxalate metabolism to recognizing microbial metabolites as active mediators of renal injury and repair. These findings broaden our understanding of the gut-kidney axis and provide a framework for developing microbiome-based therapeutic strategies targeting host signaling pathways in nephrolithiasis. © 2026 The Pathological Society of Great Britain and Ireland.},
}
RevDate: 2026-11-20
Early-Life Overfeeding Drives Lasting Species-Level Shifts of the Gut Microbiome and Exacerbates Allergic Asthma in Mice.
Immunology [Epub ahead of print].
Early-life overweight is associated with increased asthma risk in children, but the mechanisms linking metabolic status, the gut microbiome and airway disease remain poorly explored. To address this, we used a litter-size reduction model in mice to examine how early-life overfeeding and overweight shape gut microbial development and later allergic asthma severity. Overfed offspring displayed increased body weight, adiposity and altered body proportions from early postnatal life onward, with more pronounced effects in females. Shotgun metagenomic sequencing identified a specific, lasting dysbiosis in the overweight female mice, characterized by reduced alpha diversity and species-level shifts in Lactobacillus, Muribaculum and Bacteroides. Crucially, upon allergic sensitization in adulthood, these animals displayed an exacerbated disease state consistent with an 'obese-asthma' phenotype, marked by heightened airway inflammation, intense eosinophilic and neutrophilic infiltration, higher Type 2 cytokine levels (i.e., IL-4, IL-5) and altered bronchoalveolar immune profiles. These findings suggest that early-life nutritional imbalance establishes an altered immunometabolic trajectory via the gut-lung axis, providing a mechanistic basis for the increased severity observed in obesity-associated asthma.
Additional Links: PMID-43059024
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43059024,
year = {2026},
author = {Alhasan, MM and Kahhaleh, FG and Datye, S and Arntz, JL and Hambo, S and Harb, H and Garcia, SI and Aisicovich, M and Fahlbusch, FB and Conrad, ML and Barrientos, G},
title = {Early-Life Overfeeding Drives Lasting Species-Level Shifts of the Gut Microbiome and Exacerbates Allergic Asthma in Mice.},
journal = {Immunology},
volume = {},
number = {},
pages = {},
doi = {10.1111/imm.70232},
pmid = {43059024},
issn = {1365-2567},
support = {522201563 - IRTG 3019/1//Deutsche Forschungsgemeinschaft/ ; //Alexander von Humboldt-Stiftung/ ; 57507871//Deutscher Akademischer Austauschdienst/ ; },
abstract = {Early-life overweight is associated with increased asthma risk in children, but the mechanisms linking metabolic status, the gut microbiome and airway disease remain poorly explored. To address this, we used a litter-size reduction model in mice to examine how early-life overfeeding and overweight shape gut microbial development and later allergic asthma severity. Overfed offspring displayed increased body weight, adiposity and altered body proportions from early postnatal life onward, with more pronounced effects in females. Shotgun metagenomic sequencing identified a specific, lasting dysbiosis in the overweight female mice, characterized by reduced alpha diversity and species-level shifts in Lactobacillus, Muribaculum and Bacteroides. Crucially, upon allergic sensitization in adulthood, these animals displayed an exacerbated disease state consistent with an 'obese-asthma' phenotype, marked by heightened airway inflammation, intense eosinophilic and neutrophilic infiltration, higher Type 2 cytokine levels (i.e., IL-4, IL-5) and altered bronchoalveolar immune profiles. These findings suggest that early-life nutritional imbalance establishes an altered immunometabolic trajectory via the gut-lung axis, providing a mechanistic basis for the increased severity observed in obesity-associated asthma.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Gut microbiome-based interventions to prevent ICU-acquired infections: A systematic review and meta-analysis.
Gut microbes, 18(1):2765035.
Gut microbiome colonization with potential pathogens is common and often precedes clinical infection in the intensive care unit (ICU). Two key gut microbiome-based interventions seek to prevent infections yet use opposite approaches: selective digestive decontamination (SDD) utilizes antibiotics to eliminate potential pathogens, whereas biotic supplementation (prebiotics, probiotics, or synbiotics) aims to enrich beneficial microbes. In the absence of randomized controlled trials (RCTs) directly comparing these two interventions, this systematic review and meta-analysis sought to compare the effect sizes of SDD versus biotic interventions for mortality and infection-related outcomes. We searched PubMed for RCTs published between 2000 and 2025. Eligible studies recruited adult ICU patients, assessed SDD or biotics against a comparator (standard care or placebo), and reported on mortality and/or acquired infection-related outcomes. Pooled relative risks (RR) were calculated using random-effects models. Nine SDD trials involving 19,907 subjects and 29 biotic supplementation trials involving 5,483 subjects were included. When compared versus standard care or placebo, neither intervention significantly reduced overall mortality (SDD: RR = 0.96 [95%CI: 0.88-1.05]; biotics: RR = 0.93 [95%CI: 0.87-1.00]).SDD was associated with modestly lower observed risk for ICU acquired all-cause infections compared to biotics (SDD: RR = 0.76 [95%CI: 0.60-0.98]; biotics: RR = 0.82 [95%CI: 0.64-1.05], no statistically significant difference) and specifically lower risk for pneumonia (SDD: RR = 0.50 [95%CI: 0.26-0.96]; prebiotics and synbiotics: RR = 0.70 [95%CI: 0.54-0.90]). In conclusion, neither SDD nor biotics was significantly protective for mortality, but both types of interventions showed similarly promising protective associations with infections, especially pneumonia. The studies selected were heterogeneous, especially those testing biotic interventions.
Additional Links: PMID-43059105
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43059105,
year = {2026},
author = {Townsend, EC and Fisch, SA and Yip, NH and Freedberg, DE},
title = {Gut microbiome-based interventions to prevent ICU-acquired infections: A systematic review and meta-analysis.},
journal = {Gut microbes},
volume = {18},
number = {1},
pages = {2765035},
doi = {10.1080/19490976.2026.2765035},
pmid = {43059105},
issn = {1949-0984},
mesh = {Humans ; Intensive Care Units ; *Probiotics/administration & dosage ; Synbiotics/administration & dosage ; Prebiotics/administration & dosage ; *Gastrointestinal Microbiome/drug effects ; *Cross Infection/prevention & control/microbiology/mortality ; Anti-Bacterial Agents/therapeutic use/administration & dosage ; Randomized Controlled Trials as Topic ; },
abstract = {Gut microbiome colonization with potential pathogens is common and often precedes clinical infection in the intensive care unit (ICU). Two key gut microbiome-based interventions seek to prevent infections yet use opposite approaches: selective digestive decontamination (SDD) utilizes antibiotics to eliminate potential pathogens, whereas biotic supplementation (prebiotics, probiotics, or synbiotics) aims to enrich beneficial microbes. In the absence of randomized controlled trials (RCTs) directly comparing these two interventions, this systematic review and meta-analysis sought to compare the effect sizes of SDD versus biotic interventions for mortality and infection-related outcomes. We searched PubMed for RCTs published between 2000 and 2025. Eligible studies recruited adult ICU patients, assessed SDD or biotics against a comparator (standard care or placebo), and reported on mortality and/or acquired infection-related outcomes. Pooled relative risks (RR) were calculated using random-effects models. Nine SDD trials involving 19,907 subjects and 29 biotic supplementation trials involving 5,483 subjects were included. When compared versus standard care or placebo, neither intervention significantly reduced overall mortality (SDD: RR = 0.96 [95%CI: 0.88-1.05]; biotics: RR = 0.93 [95%CI: 0.87-1.00]).SDD was associated with modestly lower observed risk for ICU acquired all-cause infections compared to biotics (SDD: RR = 0.76 [95%CI: 0.60-0.98]; biotics: RR = 0.82 [95%CI: 0.64-1.05], no statistically significant difference) and specifically lower risk for pneumonia (SDD: RR = 0.50 [95%CI: 0.26-0.96]; prebiotics and synbiotics: RR = 0.70 [95%CI: 0.54-0.90]). In conclusion, neither SDD nor biotics was significantly protective for mortality, but both types of interventions showed similarly promising protective associations with infections, especially pneumonia. The studies selected were heterogeneous, especially those testing biotic interventions.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
Intensive Care Units
*Probiotics/administration & dosage
Synbiotics/administration & dosage
Prebiotics/administration & dosage
*Gastrointestinal Microbiome/drug effects
*Cross Infection/prevention & control/microbiology/mortality
Anti-Bacterial Agents/therapeutic use/administration & dosage
Randomized Controlled Trials as Topic
RevDate: 2026-11-20
CmpDate: 2026-11-20
Gut microbiome patterns in a multi-ethnic Asian population within a shared urban environment.
Gut microbes, 18(1):2760062.
The gut microbiome composition varies across human populations, but its characteristics and determinants in a multi-ethnic setting remain incompletely understood. Singapore, a multicultural city-state, provides a context in which culturally diverse groups share a broadly similar built environment. Using the Health for Life in Singapore (HELIOS) cohort, we profiled the gut microbiome of ethnic Chinese, Indian, and Malay participants (n = 861) residing in the country. These ethnicity-diet-microbiome relationships were further evaluated using data from two independent Malaysian cohorts (n = 544), a cohort from the United States (n = 210), and an in vitro microbial culture model. Each group displayed ethnicity-associated microbial patterns that paralleled culturally rooted dietary habits. Specifically, ethnic Indian participants showed enrichment of multiple Bifidobacterium species associated with greater intake of traditional grain-based staples such as idli and thosai; ethnic Malay participants exhibited higher abundance of Ruminococcaceae associated with coconut- and rice-based dishes; and ethnic Chinese participants had greater levels of Bacteroides associated with seafood- and meat-rich diets. These ethnicity-diet-microbiome relationships showed directionally consistent genus-level Bifidobacterium patterns in the Malaysian and US cohorts, as well as experimental support from an in vitro microbial culture model. Analysis of fecal microbiome-based risk scores revealed signature-dependent ethnic patterns in colorectal neoplasia scores. Together, these findings characterize gut microbiome variations across major Asian ethnicities residing in a shared urban environment, and provide a reference for precision health strategies in multi-ethnic Asian populations and other urban settings where culturally diverse communities share similar built environments.
Additional Links: PMID-43059112
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43059112,
year = {2026},
author = {Zhou, R and Shen, X and Mina, TH and Agrawal, KR and Low, DY and Kang, JX and Teo, JJY and How, SHC and Lam, BCC and Wang, T and Chong, CW and , and Sung, JJY and Nagarajan, N and Ali, Y and Chambers, JC and Wong, SH},
title = {Gut microbiome patterns in a multi-ethnic Asian population within a shared urban environment.},
journal = {Gut microbes},
volume = {18},
number = {1},
pages = {2760062},
doi = {10.1080/19490976.2026.2760062},
pmid = {43059112},
issn = {1949-0984},
mesh = {Humans ; Male ; *Gastrointestinal Microbiome ; Female ; Adult ; Singapore ; Diet ; *Bacteria/classification/isolation & purification/genetics ; Ethnicity ; Malaysia/ethnology ; Feces/microbiology ; Asian People ; Urban Population ; United States ; Middle Aged ; Bifidobacterium/isolation & purification ; Feeding Behavior ; Cohort Studies ; },
abstract = {The gut microbiome composition varies across human populations, but its characteristics and determinants in a multi-ethnic setting remain incompletely understood. Singapore, a multicultural city-state, provides a context in which culturally diverse groups share a broadly similar built environment. Using the Health for Life in Singapore (HELIOS) cohort, we profiled the gut microbiome of ethnic Chinese, Indian, and Malay participants (n = 861) residing in the country. These ethnicity-diet-microbiome relationships were further evaluated using data from two independent Malaysian cohorts (n = 544), a cohort from the United States (n = 210), and an in vitro microbial culture model. Each group displayed ethnicity-associated microbial patterns that paralleled culturally rooted dietary habits. Specifically, ethnic Indian participants showed enrichment of multiple Bifidobacterium species associated with greater intake of traditional grain-based staples such as idli and thosai; ethnic Malay participants exhibited higher abundance of Ruminococcaceae associated with coconut- and rice-based dishes; and ethnic Chinese participants had greater levels of Bacteroides associated with seafood- and meat-rich diets. These ethnicity-diet-microbiome relationships showed directionally consistent genus-level Bifidobacterium patterns in the Malaysian and US cohorts, as well as experimental support from an in vitro microbial culture model. Analysis of fecal microbiome-based risk scores revealed signature-dependent ethnic patterns in colorectal neoplasia scores. Together, these findings characterize gut microbiome variations across major Asian ethnicities residing in a shared urban environment, and provide a reference for precision health strategies in multi-ethnic Asian populations and other urban settings where culturally diverse communities share similar built environments.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
Male
*Gastrointestinal Microbiome
Female
Adult
Singapore
Diet
*Bacteria/classification/isolation & purification/genetics
Ethnicity
Malaysia/ethnology
Feces/microbiology
Asian People
Urban Population
United States
Middle Aged
Bifidobacterium/isolation & purification
Feeding Behavior
Cohort Studies
RevDate: 2026-11-20
An HA-Coated Akkermansia-Paeoniflorin Biohybrid Enables Sustained Oral Delivery for Gut-Gonad Axis Protection.
Advanced healthcare materials pii:e71989 [Epub ahead of print].
Living biohybrid materials offer a unique opportunity to couple oral drug delivery with host-microbiome interactions, yet maintaining carrier integrity, cargo retention, and biological function under gastrointestinal constraints remains challenging. Here, we engineered a hyaluronic acid (HA)-coated Akkermansia muciniphila-paeoniflorin biohybrid (PF@AKK@HA) through vacuum-enabled paeoniflorin loading followed by HA shell stabilization. Structural and colloidal analyses confirmed preserved bacterial morphology, stable negative surface charge, and HA-associated surface coating, while simulated gastrointestinal assays supported enhanced carrier resilience and diffusion-limited paeoniflorin release. In a zebrafish model of chronic chemical-induced reproductive dysfunction triggered by 6PPD-quinone, oral PF@AKK@HA administration substantially improved fecundity, gonadosomatic index, gonadal histology, endocrine balance, oxidative-stress readouts, and F1 developmental outcomes. Integrated gonadal transcriptomics and gut microbiota profiling further associated these protective effects with partial recovery of host-microbiome metabolic programs, particularly PPAR signaling, retinoid metabolism, and bile acid-related pathways. This work establishes PF@AKK@HA as a living oral biohybrid material that links sustained phytochemical delivery with microbiome-targeted gut-gonad axis protection.
Additional Links: PMID-43059128
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43059128,
year = {2026},
author = {Yi, J and Ruan, J and Xie, Y and Ma, J and Wu, B and Zhao, J and Zhu, H and Yu, H and Chen, R and Wang, H and Zeng, G and Wu, W and Sun, D and Ji, M},
title = {An HA-Coated Akkermansia-Paeoniflorin Biohybrid Enables Sustained Oral Delivery for Gut-Gonad Axis Protection.},
journal = {Advanced healthcare materials},
volume = {},
number = {},
pages = {},
doi = {10.1002/adhm.71989},
pmid = {43059128},
issn = {2192-2659},
support = {GK20250049//Wenzhou Municipal Science and Technology Bureau/ ; SHPY2025010//Scientific Research Cultivation Project of the College of Life and Environmental Sciences, Wenzhou University/ ; CSTB2025NSCQ-GPX0212//Natural Science Foundation of Chongqing/ ; JFLKYXM202303AZ-204//JinFeng Laboratory of Chongqing/ ; },
abstract = {Living biohybrid materials offer a unique opportunity to couple oral drug delivery with host-microbiome interactions, yet maintaining carrier integrity, cargo retention, and biological function under gastrointestinal constraints remains challenging. Here, we engineered a hyaluronic acid (HA)-coated Akkermansia muciniphila-paeoniflorin biohybrid (PF@AKK@HA) through vacuum-enabled paeoniflorin loading followed by HA shell stabilization. Structural and colloidal analyses confirmed preserved bacterial morphology, stable negative surface charge, and HA-associated surface coating, while simulated gastrointestinal assays supported enhanced carrier resilience and diffusion-limited paeoniflorin release. In a zebrafish model of chronic chemical-induced reproductive dysfunction triggered by 6PPD-quinone, oral PF@AKK@HA administration substantially improved fecundity, gonadosomatic index, gonadal histology, endocrine balance, oxidative-stress readouts, and F1 developmental outcomes. Integrated gonadal transcriptomics and gut microbiota profiling further associated these protective effects with partial recovery of host-microbiome metabolic programs, particularly PPAR signaling, retinoid metabolism, and bile acid-related pathways. This work establishes PF@AKK@HA as a living oral biohybrid material that links sustained phytochemical delivery with microbiome-targeted gut-gonad axis protection.},
}
RevDate: 2026-11-20
Artificial intelligence in periodontitis: current evidence, clinical limitations, and research priorities.
Journal of periodontal & implant science pii:56.e48 [Epub ahead of print].
Applications of artificial intelligence (AI) in periodontology are expanding faster than the evidence supporting their clinical use. Beyond radiographic bone-loss detection and quantification, these applications include oral-image screening, risk prediction using electronic dental records, longitudinal progression modeling, treatment-response prediction, and models based on biomarkers, the microbiome, or gene expression. Drawing on structured searches of PubMed/MEDLINE, Scopus, and Web of Science Core Collection and reference tracking of recent periodontal AI reviews, this narrative review evaluates current evidence by its clinical maturity rather than by algorithm type or reported accuracy. The review identifies study-design issues specific to periodontology that are often obscured in model-development papers: examiner-dependent probing and bleeding labels; composite stage and grade definitions; repeated observations from the same patient, tooth, or site; treatment-modified outcomes; missing or selectively collected data; and platform shifts in molecular data. Evidence is most mature for task-specific radiographic detection and quantification, radiographic assessment supporting staging or grading, and image-based screening, including recent studies with multicenter or independent testing. Models of risk, progression, and treatment response remain limited by records shaped by care and documentation processes, irregular follow-up, confounding by treatment history, and infrequent calibration. Biological, molecular, and multimodal models may support biomarker-informed screening or disease stratification, but most remain at an early stage because of small cohorts, reliance on public datasets, heterogeneity across tissues or sites, and limited independent validation. Priorities for the next phase of periodontal AI include multicenter and temporal validation; calibrated outputs that account for uncertainty; patient-grouped, time-aware longitudinal testing; explicit handling of treatment exposure and missing data; evaluation of incremental value over simpler comparators; and prospective human-AI studies measuring workflow, decisions, errors, time burden, and patient-relevant outcomes. Applying these priorities as staged expectations based on intended use should help move periodontal AI from technical feasibility to reliable use in defined clinical settings.
Additional Links: PMID-43059187
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43059187,
year = {2026},
author = {Lim, HC and Yang, SB and Jang, EY and Lee, JH and Kim, GT and Kwack, KH and Moon, JH},
title = {Artificial intelligence in periodontitis: current evidence, clinical limitations, and research priorities.},
journal = {Journal of periodontal & implant science},
volume = {},
number = {},
pages = {},
doi = {10.5051/jpis.2604400220},
pmid = {43059187},
issn = {2093-2278},
support = {RS-2025-16066503/NRF/National Research Foundation of Korea/Korea ; RS-2026-25494483/NRF/National Research Foundation of Korea/Korea ; RS-2024-00404660/KBSI/Korea Basic Science Institute/Korea ; },
abstract = {Applications of artificial intelligence (AI) in periodontology are expanding faster than the evidence supporting their clinical use. Beyond radiographic bone-loss detection and quantification, these applications include oral-image screening, risk prediction using electronic dental records, longitudinal progression modeling, treatment-response prediction, and models based on biomarkers, the microbiome, or gene expression. Drawing on structured searches of PubMed/MEDLINE, Scopus, and Web of Science Core Collection and reference tracking of recent periodontal AI reviews, this narrative review evaluates current evidence by its clinical maturity rather than by algorithm type or reported accuracy. The review identifies study-design issues specific to periodontology that are often obscured in model-development papers: examiner-dependent probing and bleeding labels; composite stage and grade definitions; repeated observations from the same patient, tooth, or site; treatment-modified outcomes; missing or selectively collected data; and platform shifts in molecular data. Evidence is most mature for task-specific radiographic detection and quantification, radiographic assessment supporting staging or grading, and image-based screening, including recent studies with multicenter or independent testing. Models of risk, progression, and treatment response remain limited by records shaped by care and documentation processes, irregular follow-up, confounding by treatment history, and infrequent calibration. Biological, molecular, and multimodal models may support biomarker-informed screening or disease stratification, but most remain at an early stage because of small cohorts, reliance on public datasets, heterogeneity across tissues or sites, and limited independent validation. Priorities for the next phase of periodontal AI include multicenter and temporal validation; calibrated outputs that account for uncertainty; patient-grouped, time-aware longitudinal testing; explicit handling of treatment exposure and missing data; evaluation of incremental value over simpler comparators; and prospective human-AI studies measuring workflow, decisions, errors, time burden, and patient-relevant outcomes. Applying these priorities as staged expectations based on intended use should help move periodontal AI from technical feasibility to reliable use in defined clinical settings.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Antimicrobial Peptides Targeting Oral Pathogens: Applicability as an Oral Disease Treatment and Dental Material.
Journal of dental hygiene science, 24(4):231-248.
BACKGROUND: Antimicrobial peptides (AMPs) are small, naturally occurring molecules that are integral components of the innate immune system across many organisms. In humans, saliva is rich in various AMPs that play a pivotal role in maintaining oral health by serving as the primary line of defense in the oral cavity. These peptides are essential for protection against a broad spectrum of pathogens, including bacteria and fungi. Recently, active research has been conducted on both naturally occurring AMPs and modified or synthetic AMPs for the treatment of oral pathogens and their application in dental materials.
METHODS: We compiled previous studies on AMPs present in saliva and their target oral microorganisms. Additionally, we summarized research on artificially created AMPs targeting oral pathogens. Furthermore, we analyzed recent trends in applied studies, such as the development of oral rinses, toothpaste, and implant coatings using AMPs.
RESULTS: Through a literature review, we identified 19 studies on AMPs present in the oral cavity and 40 studies testing AMPs derived from other organisms or synthetically engineered against oral pathogens. Additionally, we reviewed seven studies on the development of implant coatings and oral hygiene material additives using AMPs. These findings suggest the potential for discovering or developing AMPs with activity against specific oral pathogens that can be applied to improve oral health.
CONCLUSION: AMPs exhibit broad antimicrobial activity against a wide range of pathogens. Their mechanisms of action primarily involve attacking and disrupting the cell membranes of target microorganisms, making them effective against various pathogens. AMPs have the potential for use as coating materials for dental implants or restorative materials that require long-term use. Further research is needed to investigate the cytotoxicity, durability, and stability of AMPs in the oral environment to support their clinical use in dentistry.
Additional Links: PMID-43059645
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43059645,
year = {2024},
author = {Im, S and Lee, JH and Shim, YS},
title = {Antimicrobial Peptides Targeting Oral Pathogens: Applicability as an Oral Disease Treatment and Dental Material.},
journal = {Journal of dental hygiene science},
volume = {24},
number = {4},
pages = {231-248},
pmid = {43059645},
issn = {2233-7679},
abstract = {BACKGROUND: Antimicrobial peptides (AMPs) are small, naturally occurring molecules that are integral components of the innate immune system across many organisms. In humans, saliva is rich in various AMPs that play a pivotal role in maintaining oral health by serving as the primary line of defense in the oral cavity. These peptides are essential for protection against a broad spectrum of pathogens, including bacteria and fungi. Recently, active research has been conducted on both naturally occurring AMPs and modified or synthetic AMPs for the treatment of oral pathogens and their application in dental materials.
METHODS: We compiled previous studies on AMPs present in saliva and their target oral microorganisms. Additionally, we summarized research on artificially created AMPs targeting oral pathogens. Furthermore, we analyzed recent trends in applied studies, such as the development of oral rinses, toothpaste, and implant coatings using AMPs.
RESULTS: Through a literature review, we identified 19 studies on AMPs present in the oral cavity and 40 studies testing AMPs derived from other organisms or synthetically engineered against oral pathogens. Additionally, we reviewed seven studies on the development of implant coatings and oral hygiene material additives using AMPs. These findings suggest the potential for discovering or developing AMPs with activity against specific oral pathogens that can be applied to improve oral health.
CONCLUSION: AMPs exhibit broad antimicrobial activity against a wide range of pathogens. Their mechanisms of action primarily involve attacking and disrupting the cell membranes of target microorganisms, making them effective against various pathogens. AMPs have the potential for use as coating materials for dental implants or restorative materials that require long-term use. Further research is needed to investigate the cytotoxicity, durability, and stability of AMPs in the oral environment to support their clinical use in dentistry.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Broad-spectrum in situ genetic reprogramming of native microbiomes.
bioRxiv : the preprint server for biology pii:2026.11.03.764085.
Complex microbial communities are found throughout terrestrial, aquatic, and animal-associated ecosystems. Genetic modification of discrete microbial taxa within native communities represents a powerful tool to study and augment microbiome functions. Herein, we develop Synthetic Phage Assisted Reprogrammable and Targetable Addition (SPARTA) as a one-step strategy for packaging, delivering, and integrating large synthetic DNA into a broad range of native microbiomes. SPARTA leverages a broad-spectrum synthetic phage particle for in situ genome engineering within complex soil, freshwater, and mammalian fecal microbiomes, reprogramming 59 native species across 16 families. By modulating SPARTA components, we further demonstrated tunability of SPARTA towards targeted microbiome population. Additionally, we built a novel companion tool to quantitatively identify engineered taxa, named "16S crRNA-guided inference of bacterial engineering sequencing" or ScRibe-seq. The SPARTA-ScRibe-seq pipeline delivered and validated functional synthetic gene clusters in diverse native microbiomes while preserving the original microbial community structure. Together, this novel genome engineering framework constitutes an end-to-end programmable platform for rational and customizable reprogramming of native microbiomes.
Additional Links: PMID-43059731
Full Text:
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43059731,
year = {2026},
author = {Hur, J and Sanfiorenzo, C and Simpson, B and Oguienko, A and Huang, J and Lipschitz, M and Zhang, RJ and Gawda, T and Mazmanian, SK and Wang, K},
title = {Broad-spectrum in situ genetic reprogramming of native microbiomes.},
journal = {bioRxiv : the preprint server for biology},
volume = {},
number = {},
pages = {},
doi = {10.64898/2026.11.03.764085},
pmid = {43059731},
issn = {2692-8205},
abstract = {Complex microbial communities are found throughout terrestrial, aquatic, and animal-associated ecosystems. Genetic modification of discrete microbial taxa within native communities represents a powerful tool to study and augment microbiome functions. Herein, we develop Synthetic Phage Assisted Reprogrammable and Targetable Addition (SPARTA) as a one-step strategy for packaging, delivering, and integrating large synthetic DNA into a broad range of native microbiomes. SPARTA leverages a broad-spectrum synthetic phage particle for in situ genome engineering within complex soil, freshwater, and mammalian fecal microbiomes, reprogramming 59 native species across 16 families. By modulating SPARTA components, we further demonstrated tunability of SPARTA towards targeted microbiome population. Additionally, we built a novel companion tool to quantitatively identify engineered taxa, named "16S crRNA-guided inference of bacterial engineering sequencing" or ScRibe-seq. The SPARTA-ScRibe-seq pipeline delivered and validated functional synthetic gene clusters in diverse native microbiomes while preserving the original microbial community structure. Together, this novel genome engineering framework constitutes an end-to-end programmable platform for rational and customizable reprogramming of native microbiomes.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Higher-order metabolic interactions among oral commensals gate pathobiont expansion through succinate-driven pH modulation.
bioRxiv : the preprint server for biology pii:2026.11.04.764248.
Despite advances in defining microbiome shifts associated with inflammatory mucosal diseases, the ecological interactions that constrain or facilitate pathobiont expansion remain poorly understood. Using a six-species synthetic oral microbial community and factorial interaction screening, we identified a higher-order interaction governing the growth of the periodontal pathobiont Porphyromonas gingivalis . The core community member Veillonella parvula was the strongest positive determinant of P. gingivalis growth, but this effect was substantially reduced by the health-associated commensal Actinomyces oris . A. oris -mediated antagonism resulted from extracellular acidification and was enhanced under anaerobic conditions. Genetic dissection of A. oris fermentation revealed that lactate dehydrogenase (ldh1) contributes to anaerobic lactate production, but ldh1 deletion only partially relieved P. gingivalis inhibition. Instead, succinate, produced through a succinate dehydrogenase/fumarate reductase pathway (sdh2), emerged as the principal driver of acidification and P. gingivalis suppression. At high cell densities, however, V. parvula consumed both lactate and succinate, reversing acidification and restoring conditions permissive for P. gingivalis growth. To assess the relevance of these interactions in vivo, we analyzed subgingival microbiome from 1,355 adults, including 555 with detectable P. gingivalis . Among these individuals, P. gingivalis abundance was negatively associated with Actinomyces abundance after adjustment for periodontitis severity, whereas this association was attenuated at high V. parvula abundance, consistent with the interaction observed in vitro. Together, these findings identify succinate as a previously unrecognized mediator of interbacterial antagonism and reveal how higher-order metabolic interactions among oral commensals regulate pathobiont expansion through pH modulation, with protective effects shaped by oxygen availability and metabolic cross-feeding.
Additional Links: PMID-43059767
Full Text:
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43059767,
year = {2026},
author = {Soh, D and Bhat, AH and Li, L and Smardz, M and Parker, C and Tiede, ER and Nelson, B and Frerichs, VA and Wood, TD and Ikonomou, L and Ton-That, H and Diaz, PI},
title = {Higher-order metabolic interactions among oral commensals gate pathobiont expansion through succinate-driven pH modulation.},
journal = {bioRxiv : the preprint server for biology},
volume = {},
number = {},
pages = {},
doi = {10.64898/2026.11.04.764248},
pmid = {43059767},
issn = {2692-8205},
abstract = {Despite advances in defining microbiome shifts associated with inflammatory mucosal diseases, the ecological interactions that constrain or facilitate pathobiont expansion remain poorly understood. Using a six-species synthetic oral microbial community and factorial interaction screening, we identified a higher-order interaction governing the growth of the periodontal pathobiont Porphyromonas gingivalis . The core community member Veillonella parvula was the strongest positive determinant of P. gingivalis growth, but this effect was substantially reduced by the health-associated commensal Actinomyces oris . A. oris -mediated antagonism resulted from extracellular acidification and was enhanced under anaerobic conditions. Genetic dissection of A. oris fermentation revealed that lactate dehydrogenase (ldh1) contributes to anaerobic lactate production, but ldh1 deletion only partially relieved P. gingivalis inhibition. Instead, succinate, produced through a succinate dehydrogenase/fumarate reductase pathway (sdh2), emerged as the principal driver of acidification and P. gingivalis suppression. At high cell densities, however, V. parvula consumed both lactate and succinate, reversing acidification and restoring conditions permissive for P. gingivalis growth. To assess the relevance of these interactions in vivo, we analyzed subgingival microbiome from 1,355 adults, including 555 with detectable P. gingivalis . Among these individuals, P. gingivalis abundance was negatively associated with Actinomyces abundance after adjustment for periodontitis severity, whereas this association was attenuated at high V. parvula abundance, consistent with the interaction observed in vitro. Together, these findings identify succinate as a previously unrecognized mediator of interbacterial antagonism and reveal how higher-order metabolic interactions among oral commensals regulate pathobiont expansion through pH modulation, with protective effects shaped by oxygen availability and metabolic cross-feeding.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Perinatal high-fat diet induces systemic inflammation via altered tight junction complex organization during development and decreases expression of intestinal satiety peptides in male offspring.
bioRxiv : the preprint server for biology pii:2026.11.12.766002.
OBJECTIVE: Epidemiological evidence suggests that maternal obesity increases risk for offspring obesity and comorbidities, pointing to the significance of critical periods of development. Adverse metabolic effects of high fat (HF) diet consumption on the gut microbiome and inflammation have been well documented in obesity models. Emerging evidence demonstrates that the gut microbiome may play a role in transgenerational obesity, however, underlying mechanisms still need to be elucidated to identify intervention targets.
METHODS: A rat model was used to demonstrate whether maternal HF diet during gestation and lactation results in gut-brain axis deficits in rat offspring. Gene expression of small intestinal satiety hormones and C-fiber innervation in the nucleus of the solitary tract (NTS) were measured in adult offspring. At weaning, circulating inflammatory mediators and colonic microbial metabolites were measured in offspring.
RESULTS: In adulthood, HF males had reduced vagal innervation in the NTS and reduced small intestinal expression of CCK, GLP-1, and PYY. At weaning, HF offspring had elevated levels of CRP and IL-1β and depleted levels of microbially produced colonic short chain fatty acids (SCFAs), which are critical for maintaining intestinal barrier function. HF males had reduced colocalization between tight junction proteins, Claudin-1 and ZO-1 at weaning, while HF females did not.
CONCLUSION: Disorganization of tight junction complexes in HF male offspring during development may play a role in the gut-brain axis deficits seen in HF males in adulthood. Together, these data demonstrate that inflammation-induced by HF diet can negatively impact gut-brain axis development and function.
Additional Links: PMID-43059786
Full Text:
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43059786,
year = {2026},
author = {Macias, LK and Kesarwani, A and Perez, J and Shakir, J and Aston, SA and Cordner, ZA and Kitase, Y and Jantzie, LL and de La Serre, CB and Hui, KY and Moran, TH and Tamashiro, KL},
title = {Perinatal high-fat diet induces systemic inflammation via altered tight junction complex organization during development and decreases expression of intestinal satiety peptides in male offspring.},
journal = {bioRxiv : the preprint server for biology},
volume = {},
number = {},
pages = {},
doi = {10.64898/2026.11.12.766002},
pmid = {43059786},
issn = {2692-8205},
abstract = {OBJECTIVE: Epidemiological evidence suggests that maternal obesity increases risk for offspring obesity and comorbidities, pointing to the significance of critical periods of development. Adverse metabolic effects of high fat (HF) diet consumption on the gut microbiome and inflammation have been well documented in obesity models. Emerging evidence demonstrates that the gut microbiome may play a role in transgenerational obesity, however, underlying mechanisms still need to be elucidated to identify intervention targets.
METHODS: A rat model was used to demonstrate whether maternal HF diet during gestation and lactation results in gut-brain axis deficits in rat offspring. Gene expression of small intestinal satiety hormones and C-fiber innervation in the nucleus of the solitary tract (NTS) were measured in adult offspring. At weaning, circulating inflammatory mediators and colonic microbial metabolites were measured in offspring.
RESULTS: In adulthood, HF males had reduced vagal innervation in the NTS and reduced small intestinal expression of CCK, GLP-1, and PYY. At weaning, HF offspring had elevated levels of CRP and IL-1β and depleted levels of microbially produced colonic short chain fatty acids (SCFAs), which are critical for maintaining intestinal barrier function. HF males had reduced colocalization between tight junction proteins, Claudin-1 and ZO-1 at weaning, while HF females did not.
CONCLUSION: Disorganization of tight junction complexes in HF male offspring during development may play a role in the gut-brain axis deficits seen in HF males in adulthood. Together, these data demonstrate that inflammation-induced by HF diet can negatively impact gut-brain axis development and function.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
PCB-Exposed Gut Microbiota Recapitulate Neurobehavioral Deficits and Reprogram Hippocampal Transcriptomic Signatures.
bioRxiv : the preprint server for biology pii:2026.11.05.764721.
Polychlorinated biphenyls (PCBs) are persistent environmental pollutants associated with developmental neurotoxicity and autism spectrum disorder (ASD). However, whether PCB-induced alterations in gut microbiota contribute to neurodevelopmental toxicity independently of direct chemical exposure remains unclear. Here, we investigated whether transplantation of PCB-associated gut microbiota produces early neurobehavioral alterations and disrupts brain molecular pathways in offspring. Gut microbiota from conventional dams exposed to the Fox River PCB mixture (FRM; 6.0 mg/kg/day) or vehicle were transplanted into germ-free recipient females without direct PCB administration. At postnatal day 7 (P7), offspring underwent ultrasonic vocalization (USV) testing, whole-brain RNA sequencing (n = 4/sex/group), and untargeted serum metabolomics. Untargeted serum metabolomics were also performed in donor dams. PCB-associated fecal microbiota transplantation (FMT) significantly reduced offspring USVs, reproducing effects observed following direct maternal PCB exposure. Brain transcriptomics in offspring identified substantially more differentially expressed genes in males (9,339) than females (1,082), including 512 shared genes. Concordantly regulated genes revealed downregulation of neurotransmitter signaling and ion channel pathways alongside upregulation of RNA processing pathways. Male-associated responses involved altered protein synthesis and neuronal signaling, whereas female-associated responses involved DNA repair and extracellular matrix remodeling. Despite these molecular differences, behavioral responses showed no significant sex-dependent effect. Maternal metabolomics revealed increased bile acids and decreased indole-3-propionic acid, highlighting potential AhR-NFκB and bile acid-associated signaling mechanisms. Offspring metabolomics further identified alterations in lipid-associated metabolites and metabolic profiles. Collectively, these findings show that transferring PCB-exposed microbiota reproduces early neurobehavioral alterations and induces shared and sex-biased molecular responses, identifying the maternal gut microbiome as a candidate mediator linking PCB exposure to developmental neurotoxicity.
Additional Links: PMID-43059794
Full Text:
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43059794,
year = {2026},
author = {Suh, YP and Wilson, RJ and Breese, NM and Lein, PJ and Lehmler, HJ and Cui, JY},
title = {PCB-Exposed Gut Microbiota Recapitulate Neurobehavioral Deficits and Reprogram Hippocampal Transcriptomic Signatures.},
journal = {bioRxiv : the preprint server for biology},
volume = {},
number = {},
pages = {},
doi = {10.64898/2026.11.05.764721},
pmid = {43059794},
issn = {2692-8205},
abstract = {Polychlorinated biphenyls (PCBs) are persistent environmental pollutants associated with developmental neurotoxicity and autism spectrum disorder (ASD). However, whether PCB-induced alterations in gut microbiota contribute to neurodevelopmental toxicity independently of direct chemical exposure remains unclear. Here, we investigated whether transplantation of PCB-associated gut microbiota produces early neurobehavioral alterations and disrupts brain molecular pathways in offspring. Gut microbiota from conventional dams exposed to the Fox River PCB mixture (FRM; 6.0 mg/kg/day) or vehicle were transplanted into germ-free recipient females without direct PCB administration. At postnatal day 7 (P7), offspring underwent ultrasonic vocalization (USV) testing, whole-brain RNA sequencing (n = 4/sex/group), and untargeted serum metabolomics. Untargeted serum metabolomics were also performed in donor dams. PCB-associated fecal microbiota transplantation (FMT) significantly reduced offspring USVs, reproducing effects observed following direct maternal PCB exposure. Brain transcriptomics in offspring identified substantially more differentially expressed genes in males (9,339) than females (1,082), including 512 shared genes. Concordantly regulated genes revealed downregulation of neurotransmitter signaling and ion channel pathways alongside upregulation of RNA processing pathways. Male-associated responses involved altered protein synthesis and neuronal signaling, whereas female-associated responses involved DNA repair and extracellular matrix remodeling. Despite these molecular differences, behavioral responses showed no significant sex-dependent effect. Maternal metabolomics revealed increased bile acids and decreased indole-3-propionic acid, highlighting potential AhR-NFκB and bile acid-associated signaling mechanisms. Offspring metabolomics further identified alterations in lipid-associated metabolites and metabolic profiles. Collectively, these findings show that transferring PCB-exposed microbiota reproduces early neurobehavioral alterations and induces shared and sex-biased molecular responses, identifying the maternal gut microbiome as a candidate mediator linking PCB exposure to developmental neurotoxicity.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Elevational variation in gut microbial community composition and predicted functional potential across three Himalayan redstart species.
bioRxiv : the preprint server for biology pii:2026.11.09.765477.
Environmental gradients and seasonal migration may influence host-associated microbial communities, yet their contributions to gut microbiome variation in montane birds remain poorly understood. We investigated gut microbial communities across 1,300-4,200 m in three Himalayan redstarts (Phoenicurus fuliginosus, P. leucocephalus, and P. frontalis) exhibiting contrasting seasonal movement strategies. Using 16S rRNA gene sequencing of 46 fecal samples, we characterized microbial diversity, community composition, distance-decay relationships, co-occurrence networks, and predicted functional potential. Elevation was significantly associated with microbial community composition, explaining approximately 3% of variation, whereas host species showed no significant association after accounting for elevation. P. fuliginosus exhibited significant compositional differences among most sampled elevations, whereas P. leucocephalus showed significant positive distance-decay relationships. Alpha diversity showed no consistent elevational trend, while core microbial taxa and co-occurrence networks varied among elevational groups. PICRUSt2 analyses identified 28 predicted KEGG Level 3 pathways differing significantly among elevations, including pathways associated with amino acid, lipid, glycan, carbohydrate, and bile acid metabolism. Together, these findings highlight elevation as a significant correlate of gut microbial community composition and predicted functional potential, with distinct patterns of microbial turnover among closely related Himalayan redstarts.
Additional Links: PMID-43059949
Full Text:
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43059949,
year = {2026},
author = {Chhetri, P and Dahal, N and Kumar, A and Rai, S and Bhattacharjee, S and Kumar, R and Lamichhaney, S},
title = {Elevational variation in gut microbial community composition and predicted functional potential across three Himalayan redstart species.},
journal = {bioRxiv : the preprint server for biology},
volume = {},
number = {},
pages = {},
doi = {10.64898/2026.11.09.765477},
pmid = {43059949},
issn = {2692-8205},
abstract = {Environmental gradients and seasonal migration may influence host-associated microbial communities, yet their contributions to gut microbiome variation in montane birds remain poorly understood. We investigated gut microbial communities across 1,300-4,200 m in three Himalayan redstarts (Phoenicurus fuliginosus, P. leucocephalus, and P. frontalis) exhibiting contrasting seasonal movement strategies. Using 16S rRNA gene sequencing of 46 fecal samples, we characterized microbial diversity, community composition, distance-decay relationships, co-occurrence networks, and predicted functional potential. Elevation was significantly associated with microbial community composition, explaining approximately 3% of variation, whereas host species showed no significant association after accounting for elevation. P. fuliginosus exhibited significant compositional differences among most sampled elevations, whereas P. leucocephalus showed significant positive distance-decay relationships. Alpha diversity showed no consistent elevational trend, while core microbial taxa and co-occurrence networks varied among elevational groups. PICRUSt2 analyses identified 28 predicted KEGG Level 3 pathways differing significantly among elevations, including pathways associated with amino acid, lipid, glycan, carbohydrate, and bile acid metabolism. Together, these findings highlight elevation as a significant correlate of gut microbial community composition and predicted functional potential, with distinct patterns of microbial turnover among closely related Himalayan redstarts.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Defining the Functional Consequence of the Human Ocular Microbiome.
bioRxiv : the preprint server for biology pii:2026.10.28.762462.
The ocular surface is one of the body's most environmentally exposed mucosal barriers, yet it is considered low biomass and harbors orders of magnitude fewer bacteria than microbe-rich sites like the gut. This has cast doubt on whether a functional core ocular microbiome exists at all. Having previously defined a protective γδ T cell-IL-17 axis engaged by the murine commensal Corynebacterium mastitidis , we asked whether human-derived bacteria could do the same. Pairing sequencing and culturomics of healthy human conjunctiva from two geographically distinct cohorts, we define a stable core microbiome and identify Corynebacterium bovis as a consistent eye-resident commensal rather than a transient contaminant. In humans, C. bovis elicits a non-pathogenic response marked by IL-17 secretion by γδ T cells and circulating C. bovis -specific IgG, which suggests commensalism rather than pathology. Colonizing mice with human C. bovis strains from Pittsburgh or Miami reproduced this program and conferred protection against ocular infection with Staphylococcus aureus . Together, these findings identify C. bovis as a human-derived ocular commensal that can drive protective γδ T cell immunity, translating a mechanism previously defined only in mice into human relevance and a rational target against sight-threatening infection.
Additional Links: PMID-43060071
Full Text:
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43060071,
year = {2026},
author = {Gandhi, J and Desai, B and Mangwani-Mordani, S and Shane, J and Bierker, J and Wessell, A and Rodriguez J, DM and Randhawa, SK and Ma, X and Phelps, CM and Meisel, M and Patel, A and Li, K and Fitch, A and Methe, B and Jhanji, V and Galor, A and St Leger, AJ},
title = {Defining the Functional Consequence of the Human Ocular Microbiome.},
journal = {bioRxiv : the preprint server for biology},
volume = {},
number = {},
pages = {},
doi = {10.64898/2026.10.28.762462},
pmid = {43060071},
issn = {2692-8205},
abstract = {The ocular surface is one of the body's most environmentally exposed mucosal barriers, yet it is considered low biomass and harbors orders of magnitude fewer bacteria than microbe-rich sites like the gut. This has cast doubt on whether a functional core ocular microbiome exists at all. Having previously defined a protective γδ T cell-IL-17 axis engaged by the murine commensal Corynebacterium mastitidis , we asked whether human-derived bacteria could do the same. Pairing sequencing and culturomics of healthy human conjunctiva from two geographically distinct cohorts, we define a stable core microbiome and identify Corynebacterium bovis as a consistent eye-resident commensal rather than a transient contaminant. In humans, C. bovis elicits a non-pathogenic response marked by IL-17 secretion by γδ T cells and circulating C. bovis -specific IgG, which suggests commensalism rather than pathology. Colonizing mice with human C. bovis strains from Pittsburgh or Miami reproduced this program and conferred protection against ocular infection with Staphylococcus aureus . Together, these findings identify C. bovis as a human-derived ocular commensal that can drive protective γδ T cell immunity, translating a mechanism previously defined only in mice into human relevance and a rational target against sight-threatening infection.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Lifestyle-mediated shifts in the gut microbiome and host genetics modulate gene expression in intestinal organoids.
bioRxiv : the preprint server for biology pii:2026.11.07.765058.
Industrialization-associated shifts in the gut microbiome have been linked to disease, but the mechanisms by which microbial communities influence host gene regulation remain poorly understood. We developed a live microbiome-colonic organoid (colonoid) co-culture system to investigate genotype-dependent host responses to gut microbial community variation. Colonoid 2D monolayers from healthy donors were co-cultured with live gut microbial communities from individuals living urban or rural lifestyles, followed by RNA-sequencing. Urban and rural microbiomes elicited largely shared transcriptional responses, however they induced distinct host genetic effects on gene expression. We identified 511 host genes with microbiome-dependent allele-specific expression (ASE) which were involved in epithelial architecture, cell-matrix interactions and structural integrity. Notably, 149 host genes had distinct allelic effects between Urban and Rural microbiomes (urban-rural condition specific ASE or cASE), revealing genotype-dependent host responses to lifestyle-associated microbiomes. Urban-rural cASE was associated with microbial community composition, predominantly involving Prevotella and Bacteroides species. Targeted Prevotella copri spike-in recapitulated Prevotella-associated allelic effects at specific loci, including one in the IBD-associated autophagy gene, ATG4B. Together, these findings establish an experimental framework to investigate genotype-by-microbiome interactions, and demonstrate that lifestyle-mediated shifts in the microbiome modify host cis-regulatory genetic effects on gene expression.
Additional Links: PMID-43060076
Full Text:
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43060076,
year = {2026},
author = {Nirmalan, S and Arif, S and Garlicki, G and Alazizi, A and Hutchins, K and Poyet, M and Groussin, M and Carbonetto, P and Pique-Regi, R and Blekhman, R and Luca, F},
title = {Lifestyle-mediated shifts in the gut microbiome and host genetics modulate gene expression in intestinal organoids.},
journal = {bioRxiv : the preprint server for biology},
volume = {},
number = {},
pages = {},
doi = {10.64898/2026.11.07.765058},
pmid = {43060076},
issn = {2692-8205},
abstract = {Industrialization-associated shifts in the gut microbiome have been linked to disease, but the mechanisms by which microbial communities influence host gene regulation remain poorly understood. We developed a live microbiome-colonic organoid (colonoid) co-culture system to investigate genotype-dependent host responses to gut microbial community variation. Colonoid 2D monolayers from healthy donors were co-cultured with live gut microbial communities from individuals living urban or rural lifestyles, followed by RNA-sequencing. Urban and rural microbiomes elicited largely shared transcriptional responses, however they induced distinct host genetic effects on gene expression. We identified 511 host genes with microbiome-dependent allele-specific expression (ASE) which were involved in epithelial architecture, cell-matrix interactions and structural integrity. Notably, 149 host genes had distinct allelic effects between Urban and Rural microbiomes (urban-rural condition specific ASE or cASE), revealing genotype-dependent host responses to lifestyle-associated microbiomes. Urban-rural cASE was associated with microbial community composition, predominantly involving Prevotella and Bacteroides species. Targeted Prevotella copri spike-in recapitulated Prevotella-associated allelic effects at specific loci, including one in the IBD-associated autophagy gene, ATG4B. Together, these findings establish an experimental framework to investigate genotype-by-microbiome interactions, and demonstrate that lifestyle-mediated shifts in the microbiome modify host cis-regulatory genetic effects on gene expression.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Isolation and characterization of diverse Veillonella phages reveal novel lineages and distinct host interactions.
bioRxiv : the preprint server for biology pii:2026.11.01.763356.
The human oral microbiome is diverse and home to many species of bacteria, archaea, microeukaryotes, fungi and viruses. Homeostasis in the oral microbiome is important for health and dysbiosis in these communities leads to periodontal and systemic diseases. Veillonella are gram-negative, anaerobic, lactate-fermenting early colonizers of the mouth and are abundant in healthy oral microbiomes. Although considered commensals, Veillonella serve as bridging species in dental biofilms, promoting later colonization by pathogens, with mounting evidence supporting their roles as accessory pathogens in dental caries and periodontal disease. Bacteriophages are key regulators of bacterial community composition and are important drivers of microbial diversity, evolution, and ecology of the oral environment. Despite the ecological importance of Veillonella in the oral microbiome, phages infecting Veillonella remain largely uncharacterized. Here, we report the isolation of ten phages infecting natural isolates of three Veillonella species, representing seven distinct phage genomes. These phages exhibit diverse morphologies, genome organizations, and host ranges, with infection restricted to strains within the species of isolation. Several phages establish stable lysogeny, confer resistance to superinfection, and differ substantially in spontaneous production of infectious phage progeny. Genetic analysis of resistant mutants implicates lipopolysaccharide O-antigen as the receptor for one phage. Although none of the isolated phages had close matches in existing oral virome catalogs, related sequences were detected in oral metagenomes from geographically diverse populations. Together, these findings establish an experimentally characterized collection of Veillonella phages and connect previously uncharacterized oral viral diversity to bacterial hosts and infection phenotypes.
Additional Links: PMID-43060151
Full Text:
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43060151,
year = {2026},
author = {Basu, A and Lee, H and Fenner, J and Ruan, J and Gaulke, C and Vanderpool, CK},
title = {Isolation and characterization of diverse Veillonella phages reveal novel lineages and distinct host interactions.},
journal = {bioRxiv : the preprint server for biology},
volume = {},
number = {},
pages = {},
doi = {10.64898/2026.11.01.763356},
pmid = {43060151},
issn = {2692-8205},
abstract = {The human oral microbiome is diverse and home to many species of bacteria, archaea, microeukaryotes, fungi and viruses. Homeostasis in the oral microbiome is important for health and dysbiosis in these communities leads to periodontal and systemic diseases. Veillonella are gram-negative, anaerobic, lactate-fermenting early colonizers of the mouth and are abundant in healthy oral microbiomes. Although considered commensals, Veillonella serve as bridging species in dental biofilms, promoting later colonization by pathogens, with mounting evidence supporting their roles as accessory pathogens in dental caries and periodontal disease. Bacteriophages are key regulators of bacterial community composition and are important drivers of microbial diversity, evolution, and ecology of the oral environment. Despite the ecological importance of Veillonella in the oral microbiome, phages infecting Veillonella remain largely uncharacterized. Here, we report the isolation of ten phages infecting natural isolates of three Veillonella species, representing seven distinct phage genomes. These phages exhibit diverse morphologies, genome organizations, and host ranges, with infection restricted to strains within the species of isolation. Several phages establish stable lysogeny, confer resistance to superinfection, and differ substantially in spontaneous production of infectious phage progeny. Genetic analysis of resistant mutants implicates lipopolysaccharide O-antigen as the receptor for one phage. Although none of the isolated phages had close matches in existing oral virome catalogs, related sequences were detected in oral metagenomes from geographically diverse populations. Together, these findings establish an experimentally characterized collection of Veillonella phages and connect previously uncharacterized oral viral diversity to bacterial hosts and infection phenotypes.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
A genetic screen to identify host factors required for commensal bacterial adherence to the gut epithelia.
bioRxiv : the preprint server for biology pii:2026.11.09.765429.
Bacterial adherence to gut epithelial cells likely involves host genetic components. We isolated a gut commensal bacterium, Lelliottia jeotgali , that can robustly colonize C. elegans through attachment to intestinal epithelial cells. Here, we developed a novel screen in C. elegans to identify host genes required for microbiome bacterial colonization. Using transgenic L. jeotgali strain expressing tdTomato, we conducted forward genetic screens in C. elegans to select for mutants that completely lost colonization. We identified multiple allelic mutations in five different C. elegans genes, termed k nockout o f L elliottia a dherence (kola) mutants, with a near complete loss of adherence. Each of kola-1-5 is uncharacterized and predicted to encode for a secreted or membrane-bound protein. We also identified gly-5 , a GalNAc transferase that initiates O-linked glycosylation. Overall, we describe the first C. elegans screen to identify host factors that control microbiome bacterial colonization in the gut.
Additional Links: PMID-43060167
Full Text:
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43060167,
year = {2026},
author = {Singh, A and Rivera, DE and Cruse, C and Nguyen, T and Gupta, P and Poirier, K and Luallen, RJ},
title = {A genetic screen to identify host factors required for commensal bacterial adherence to the gut epithelia.},
journal = {bioRxiv : the preprint server for biology},
volume = {},
number = {},
pages = {},
doi = {10.64898/2026.11.09.765429},
pmid = {43060167},
issn = {2692-8205},
abstract = {Bacterial adherence to gut epithelial cells likely involves host genetic components. We isolated a gut commensal bacterium, Lelliottia jeotgali , that can robustly colonize C. elegans through attachment to intestinal epithelial cells. Here, we developed a novel screen in C. elegans to identify host genes required for microbiome bacterial colonization. Using transgenic L. jeotgali strain expressing tdTomato, we conducted forward genetic screens in C. elegans to select for mutants that completely lost colonization. We identified multiple allelic mutations in five different C. elegans genes, termed k nockout o f L elliottia a dherence (kola) mutants, with a near complete loss of adherence. Each of kola-1-5 is uncharacterized and predicted to encode for a secreted or membrane-bound protein. We also identified gly-5 , a GalNAc transferase that initiates O-linked glycosylation. Overall, we describe the first C. elegans screen to identify host factors that control microbiome bacterial colonization in the gut.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
A Urinary Metabolomic Signature Associated with Small Intestinal Bacterial Overgrowth in Children with Short Bowel Syndrome.
bioRxiv : the preprint server for biology pii:2026.11.04.762217.
Direct sampling of the small intestinal microbiome is challenging. Urinary metabolites may offer a noninvasive approach to studying microbial functional activity. We used clinically available gas chromatography-mass spectrometry to profile urinary organic acids in 94 children with short bowel syndrome, comparing those with clinically defined small intestinal bacterial overgrowth (SIBO; n=21) with those without SIBO (n=73). SIBO-associated metabolites included microbial fermentation products, dietary derivatives, and host metabolic intermediates. Metabolites enriched in SIBO mapped to aromatic amino acid metabolism, including tryptophan and tyrosine pathways, consistent with altered microbial fermentation. Many associations persisted after adjustment for intestinal anatomy, age, antibiotic exposure, and nutritional composition. These findings identified a urinary metabolic profile associated with clinically defined SIBO in children with short bowel syndrome and support further evaluation of urinary metabolomics as a noninvasive approach to studying small intestinal microbial function.
Additional Links: PMID-43060210
Full Text:
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43060210,
year = {2026},
author = {Zong, W and Gan, S and Zarek, CM and He, M and Alame, R and Tovar, E and Yang, S and Huo, S and Albenberg, L and Zhan, X and Wu, GD and Bales, C and Koh, AY},
title = {A Urinary Metabolomic Signature Associated with Small Intestinal Bacterial Overgrowth in Children with Short Bowel Syndrome.},
journal = {bioRxiv : the preprint server for biology},
volume = {},
number = {},
pages = {},
doi = {10.64898/2026.11.04.762217},
pmid = {43060210},
issn = {2692-8205},
abstract = {Direct sampling of the small intestinal microbiome is challenging. Urinary metabolites may offer a noninvasive approach to studying microbial functional activity. We used clinically available gas chromatography-mass spectrometry to profile urinary organic acids in 94 children with short bowel syndrome, comparing those with clinically defined small intestinal bacterial overgrowth (SIBO; n=21) with those without SIBO (n=73). SIBO-associated metabolites included microbial fermentation products, dietary derivatives, and host metabolic intermediates. Metabolites enriched in SIBO mapped to aromatic amino acid metabolism, including tryptophan and tyrosine pathways, consistent with altered microbial fermentation. Many associations persisted after adjustment for intestinal anatomy, age, antibiotic exposure, and nutritional composition. These findings identified a urinary metabolic profile associated with clinically defined SIBO in children with short bowel syndrome and support further evaluation of urinary metabolomics as a noninvasive approach to studying small intestinal microbial function.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Diet Soda Consumption is Associated with Shifts in Gut Microbiome Function of Overweight Young Women.
medRxiv : the preprint server for health sciences pii:2026.11.12.26367968.
BACKGROUND: Low-calorie sweeteners (LCS) are consumed as sugar substitutes and may alter gut microbial composition. Their effects on microbial functional pathways and cardiometabolic physiology in humans remain poorly understood, particularly among individuals with overweight.
METHODS: We conducted a secondary analysis of an 8-week, single-arm pre/post intervention involving eight overweight young adult women who consumed sucralose- and acesulfame-potassium-sweetened Diet Pepsi three times daily. Shotgun metagenomic sequencing of stool samples was used to profile microbial functional pathways with HUMAnN2. Multivariable linear mixed models (MaAsLin2) assessed associations between pathways and metabolic biomarkers. We hierarchically clustered nominally significant pathways into six representative groups and calculated Spearman correlations with interleukin-6 (IL-6), leptin, and HOMA-IR. P values were adjusted using the Benjamini-Hochberg false discovery rate (FDR) procedure. Biomarkers were measured using clinical chemistry and immunoassays.
RESULTS: MaAsLin2 identified 33 microbial pathways nominally associated with the intervention (exploratory FDR ≤ 0.25); one pathway (PWY-5104) also met the conventional FDR ≤ 0.10 threshold. Eighteen pathways were upregulated and 15 downregulated, with log fold changes ranging from -2.47 to 3.18. The 33 pathways were grouped into six functional clusters. L-alanine biosynthesis (PWY0-1061) was positively correlated with circulating IL-6 (ρ = 0.74; q < 0.01). Phosphopantothenate biosynthesis I (PANTO-PWY) was not significantly correlated with IL-6 (ρ = -0.46; q = 0.22).
CONCLUSION: Gut microbial functional analysis identified a positive association between L-alanine biosynthesis and circulating IL-6. This finding complements previously reported taxonomic shifts in this cohort and suggests a potential relationship between LCS consumption, microbial function, and host inflammatory signaling.
Additional Links: PMID-43060231
Full Text:
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43060231,
year = {2026},
author = {Appiah, PY and Perez-Losada, M and Sylvestsky, AC and Ortega-Santos, CP and Crandall, KA},
title = {Diet Soda Consumption is Associated with Shifts in Gut Microbiome Function of Overweight Young Women.},
journal = {medRxiv : the preprint server for health sciences},
volume = {},
number = {},
pages = {},
doi = {10.64898/2026.11.12.26367968},
pmid = {43060231},
abstract = {BACKGROUND: Low-calorie sweeteners (LCS) are consumed as sugar substitutes and may alter gut microbial composition. Their effects on microbial functional pathways and cardiometabolic physiology in humans remain poorly understood, particularly among individuals with overweight.
METHODS: We conducted a secondary analysis of an 8-week, single-arm pre/post intervention involving eight overweight young adult women who consumed sucralose- and acesulfame-potassium-sweetened Diet Pepsi three times daily. Shotgun metagenomic sequencing of stool samples was used to profile microbial functional pathways with HUMAnN2. Multivariable linear mixed models (MaAsLin2) assessed associations between pathways and metabolic biomarkers. We hierarchically clustered nominally significant pathways into six representative groups and calculated Spearman correlations with interleukin-6 (IL-6), leptin, and HOMA-IR. P values were adjusted using the Benjamini-Hochberg false discovery rate (FDR) procedure. Biomarkers were measured using clinical chemistry and immunoassays.
RESULTS: MaAsLin2 identified 33 microbial pathways nominally associated with the intervention (exploratory FDR ≤ 0.25); one pathway (PWY-5104) also met the conventional FDR ≤ 0.10 threshold. Eighteen pathways were upregulated and 15 downregulated, with log fold changes ranging from -2.47 to 3.18. The 33 pathways were grouped into six functional clusters. L-alanine biosynthesis (PWY0-1061) was positively correlated with circulating IL-6 (ρ = 0.74; q < 0.01). Phosphopantothenate biosynthesis I (PANTO-PWY) was not significantly correlated with IL-6 (ρ = -0.46; q = 0.22).
CONCLUSION: Gut microbial functional analysis identified a positive association between L-alanine biosynthesis and circulating IL-6. This finding complements previously reported taxonomic shifts in this cohort and suggests a potential relationship between LCS consumption, microbial function, and host inflammatory signaling.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Mapping bacterial bile amidation across the bile salt hydrolase family.
bioRxiv : the preprint server for biology pii:2026.11.01.763480.
Evaluating enzyme activity and specificity in complex microbiomes is challenging. The recent discovery that bacterial bile salt hydrolases (BSHs) also function as transaminases in the human gut microbiome highlights what remains to be disentangled, even within one of the most extensively studied microbiomes. BSHs as transaminases can conjugate bile acids with bioavailable amines to produce bacterial bile amidates (BBAs). The implications of BBAs for human health are rapidly evolving, but our understanding of which BSHs produce which specific BBAs remains limited. Here, we connect BSH sequence and function by evaluating the transaminase activities of 115 BSHs and reveal distinct amine specificities using molecular networking. Additionally, we identify enzymatically generated BBAs distributed across life-stage, tissue-, and disease-specific human samples by mining public metabolomics repositories, highlighting the previously unrecognized catalytic diversity of BSHs and their potential relevance to human health.
Additional Links: PMID-43060418
Full Text:
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43060418,
year = {2026},
author = {Skrip, AE and Prasad, SS and Wierzbicki, IH and Charron-Lamoureux, V and Trithart, HC and Pattynama, D and Deleray, V and Lee, C and Vitalli, K and Liu, Y and Zemlin, J and Nguyen, A and Lee, E and Hagey, LR and Gonzalez, DJ and Dorrestein, PC and Mohanty, I and Lukowski, AL},
title = {Mapping bacterial bile amidation across the bile salt hydrolase family.},
journal = {bioRxiv : the preprint server for biology},
volume = {},
number = {},
pages = {},
doi = {10.64898/2026.11.01.763480},
pmid = {43060418},
issn = {2692-8205},
abstract = {Evaluating enzyme activity and specificity in complex microbiomes is challenging. The recent discovery that bacterial bile salt hydrolases (BSHs) also function as transaminases in the human gut microbiome highlights what remains to be disentangled, even within one of the most extensively studied microbiomes. BSHs as transaminases can conjugate bile acids with bioavailable amines to produce bacterial bile amidates (BBAs). The implications of BBAs for human health are rapidly evolving, but our understanding of which BSHs produce which specific BBAs remains limited. Here, we connect BSH sequence and function by evaluating the transaminase activities of 115 BSHs and reveal distinct amine specificities using molecular networking. Additionally, we identify enzymatically generated BBAs distributed across life-stage, tissue-, and disease-specific human samples by mining public metabolomics repositories, highlighting the previously unrecognized catalytic diversity of BSHs and their potential relevance to human health.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
NanoPAMDA enables rapid PAM characterization of metagenome-derived Cas9 effectors.
bioRxiv : the preprint server for biology pii:2026.11.04.764188.
CRISPR-Cas9 orthologs remain functionally underexplored despite the rapidly growing scale of publicly available metagenomic sequencing data. Here, we applied a multi-stage computational discovery pipeline to two independent sources of metagenomic sequence data, a multi-biome collection of 620,185 metagenome-assembled genomes spanning 17 public catalogs, and raw sequencing reads from human microbiome studies assembled de novo, to identify novel Cas9 orthologs. Candidates were filtered for guide RNA architectural plausibility, sequence novelty, conservation of catalytic residues, and structural integrity, yielding 14 candidates spanning both data sources for experimental characterization. To determine PAM preference at scale, we developed a cost-effective Nanopore long-read-based adaptation of the high-throughput PAM determination assay (NanoPAMDA), enabling rapid, time-resolved, kinetic PAM profiling across many candidates in parallel. One Cas9 effector, E10, showed PAM-specific activity in vitro and was catalytically active in E. coli . Together, these findings demonstrate a scalable, long-read sequencing-based framework for discovering and biochemically characterizing novel Cas9 orthologs from metagenomic data.
Additional Links: PMID-43060467
Full Text:
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43060467,
year = {2026},
author = {Genel, I and Suren, C and Kurt, IC},
title = {NanoPAMDA enables rapid PAM characterization of metagenome-derived Cas9 effectors.},
journal = {bioRxiv : the preprint server for biology},
volume = {},
number = {},
pages = {},
doi = {10.64898/2026.11.04.764188},
pmid = {43060467},
issn = {2692-8205},
abstract = {CRISPR-Cas9 orthologs remain functionally underexplored despite the rapidly growing scale of publicly available metagenomic sequencing data. Here, we applied a multi-stage computational discovery pipeline to two independent sources of metagenomic sequence data, a multi-biome collection of 620,185 metagenome-assembled genomes spanning 17 public catalogs, and raw sequencing reads from human microbiome studies assembled de novo, to identify novel Cas9 orthologs. Candidates were filtered for guide RNA architectural plausibility, sequence novelty, conservation of catalytic residues, and structural integrity, yielding 14 candidates spanning both data sources for experimental characterization. To determine PAM preference at scale, we developed a cost-effective Nanopore long-read-based adaptation of the high-throughput PAM determination assay (NanoPAMDA), enabling rapid, time-resolved, kinetic PAM profiling across many candidates in parallel. One Cas9 effector, E10, showed PAM-specific activity in vitro and was catalytically active in E. coli . Together, these findings demonstrate a scalable, long-read sequencing-based framework for discovering and biochemically characterizing novel Cas9 orthologs from metagenomic data.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
β-glucosidase-mediated hydrolysis of Ophiocordyceps polysaccharides enhances antioxidant and immunomodulatory activities and ameliorates intestinal barrier function to maintain gut homeostasis.
Frontiers in pharmacology, 17:1957172.
Polysaccharides derived from Ophiocordyceps (Chinese Cordyceps) exhibit notable bioactivities, yet their high molecular weight may limit their fermentability by the gut microbiota, thereby modulating the production of bioactive metabolites. This study aimed to prepare low-molecular-weight Ophiocordyceps polysaccharides (OPs) through enzymatic modification and to elucidate the associated structural alterations and mechanisms underlying intestinal barrier regulation. Hydrolysis with β-glucosidase yielded the enzymatically modified product OPs-80E. Structural characterization demonstrated that hydrolysis significantly reduced the average molecular weight from 8.64 × 10[5] Da to 2.99 × 10[4] Da and altered the monosaccharide composition profile. In vitro assays showed that OPs-80E exhibited greater antioxidant capacity and immunomodulatory activity than native OPs-80, as evidenced by enhanced RAW264.7 cell proliferation, phagocytosis, and cytokine secretion. In a cyclophosphamide-induced immunosuppressed mouse model, OPs-80E was more effective than OPs-80 in reversing intestinal histopathological damage, significantly upregulating the expression of tight junction proteins (ZO-1 and Claudin-1), and remodeling the gut microbiota architecture. 16S rRNA gene sequencing analysis indicated that OPs-80E significantly enriched butyrate-producing taxa, such as Lachnospiraceae, while suppressing potential pathogens. Correlation network analysis further revealed that OPs-80E established a symbiotic network centered on the Prevotellaceae Ga6A1 group and Clade Ia, facilitating synergistic "polysaccharide degradation and butyrate production" metabolic cross-feeding to maintain intestinal barrier integrity. Collectively, enzymatic hydrolysis represents an effective strategy for enhancing the bioactivity of Chinese Cordyceps polysaccharides. OPs-80E exerts intestinal protective effects by modulating the "microbiota and barrier" axis, highlighting its broad application prospects in functional foods and pharmaceutical development.
Additional Links: PMID-43060484
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43060484,
year = {2026},
author = {Bian, Z and Zhao, A and Jiang, L and Ruan, Y and Yue, X and Fang, J and Bai, J and Niu, S and Liu, S and Guo, J},
title = {β-glucosidase-mediated hydrolysis of Ophiocordyceps polysaccharides enhances antioxidant and immunomodulatory activities and ameliorates intestinal barrier function to maintain gut homeostasis.},
journal = {Frontiers in pharmacology},
volume = {17},
number = {},
pages = {1957172},
pmid = {43060484},
issn = {1663-9812},
abstract = {Polysaccharides derived from Ophiocordyceps (Chinese Cordyceps) exhibit notable bioactivities, yet their high molecular weight may limit their fermentability by the gut microbiota, thereby modulating the production of bioactive metabolites. This study aimed to prepare low-molecular-weight Ophiocordyceps polysaccharides (OPs) through enzymatic modification and to elucidate the associated structural alterations and mechanisms underlying intestinal barrier regulation. Hydrolysis with β-glucosidase yielded the enzymatically modified product OPs-80E. Structural characterization demonstrated that hydrolysis significantly reduced the average molecular weight from 8.64 × 10[5] Da to 2.99 × 10[4] Da and altered the monosaccharide composition profile. In vitro assays showed that OPs-80E exhibited greater antioxidant capacity and immunomodulatory activity than native OPs-80, as evidenced by enhanced RAW264.7 cell proliferation, phagocytosis, and cytokine secretion. In a cyclophosphamide-induced immunosuppressed mouse model, OPs-80E was more effective than OPs-80 in reversing intestinal histopathological damage, significantly upregulating the expression of tight junction proteins (ZO-1 and Claudin-1), and remodeling the gut microbiota architecture. 16S rRNA gene sequencing analysis indicated that OPs-80E significantly enriched butyrate-producing taxa, such as Lachnospiraceae, while suppressing potential pathogens. Correlation network analysis further revealed that OPs-80E established a symbiotic network centered on the Prevotellaceae Ga6A1 group and Clade Ia, facilitating synergistic "polysaccharide degradation and butyrate production" metabolic cross-feeding to maintain intestinal barrier integrity. Collectively, enzymatic hydrolysis represents an effective strategy for enhancing the bioactivity of Chinese Cordyceps polysaccharides. OPs-80E exerts intestinal protective effects by modulating the "microbiota and barrier" axis, highlighting its broad application prospects in functional foods and pharmaceutical development.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Stochastic assembly outweighs deterministic filtering: crop phenological stages drive bacterial-fungal divergence between bulk and rhizosphere soils in saline-alkali fields.
Frontiers in microbiology, 17:1992553.
Soil salinization threatens crop productivity partly by disrupting rhizosphere microbiomes that support plant stress tolerance. However, most studies have focused on single growth stages or bulk soil, limiting a deeper insight into the temporal dynamics and assembly mechanisms of rhizosphere communities across the crop life cycle. We investigated bacterial and fungal communities in a long-term maize field with saline-alkali soil. Bulk and rhizosphere soils were sampled at seedling, heading, and maturity. Using 16S rRNA and ITS amplicon sequencing, iCAMP, functional prediction, and co-occurrence networks, we found that maize phenological stage significantly structured bacterial and fungal community composition, while the difference between the rhizosphere and bulk soil was not significant. Microbial diversity increased toward maturity in bulk soil, whereas rhizosphere bacterial diversity showed a seedling-stage bottleneck and fungal diversity remained higher than that in bulk soil. The rhizosphere enriched copiotrophic Proteobacteria and Actinobacteriota, whereas bulk soil favored oligotrophic Chloroflexi and Acidobacteriota. Drift (and others) represented the largest single assembly category across phenological stages in both compartments, with relative contributions exceeding 38%. Deterministic contributions to bacterial assembly remained stable across stages and compartments, whereas rhizosphere fungal assembly became more stochastic at maturity. Under the saline-alkali conditions examined here, stochastic processes remained dominant, and deterministic filtering did not become the predominant mode of community assembly. Predicted functional profiles shifted with plant development: organic phosphorus mineralization was enriched at seedling, phosphate transport and nitrogen fixation at maturity, and salt-tolerance functions shifted from compatible-solute synthesis to ion homeostasis and antioxidant defense. The rhizosphere showed reduced bacterial network connectivity but more positive fungal associations and a higher proportion of cross-kingdom associations. Together, these results characterize a "growth stage-rhizosphere effect-salinity stress" framework in saline-alkali maize field, in which environmental control shifts from salinity toward nutrient stoichiometry for bacteria and microbial biomass for fungi. These patterns may inform growth-stage-specific microbiome management in saline-alkali soil.
Additional Links: PMID-43060516
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43060516,
year = {2026},
author = {Wu, D and Hou, S and Wang, J and Song, D and Wang, Z and Wang, J and Li, Y and Zhang, F and Ai, C and Zhou, W and Gao, M},
title = {Stochastic assembly outweighs deterministic filtering: crop phenological stages drive bacterial-fungal divergence between bulk and rhizosphere soils in saline-alkali fields.},
journal = {Frontiers in microbiology},
volume = {17},
number = {},
pages = {1992553},
pmid = {43060516},
issn = {1664-302X},
abstract = {Soil salinization threatens crop productivity partly by disrupting rhizosphere microbiomes that support plant stress tolerance. However, most studies have focused on single growth stages or bulk soil, limiting a deeper insight into the temporal dynamics and assembly mechanisms of rhizosphere communities across the crop life cycle. We investigated bacterial and fungal communities in a long-term maize field with saline-alkali soil. Bulk and rhizosphere soils were sampled at seedling, heading, and maturity. Using 16S rRNA and ITS amplicon sequencing, iCAMP, functional prediction, and co-occurrence networks, we found that maize phenological stage significantly structured bacterial and fungal community composition, while the difference between the rhizosphere and bulk soil was not significant. Microbial diversity increased toward maturity in bulk soil, whereas rhizosphere bacterial diversity showed a seedling-stage bottleneck and fungal diversity remained higher than that in bulk soil. The rhizosphere enriched copiotrophic Proteobacteria and Actinobacteriota, whereas bulk soil favored oligotrophic Chloroflexi and Acidobacteriota. Drift (and others) represented the largest single assembly category across phenological stages in both compartments, with relative contributions exceeding 38%. Deterministic contributions to bacterial assembly remained stable across stages and compartments, whereas rhizosphere fungal assembly became more stochastic at maturity. Under the saline-alkali conditions examined here, stochastic processes remained dominant, and deterministic filtering did not become the predominant mode of community assembly. Predicted functional profiles shifted with plant development: organic phosphorus mineralization was enriched at seedling, phosphate transport and nitrogen fixation at maturity, and salt-tolerance functions shifted from compatible-solute synthesis to ion homeostasis and antioxidant defense. The rhizosphere showed reduced bacterial network connectivity but more positive fungal associations and a higher proportion of cross-kingdom associations. Together, these results characterize a "growth stage-rhizosphere effect-salinity stress" framework in saline-alkali maize field, in which environmental control shifts from salinity toward nutrient stoichiometry for bacteria and microbial biomass for fungi. These patterns may inform growth-stage-specific microbiome management in saline-alkali soil.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Tyrosine hydroxylase deletion in Ntsr1 neurons confers resistance to diet-induced weight gain: an energy-balance analysis.
bioRxiv : the preprint server for biology pii:2026.11.05.764678.
High-fat diet (HFD) disrupts circadian feeding rhythms and promotes diet-induced obesity (DIO), but the neural mechanisms linking diet to energy balance remain unclear. Previously, we demonstrated that dopamine production in neurotensin receptor 1 (Ntsr1)-expressing neurons was required for HFD-induced daytime overfeeding and DIO. Here, we tested whether DIO resistance in Ntsr1 [Cre] ;Th [flox] conditional knockout (cKO) mice was explained by altered energy expenditure. We replicated resistance to HFD-induced weight gain and assessed food intake, indirect calorimetry, activity, body temperature, fecal energy, fecal nonesterified fatty acids, and the gut microbiome. Indirect calorimetry on standard chow diet (SCD) was confounded by reduced intake and body weight loss, whereas HFD-fed cKO mice consumed food readily and resisted weight gain. Unlike our previous study, daytime feeding was not suppressed; instead, cKO mice were slightly and variably hypophagic on HFD but not SCD. DIO resistance was not accompanied by increased energy expenditure, activity, or body temperature. Rather, cKO mice showed reduced energy expenditure and activity and lower body temperature on both diets. In the replication cohort, HFD fecal output was lower in cKO mice, whereas the independent bomb-calorimetry cohort showed no genotype difference in fecal mass; fecal energy density and nonesterified fatty acid concentration were unchanged. Preliminary analysis of the microbiome was consistent with an obesity-resistant gut profile. Together, these findings indicate that the feeding phenotype is diet- and experiment-dependent and that DIO resistance is not explained by increased energy expenditure, activity, thermogenesis, or detectable changes in fecal energy or fat content.
Additional Links: PMID-43060628
Full Text:
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43060628,
year = {2026},
author = {Wu, R and Gomez, A and Wong, JT and Gordillo, R and Kamitakahara, AK and Steele, AD},
title = {Tyrosine hydroxylase deletion in Ntsr1 neurons confers resistance to diet-induced weight gain: an energy-balance analysis.},
journal = {bioRxiv : the preprint server for biology},
volume = {},
number = {},
pages = {},
doi = {10.64898/2026.11.05.764678},
pmid = {43060628},
issn = {2692-8205},
abstract = {High-fat diet (HFD) disrupts circadian feeding rhythms and promotes diet-induced obesity (DIO), but the neural mechanisms linking diet to energy balance remain unclear. Previously, we demonstrated that dopamine production in neurotensin receptor 1 (Ntsr1)-expressing neurons was required for HFD-induced daytime overfeeding and DIO. Here, we tested whether DIO resistance in Ntsr1 [Cre] ;Th [flox] conditional knockout (cKO) mice was explained by altered energy expenditure. We replicated resistance to HFD-induced weight gain and assessed food intake, indirect calorimetry, activity, body temperature, fecal energy, fecal nonesterified fatty acids, and the gut microbiome. Indirect calorimetry on standard chow diet (SCD) was confounded by reduced intake and body weight loss, whereas HFD-fed cKO mice consumed food readily and resisted weight gain. Unlike our previous study, daytime feeding was not suppressed; instead, cKO mice were slightly and variably hypophagic on HFD but not SCD. DIO resistance was not accompanied by increased energy expenditure, activity, or body temperature. Rather, cKO mice showed reduced energy expenditure and activity and lower body temperature on both diets. In the replication cohort, HFD fecal output was lower in cKO mice, whereas the independent bomb-calorimetry cohort showed no genotype difference in fecal mass; fecal energy density and nonesterified fatty acid concentration were unchanged. Preliminary analysis of the microbiome was consistent with an obesity-resistant gut profile. Together, these findings indicate that the feeding phenotype is diet- and experiment-dependent and that DIO resistance is not explained by increased energy expenditure, activity, thermogenesis, or detectable changes in fecal energy or fat content.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Drug-induced gastrointestinal toxicity: from pathophysiological mechanisms to human-relevant preclinical models.
Frontiers in bioengineering and biotechnology, 14:1994581.
Drug-induced gastrointestinal toxicity (DiGIT) represents a major dose-limiting adverse effect that severely compromises patient outcomes and therapeutic efficacy across global populations. Frequently triggered by chemotherapeutic agents and non-steroidal anti-inflammatory drugs (NSAIDs), DiGIT spans a clinical spectrum from mild dyspepsia to life-threatening complications, including severe mucositis, ulceration, and gastrointestinal (GI) bleeding. Because the GI tract serves as a primary site of drug exposure, its rapidly proliferating epithelial architecture, mucosal immune interface, and complex microbiota, essential components of intestinal homeostasis, are particularly susceptible to off-target therapeutic damage. This review provides a comprehensive analysis of DiGIT across the upper and lower GI tracts, examining the distinct toxicity profiles of NSAIDs and chemotherapy. We detail the underlying pathophysiological mechanisms, focusing on drug-induced epithelial damage, innate immune system activation, and microbiome dysbiosis, alongside current supportive management strategies. Finally, we highlight the preclinical landscape of in vitro toxicity testing, outlining how emerging, physiologically representative bioengineered models can better evaluate GI safety, streamline risk assessment, and improve candidate drug success.
Additional Links: PMID-43060690
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43060690,
year = {2026},
author = {Borka, G and Aiello, M and Scaglione, S and Palamà, MEF},
title = {Drug-induced gastrointestinal toxicity: from pathophysiological mechanisms to human-relevant preclinical models.},
journal = {Frontiers in bioengineering and biotechnology},
volume = {14},
number = {},
pages = {1994581},
pmid = {43060690},
issn = {2296-4185},
abstract = {Drug-induced gastrointestinal toxicity (DiGIT) represents a major dose-limiting adverse effect that severely compromises patient outcomes and therapeutic efficacy across global populations. Frequently triggered by chemotherapeutic agents and non-steroidal anti-inflammatory drugs (NSAIDs), DiGIT spans a clinical spectrum from mild dyspepsia to life-threatening complications, including severe mucositis, ulceration, and gastrointestinal (GI) bleeding. Because the GI tract serves as a primary site of drug exposure, its rapidly proliferating epithelial architecture, mucosal immune interface, and complex microbiota, essential components of intestinal homeostasis, are particularly susceptible to off-target therapeutic damage. This review provides a comprehensive analysis of DiGIT across the upper and lower GI tracts, examining the distinct toxicity profiles of NSAIDs and chemotherapy. We detail the underlying pathophysiological mechanisms, focusing on drug-induced epithelial damage, innate immune system activation, and microbiome dysbiosis, alongside current supportive management strategies. Finally, we highlight the preclinical landscape of in vitro toxicity testing, outlining how emerging, physiologically representative bioengineered models can better evaluate GI safety, streamline risk assessment, and improve candidate drug success.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Association between gut microbiota and osteoporosis in adults: a systematic review and meta-analysis.
Frontiers in nutrition, 13:1940274.
OBJECTIVES: To systematically review and quantitatively synthesize observational evidence on gut microbiota alterations in adults with osteoporosis, osteopenia or low bone mineral density, with particular emphasis on α-diversity, β-diversity and taxonomic composition.
METHODS: A systematic search of PubMed, Embase, Web of Science, the Cochrane Library and EBSCO were conducted for studies published between 1 June 2012 and 31 December 2025. Observational studies comparing adults with osteoporosis, osteopenia or low bone mineral density against controls and using fecal microbiome sequencing were eligible. Standardized mean differences (SMDs) with 95% confidence intervals (CIs) were pooled for extractable α-diversity outcomes. β-diversity findings and taxonomic differences were synthesized descriptively. Methodological quality was assessed using a modified Newcastle-Ottawa Scale.
RESULTS: Eighteen studies were included in the systematic review and 15 contributed to the quantitative synthesis, representing 2,851 participants (1,094 cases/abnormal bone mass and 1,757 controls). Meta-analysis showed no significant overall differences in the Shannon index (SMD = 0.27, 95% CI: -0.03 to 0.57; I [2] = 81.8%) or the Chao1 index (SMD = -0.13, 95% CI: -0.82 to 0.55; I [2] = 85.4%). Descriptive synthesis of β-diversity more often suggested structural differences in gut microbial communities between case groups and controls. At the taxonomic level, Bacteroides was more frequently enriched in case groups, whereas evidence for several other genera, including Blautia, was less consistent. Direction-of-effect synthesis further indicated recurrent enrichment of Bacteroides and Lactobacillus in case groups and more frequent enrichment of Roseburia in controls. Overall study quality was moderate to high.
CONCLUSIONS: This review reveals that osteoporosis and abnormal bone mass present no significant differences in gut microbial alpha-diversity, but exhibit distinct β-diversity and consistent taxonomic alterations. Gut dysbiosis is potentially associated with compromised bone health; nevertheless, marked heterogeneity persists, necessitating further standardized studies to validate clinically valuable microbial signatures.
https://www.crd.york.ac.uk/PROSPERO/view/CRD420261382643, identifier CRD420261382643.
Additional Links: PMID-43060861
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43060861,
year = {2026},
author = {Cao, W and Liu, Y and Yin, S and Zhang, H and Li, R and Zhang, P and Petersen, JD},
title = {Association between gut microbiota and osteoporosis in adults: a systematic review and meta-analysis.},
journal = {Frontiers in nutrition},
volume = {13},
number = {},
pages = {1940274},
pmid = {43060861},
issn = {2296-861X},
abstract = {OBJECTIVES: To systematically review and quantitatively synthesize observational evidence on gut microbiota alterations in adults with osteoporosis, osteopenia or low bone mineral density, with particular emphasis on α-diversity, β-diversity and taxonomic composition.
METHODS: A systematic search of PubMed, Embase, Web of Science, the Cochrane Library and EBSCO were conducted for studies published between 1 June 2012 and 31 December 2025. Observational studies comparing adults with osteoporosis, osteopenia or low bone mineral density against controls and using fecal microbiome sequencing were eligible. Standardized mean differences (SMDs) with 95% confidence intervals (CIs) were pooled for extractable α-diversity outcomes. β-diversity findings and taxonomic differences were synthesized descriptively. Methodological quality was assessed using a modified Newcastle-Ottawa Scale.
RESULTS: Eighteen studies were included in the systematic review and 15 contributed to the quantitative synthesis, representing 2,851 participants (1,094 cases/abnormal bone mass and 1,757 controls). Meta-analysis showed no significant overall differences in the Shannon index (SMD = 0.27, 95% CI: -0.03 to 0.57; I [2] = 81.8%) or the Chao1 index (SMD = -0.13, 95% CI: -0.82 to 0.55; I [2] = 85.4%). Descriptive synthesis of β-diversity more often suggested structural differences in gut microbial communities between case groups and controls. At the taxonomic level, Bacteroides was more frequently enriched in case groups, whereas evidence for several other genera, including Blautia, was less consistent. Direction-of-effect synthesis further indicated recurrent enrichment of Bacteroides and Lactobacillus in case groups and more frequent enrichment of Roseburia in controls. Overall study quality was moderate to high.
CONCLUSIONS: This review reveals that osteoporosis and abnormal bone mass present no significant differences in gut microbial alpha-diversity, but exhibit distinct β-diversity and consistent taxonomic alterations. Gut dysbiosis is potentially associated with compromised bone health; nevertheless, marked heterogeneity persists, necessitating further standardized studies to validate clinically valuable microbial signatures.
https://www.crd.york.ac.uk/PROSPERO/view/CRD420261382643, identifier CRD420261382643.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Multi-omics integration for precision tuberculosis medicine: from molecular atlases to clinical translation.
Frontiers in microbiology, 17:1963558.
Tuberculosis (TB) remains a major global health threat. Its management is constrained by incomplete prediction of antimicrobial resistance, limited ability to identify patients at risk of anti-tuberculosis drug-induced liver injury (AT-DILI), and heterogeneous treatment responses. This narrative review examines how multi-omics can address these challenges and adapts an established translational framework to TB-specific decisions. Clinically useful integration requires reproducible measurements, independent validation, and evidence that a result improves care. The relevant phenotypes emerge from interactions among Mycobacterium tuberculosis, host genetic and immune variation, lesion microenvironments, drug exposure, and microbial ecology. No single molecular layer adequately resolves this system. We examine pathogen and host genomics, epigenomics, transcriptomics, proteomics, metabolomics, microbiome profiling, and single-cell and spatial technologies. We distinguish replicated resistance and NAT2-associated toxicity findings from emerging bacterial regulatory, immunometabolic, and microbiome associations. Selected diagnostic, prognostic, treatment-monitoring, and toxicity classifiers illustrate both the promise of integration and limitations in sample size, comparator selection, confounding, and validation. Their high training discrimination does not establish external performance or clinical utility. The framework links standardized biobanking and fit-for-purpose integration to analytical and clinical validation, functional testing, and evaluation of utility and equitable implementation. Explicit transition criteria distinguish these stages without treating proposed planning thresholds as universal standards. The clinical value of multi-omics will depend less on the number of measured features than on rigorous study design, affordability, and demonstrable benefit to patients.
Additional Links: PMID-43060891
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43060891,
year = {2026},
author = {Zhang, L and Liu, Y and Sun, W and Shen, Q and Zhou, S and Qin, X and Gao, B and Tian, Y and Zhang, M and Li, Y and Ni, R and An, Y and Gong, W},
title = {Multi-omics integration for precision tuberculosis medicine: from molecular atlases to clinical translation.},
journal = {Frontiers in microbiology},
volume = {17},
number = {},
pages = {1963558},
pmid = {43060891},
issn = {1664-302X},
abstract = {Tuberculosis (TB) remains a major global health threat. Its management is constrained by incomplete prediction of antimicrobial resistance, limited ability to identify patients at risk of anti-tuberculosis drug-induced liver injury (AT-DILI), and heterogeneous treatment responses. This narrative review examines how multi-omics can address these challenges and adapts an established translational framework to TB-specific decisions. Clinically useful integration requires reproducible measurements, independent validation, and evidence that a result improves care. The relevant phenotypes emerge from interactions among Mycobacterium tuberculosis, host genetic and immune variation, lesion microenvironments, drug exposure, and microbial ecology. No single molecular layer adequately resolves this system. We examine pathogen and host genomics, epigenomics, transcriptomics, proteomics, metabolomics, microbiome profiling, and single-cell and spatial technologies. We distinguish replicated resistance and NAT2-associated toxicity findings from emerging bacterial regulatory, immunometabolic, and microbiome associations. Selected diagnostic, prognostic, treatment-monitoring, and toxicity classifiers illustrate both the promise of integration and limitations in sample size, comparator selection, confounding, and validation. Their high training discrimination does not establish external performance or clinical utility. The framework links standardized biobanking and fit-for-purpose integration to analytical and clinical validation, functional testing, and evaluation of utility and equitable implementation. Explicit transition criteria distinguish these stages without treating proposed planning thresholds as universal standards. The clinical value of multi-omics will depend less on the number of measured features than on rigorous study design, affordability, and demonstrable benefit to patients.},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Editorial: Advances in urobiome and immunogenomics for cancer, infections, diagnostics, and personalized therapeutics.
Frontiers in urology, 6:1998629.
Additional Links: PMID-43060924
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43060924,
year = {2026},
author = {Onywera, H and Chambuso, R},
title = {Editorial: Advances in urobiome and immunogenomics for cancer, infections, diagnostics, and personalized therapeutics.},
journal = {Frontiers in urology},
volume = {6},
number = {},
pages = {1998629},
pmid = {43060924},
issn = {2673-9828},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Paneth cell TNF receptor 1 controls zinc deficiency-induced diarrhea.
Frontiers in immunology, 17:1918555.
INTRODUCTION: Zinc deficiency impairs intestinal homeostasis and alters the gut microbiota composition, ultimately leading to diarrhea. Paneth cells (PCs) are key regulators of intestinal microbial homeostasis by producing antimicrobial peptides, but their role in zinc deficiency-induced diarrhea remains poorly understood. In addition, TNF signaling can regulate PC biology and intestinal barrier function, however, its role during zinc deficiency has not been investigated. This study examined how chronic dietary zinc deficiency affects PCs and the intestinal microbiota, and whether TNF receptor 1 signaling in PCs influences the zinc deficiency-associated intestinal pathology.
METHODS: We established a mouse model based on a zinc-deficient diet (ZDD) and compared it with a standard diet (StD) over 8 weeks. We assessed fecal consistency, PC morphology, the PC transcriptome via bulk RNA sequencing, and ileal microbiome composition via 16S rRNA sequencing. Mice were challenged with peritoneal sepsis or TNF-induced systemic inflammatory response syndrome (SIRS). To study the role of the TNF receptor P55 in PCs, we used mice with a PC-specific P55 deletion (P55[PanethKO] mice) and wild-type controls (P55[PanethWT]).
RESULTS: Eight weeks of ZDD had mild effects on fecal consistency, PC morphology, and the PC transcriptome. However, 16S sequencing revealed important changes in ileal microbiome composition. These changes made mice significantly more sensitive to challenges that depend on the intestinal bacterial composition, such as peritoneal sepsis and TNF-induced SIRS. P55[PanethKO] mice on ZDD displayed severe diarrhea. Compared with P55[PanethWT] controls on ZDD, their PC transcriptome showed a strong STAT/ISRE/IRF signature and a complete absence of the otherwise abundant XBP1s part of the unfolded protein response (UPR). Ileal bacterial isolates were further skewed towards the diarrhea-causing Enterococcus gallinarum.
DISCUSSION: PC-specific P55 is essential for suppressing this STAT/ISRE/IRF response specifically under ZDD conditions. We suggest that in wild-type mammals, the biological activity of TNF on PCs is essential to protect them and to prevent diarrhea. Potential underlying mechanisms are discussed.
Additional Links: PMID-43060996
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43060996,
year = {2026},
author = {De Beul, S and Garcia-Gonzalez, N and Vanderhaeghen, T and Wallaeys, C and Vandewalle, J and De Rycke, R and Thery, F and Impens, F and Verbanck, S and Van Immerseel, F and Boyen, F and Iwawaki, T and Blumberg, RS and Timmermans, S and Libert, C},
title = {Paneth cell TNF receptor 1 controls zinc deficiency-induced diarrhea.},
journal = {Frontiers in immunology},
volume = {17},
number = {},
pages = {1918555},
pmid = {43060996},
issn = {1664-3224},
mesh = {Animals ; *Zinc/deficiency ; *Paneth Cells/metabolism/immunology ; Mice ; *Diarrhea/metabolism/etiology/microbiology ; *Receptors, Tumor Necrosis Factor, Type I/metabolism/genetics ; Mice, Knockout ; Gastrointestinal Microbiome ; Disease Models, Animal ; Mice, Inbred C57BL ; Male ; Intestinal Barrier Function ; Signal Transduction ; Tumor Necrosis Factor-alpha ; },
abstract = {INTRODUCTION: Zinc deficiency impairs intestinal homeostasis and alters the gut microbiota composition, ultimately leading to diarrhea. Paneth cells (PCs) are key regulators of intestinal microbial homeostasis by producing antimicrobial peptides, but their role in zinc deficiency-induced diarrhea remains poorly understood. In addition, TNF signaling can regulate PC biology and intestinal barrier function, however, its role during zinc deficiency has not been investigated. This study examined how chronic dietary zinc deficiency affects PCs and the intestinal microbiota, and whether TNF receptor 1 signaling in PCs influences the zinc deficiency-associated intestinal pathology.
METHODS: We established a mouse model based on a zinc-deficient diet (ZDD) and compared it with a standard diet (StD) over 8 weeks. We assessed fecal consistency, PC morphology, the PC transcriptome via bulk RNA sequencing, and ileal microbiome composition via 16S rRNA sequencing. Mice were challenged with peritoneal sepsis or TNF-induced systemic inflammatory response syndrome (SIRS). To study the role of the TNF receptor P55 in PCs, we used mice with a PC-specific P55 deletion (P55[PanethKO] mice) and wild-type controls (P55[PanethWT]).
RESULTS: Eight weeks of ZDD had mild effects on fecal consistency, PC morphology, and the PC transcriptome. However, 16S sequencing revealed important changes in ileal microbiome composition. These changes made mice significantly more sensitive to challenges that depend on the intestinal bacterial composition, such as peritoneal sepsis and TNF-induced SIRS. P55[PanethKO] mice on ZDD displayed severe diarrhea. Compared with P55[PanethWT] controls on ZDD, their PC transcriptome showed a strong STAT/ISRE/IRF signature and a complete absence of the otherwise abundant XBP1s part of the unfolded protein response (UPR). Ileal bacterial isolates were further skewed towards the diarrhea-causing Enterococcus gallinarum.
DISCUSSION: PC-specific P55 is essential for suppressing this STAT/ISRE/IRF response specifically under ZDD conditions. We suggest that in wild-type mammals, the biological activity of TNF on PCs is essential to protect them and to prevent diarrhea. Potential underlying mechanisms are discussed.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
*Zinc/deficiency
*Paneth Cells/metabolism/immunology
Mice
*Diarrhea/metabolism/etiology/microbiology
*Receptors, Tumor Necrosis Factor, Type I/metabolism/genetics
Mice, Knockout
Gastrointestinal Microbiome
Disease Models, Animal
Mice, Inbred C57BL
Male
Intestinal Barrier Function
Signal Transduction
Tumor Necrosis Factor-alpha
RevDate: 2026-11-20
CmpDate: 2026-11-20
Gut microbiome and fecal metabolome dysregulation in pediatric atopic eczema: a multi-omics correlation study.
PeerJ, 14:e21838.
BACKGROUND: Atopic eczema (AE) is a highly prevalent inflammatory skin disorder in children, with growing evidence underscoring the role of gut microbiota dysbiosis in its pathogenesis. However, the specific mechanisms by which gut microbes and their metabolic products contribute to AE development remain poorly understood.
METHODS: This study employed an integrated multi-omics approach to investigate the gut ecosystem in pediatric AE. Fecal samples from affected children and matched controls were analyzed using 16S rRNA gene sequencing to profile the gut microbiota and liquid chromatography-mass spectrometry (LC-MS)-based metabolomics to characterize the fecal metabolome.
RESULTS: Significant gut microbial dysbiosis was observed in children with AE, marked by reduced species diversity and altered community structure. Specifically, the relative abundances of key genera such as Streptococcus, Enterococcus, and Bifidobacterium were significantly diminished. Correlation network analysis revealed the metabolite Fruleuile as a central hub in the microbe-metabolite interaction network, demonstrating significant associations with several bacterial genera, including Mycobacterium. Our findings confirm significant gut microbiota dysbiosis in pediatric AE and identify distinct microbial and metabolic signatures associated with the condition. The metabolite Fruleuile emerges as a potential key mediator in the gut-skin axis, highlighting the importance of host-microbiota metabolic interactions in the pathophysiology of AE patients.
Additional Links: PMID-43061064
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43061064,
year = {2026},
author = {Zhao, X and Ren, Y and Song, L and Lin, Y and Chu, X},
title = {Gut microbiome and fecal metabolome dysregulation in pediatric atopic eczema: a multi-omics correlation study.},
journal = {PeerJ},
volume = {14},
number = {},
pages = {e21838},
pmid = {43061064},
issn = {2167-8359},
mesh = {Humans ; *Dermatitis, Atopic/microbiology/metabolism ; *Feces/microbiology/chemistry ; *Metabolome ; Child ; *Gastrointestinal Microbiome ; Multiomics ; Female ; *Dysbiosis/microbiology ; Male ; RNA, Ribosomal, 16S/genetics ; Child, Preschool ; Case-Control Studies ; Metabolomics ; },
abstract = {BACKGROUND: Atopic eczema (AE) is a highly prevalent inflammatory skin disorder in children, with growing evidence underscoring the role of gut microbiota dysbiosis in its pathogenesis. However, the specific mechanisms by which gut microbes and their metabolic products contribute to AE development remain poorly understood.
METHODS: This study employed an integrated multi-omics approach to investigate the gut ecosystem in pediatric AE. Fecal samples from affected children and matched controls were analyzed using 16S rRNA gene sequencing to profile the gut microbiota and liquid chromatography-mass spectrometry (LC-MS)-based metabolomics to characterize the fecal metabolome.
RESULTS: Significant gut microbial dysbiosis was observed in children with AE, marked by reduced species diversity and altered community structure. Specifically, the relative abundances of key genera such as Streptococcus, Enterococcus, and Bifidobacterium were significantly diminished. Correlation network analysis revealed the metabolite Fruleuile as a central hub in the microbe-metabolite interaction network, demonstrating significant associations with several bacterial genera, including Mycobacterium. Our findings confirm significant gut microbiota dysbiosis in pediatric AE and identify distinct microbial and metabolic signatures associated with the condition. The metabolite Fruleuile emerges as a potential key mediator in the gut-skin axis, highlighting the importance of host-microbiota metabolic interactions in the pathophysiology of AE patients.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Dermatitis, Atopic/microbiology/metabolism
*Feces/microbiology/chemistry
*Metabolome
Child
*Gastrointestinal Microbiome
Multiomics
Female
*Dysbiosis/microbiology
Male
RNA, Ribosomal, 16S/genetics
Child, Preschool
Case-Control Studies
Metabolomics
RevDate: 2026-11-20
Commentary: Fecal microbiome and metabolome dynamics during immunotherapy-based total neoadjuvant therapy in rectal cancer: associations with treatment response and toxicity.
Frontiers in immunology, 17:1981594.
Additional Links: PMID-43061135
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43061135,
year = {2026},
author = {Li, B and Song, C and Li, H and Li, Z and Wang, Z and Yang, K and Sun, W and Wang, B},
title = {Commentary: Fecal microbiome and metabolome dynamics during immunotherapy-based total neoadjuvant therapy in rectal cancer: associations with treatment response and toxicity.},
journal = {Frontiers in immunology},
volume = {17},
number = {},
pages = {1981594},
pmid = {43061135},
issn = {1664-3224},
}
RevDate: 2026-11-20
CmpDate: 2026-11-20
Larval performance, gut microbiome and predicted functions of Zophobas morio under fruit-vegetable waste and expanded-polystyrene exposure.
Food chemistry. Molecular sciences, 13:100468.
Fruit-vegetable waste valorisation through insect bioconversion offers a route for recovering nutrients from food residues, but evidence linking larval performance with gut microbiome and predicted functional responses in superworm (Zophobas morio) remains limited. This study compared larvae reared for 90 days on wheat bran (WB), fruit-vegetable waste (FV) or expanded polystyrene/styrofoam (SF), representing a nutritional reference, heterogeneous organic-residue substrate and nutrient-poor polymer-exposure condition. We hypothesized that the treatment conditions would be associated with differences in larval performance, whereas gut bacterial community structure and predicted functional potential were assessed exploratorily. WB supported the highest performance, with length increase of 40.64 ± 1.56 mm, survival of 86.22 ± 0.77% and relative biomass gain of 177.22 ± 15.96%. FV showed intermediate responses (38.53 ± 0.79 mm; 80.67 ± 2.40%; 149.38 ± 9.38%), whereas SF showed lower performance (36.83 ± 1.07 mm; 72.89 ± 0.38%; 135.24 ± 10.60%). Endpoint 16S rRNA profiling showed treatment-associated differences in bacterial composition. FV samples showed higher representation of Stenotrophomonas, Jejubacter, Enterococcus and Lactococcus, whereas SF samples were dominated by Bacillota and Pseudomonadota, including Lactococcus, Acinetobacter and Stenotrophomonas. Alpha-diversity differences were not significant after FDR correction, while beta-diversity showed exploratory treatment-associated patterns; Jaccard distance had the lowest p-value (p = 0.016; FDR q = 0.062). PICRUSt2 profiles descriptively indicated higher carbohydrate-, energy- and cofactor/vitamin-related functions in FV and more stress- and xenobiotic-related predicted functions in SF. Overall, the hypothesis was partially supported, identifying FV as a substrate for optimisation while highlighting microbial functions requiring direct molecular validation.
Additional Links: PMID-43061246
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43061246,
year = {2026},
author = {Gali, SP and Krishnamoorthy, S and Rajamani, M},
title = {Larval performance, gut microbiome and predicted functions of Zophobas morio under fruit-vegetable waste and expanded-polystyrene exposure.},
journal = {Food chemistry. Molecular sciences},
volume = {13},
number = {},
pages = {100468},
pmid = {43061246},
issn = {2666-5662},
abstract = {Fruit-vegetable waste valorisation through insect bioconversion offers a route for recovering nutrients from food residues, but evidence linking larval performance with gut microbiome and predicted functional responses in superworm (Zophobas morio) remains limited. This study compared larvae reared for 90 days on wheat bran (WB), fruit-vegetable waste (FV) or expanded polystyrene/styrofoam (SF), representing a nutritional reference, heterogeneous organic-residue substrate and nutrient-poor polymer-exposure condition. We hypothesized that the treatment conditions would be associated with differences in larval performance, whereas gut bacterial community structure and predicted functional potential were assessed exploratorily. WB supported the highest performance, with length increase of 40.64 ± 1.56 mm, survival of 86.22 ± 0.77% and relative biomass gain of 177.22 ± 15.96%. FV showed intermediate responses (38.53 ± 0.79 mm; 80.67 ± 2.40%; 149.38 ± 9.38%), whereas SF showed lower performance (36.83 ± 1.07 mm; 72.89 ± 0.38%; 135.24 ± 10.60%). Endpoint 16S rRNA profiling showed treatment-associated differences in bacterial composition. FV samples showed higher representation of Stenotrophomonas, Jejubacter, Enterococcus and Lactococcus, whereas SF samples were dominated by Bacillota and Pseudomonadota, including Lactococcus, Acinetobacter and Stenotrophomonas. Alpha-diversity differences were not significant after FDR correction, while beta-diversity showed exploratory treatment-associated patterns; Jaccard distance had the lowest p-value (p = 0.016; FDR q = 0.062). PICRUSt2 profiles descriptively indicated higher carbohydrate-, energy- and cofactor/vitamin-related functions in FV and more stress- and xenobiotic-related predicted functions in SF. Overall, the hypothesis was partially supported, identifying FV as a substrate for optimisation while highlighting microbial functions requiring direct molecular validation.},
}
RevDate: 2026-11-18
CmpDate: 2026-11-18
Moderate Phosphorus Application Reshapes Rhizosphere Microbial Ecology and Coordinates Host Metabolic Responses to Improve Sweet Potato Yield and Quality: A Multiomics System-Level Analysis.
Journal of agricultural and food chemistry, 74(45):35330-35354.
Sweet potato is an important food, feed, and industrial crop whose storage root development and quality depend on phosphorus (P) availability, yet plant-soil-microbe responses to P fertilization remain unclear. We integrated agronomic, metagenomic, transcriptomic, metabolomic, and WGCNA analyses comparing moderate P application (P110; 110 kg P2O5 ha-1) with no P (P0). P110 increased soil organic carbon by 45.03% and available potassium by 9.58%; organic/inorganic P declined, while available P remained unchanged. Rhizosphere shifts included higher Acidobacteriota, Basidiomycota, and fungal diversity. P-cycling genes pckA, gcd, and ppk were higher, indicating altered metagenomic potential for soil P turnover. P110 increased storage roots per plant by 20.31-27.83%, yield by 31.88-41.45%, and plant P accumulation by 134.01%. Multiomics-linked hub genes (ARR6, LRR4, LRR3, FKF1, TIC100) and pathways to root traits, yield, and quality. Moderate P coordinates rhizosphere microbial ecology with host transcriptional and metabolic responses, improving P-use, yield, and quality.
Additional Links: PMID-43049413
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43049413,
year = {2026},
author = {Zhao, J and Li, Y and Shahid, M and Khan, K and Khan, L and Si, C},
title = {Moderate Phosphorus Application Reshapes Rhizosphere Microbial Ecology and Coordinates Host Metabolic Responses to Improve Sweet Potato Yield and Quality: A Multiomics System-Level Analysis.},
journal = {Journal of agricultural and food chemistry},
volume = {74},
number = {45},
pages = {35330-35354},
doi = {10.1021/acs.jafc.6c10961},
pmid = {43049413},
issn = {1520-5118},
support = {32560771//National Natural Science Foundation of China/ ; B24YQ0013//Hainan Seed Industry Laboratory/ ; B25Z10C10//Hainan Seed Industry Laboratory/ ; ZDYF2025XDNY070//Science and Technology Special Fund of Hainan Province/ ; },
mesh = {Rhizosphere ; *Phosphorus/metabolism/analysis ; Multiomics ; Plant Roots/metabolism/growth & development/microbiology/chemistry ; Soil Microbiology ; *Ipomoea batatas/metabolism/growth & development/microbiology/chemistry/genetics ; Bacteria/genetics/isolation & purification/classification/metabolism ; Fungi/genetics/classification/isolation & purification/metabolism ; Fertilizers/analysis ; Microbiota ; Soil/chemistry ; },
abstract = {Sweet potato is an important food, feed, and industrial crop whose storage root development and quality depend on phosphorus (P) availability, yet plant-soil-microbe responses to P fertilization remain unclear. We integrated agronomic, metagenomic, transcriptomic, metabolomic, and WGCNA analyses comparing moderate P application (P110; 110 kg P2O5 ha-1) with no P (P0). P110 increased soil organic carbon by 45.03% and available potassium by 9.58%; organic/inorganic P declined, while available P remained unchanged. Rhizosphere shifts included higher Acidobacteriota, Basidiomycota, and fungal diversity. P-cycling genes pckA, gcd, and ppk were higher, indicating altered metagenomic potential for soil P turnover. P110 increased storage roots per plant by 20.31-27.83%, yield by 31.88-41.45%, and plant P accumulation by 134.01%. Multiomics-linked hub genes (ARR6, LRR4, LRR3, FKF1, TIC100) and pathways to root traits, yield, and quality. Moderate P coordinates rhizosphere microbial ecology with host transcriptional and metabolic responses, improving P-use, yield, and quality.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Rhizosphere
*Phosphorus/metabolism/analysis
Multiomics
Plant Roots/metabolism/growth & development/microbiology/chemistry
Soil Microbiology
*Ipomoea batatas/metabolism/growth & development/microbiology/chemistry/genetics
Bacteria/genetics/isolation & purification/classification/metabolism
Fungi/genetics/classification/isolation & purification/metabolism
Fertilizers/analysis
Microbiota
Soil/chemistry
RevDate: 2026-11-18
Beyond growth: engineering the root microbiota to shape fruit flavor.
Letters in applied microbiology pii:9089866 [Epub ahead of print].
Rhizosphere microbiota are increasingly recognized as key biological regulators of host metabolism, contributing to plant growth, nutrient acquisition, and secondary metabolism. Yet, compared with their well-established roles in promoting growth and enhancing stress resistance, the functions of the microbiota in fruit flavor formation remain poorly understood. We first outline the metabolic basis of fruit flavor formation, focusing on the major VOC biosynthetic pathways derived from fatty acids, amino acids, and terpenoids. We then synthesize current evidence that rhizosphere microorganisms modulate flavor in tomato, strawberry, and pepper. By integrating current studies on microbial remodeling of host VOC synthetic pathways, we discuss the potential contributions of the microbiome to fruit flavor. This review provides an integrated overview of microbiota-driven flavor regulation and highlights the potential of rhizosphere microbiome engineering as a targeted strategy to improve fruit flavor.
Additional Links: PMID-43049531
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43049531,
year = {2026},
author = {Zhou, M and Li, W and Sun, W and Jia, B and Liu, Y},
title = {Beyond growth: engineering the root microbiota to shape fruit flavor.},
journal = {Letters in applied microbiology},
volume = {},
number = {},
pages = {},
doi = {10.1093/lambio/ovag102},
pmid = {43049531},
issn = {1472-765X},
abstract = {Rhizosphere microbiota are increasingly recognized as key biological regulators of host metabolism, contributing to plant growth, nutrient acquisition, and secondary metabolism. Yet, compared with their well-established roles in promoting growth and enhancing stress resistance, the functions of the microbiota in fruit flavor formation remain poorly understood. We first outline the metabolic basis of fruit flavor formation, focusing on the major VOC biosynthetic pathways derived from fatty acids, amino acids, and terpenoids. We then synthesize current evidence that rhizosphere microorganisms modulate flavor in tomato, strawberry, and pepper. By integrating current studies on microbial remodeling of host VOC synthetic pathways, we discuss the potential contributions of the microbiome to fruit flavor. This review provides an integrated overview of microbiota-driven flavor regulation and highlights the potential of rhizosphere microbiome engineering as a targeted strategy to improve fruit flavor.},
}
RevDate: 2026-11-18
Bidirectional Interplay Between the Skin Microbiota and the Host: An EAACI Task Force Report.
Allergy [Epub ahead of print].
The skin microbiome is a diverse community of bacteria, fungi, archaea, and viruses colonizing the human skin and is thought to play an important role in skin health. Skin homeostasis and immunity are influenced by a dynamic interplay between the host immune system, the skin microbiome, and other host factors. Disruption of the skin microbiome well-functioning by environmental, lifestyle, and host-related factors can lead to dysbiosis, which has been associated to some pathological skin conditions, resulting in skin inflammation and an impaired barrier function. Building on the previous work from the EAACI Task Force that emphasized how environmental and lifestyle factors impact host resilience through the skin microbiome, the present review focuses on intrinsic host factors. We provide a comprehensive discussion on how the skin composition differs at different anatomical locations and is influenced by age, gender, hormones, immune system activity, and how the host "multi-omes" (genome, transcriptome, proteome, and metabolome) interact with the skin microbiome. Additionally, we review current strategies to modify skin microbiome functions, including the role of diseases and medication, as well as topical microbiome-targeting biotic and bacteriophage therapies. Overall, this review highlights current knowledge and key research gaps, offering insights to guide future investigations and therapeutic innovations in skin health.
Additional Links: PMID-43049533
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43049533,
year = {2026},
author = {Callewaert, C and Spacova, I and Minnebo, Y and De Pessemier, B and De Muynck, M and Belasri, H and Unger, Z and Pérez-Gordo, M and Sokolowska, M and Untersmayr, E and Lebeer, S and O'Mahony, L and Krohn, IK and Gomez-Casado, C},
title = {Bidirectional Interplay Between the Skin Microbiota and the Host: An EAACI Task Force Report.},
journal = {Allergy},
volume = {},
number = {},
pages = {},
doi = {10.1111/all.70564},
pmid = {43049533},
issn = {1398-9995},
support = {40320//European Academy of Allergy and Clinical Immunology (EAACI)/ ; },
abstract = {The skin microbiome is a diverse community of bacteria, fungi, archaea, and viruses colonizing the human skin and is thought to play an important role in skin health. Skin homeostasis and immunity are influenced by a dynamic interplay between the host immune system, the skin microbiome, and other host factors. Disruption of the skin microbiome well-functioning by environmental, lifestyle, and host-related factors can lead to dysbiosis, which has been associated to some pathological skin conditions, resulting in skin inflammation and an impaired barrier function. Building on the previous work from the EAACI Task Force that emphasized how environmental and lifestyle factors impact host resilience through the skin microbiome, the present review focuses on intrinsic host factors. We provide a comprehensive discussion on how the skin composition differs at different anatomical locations and is influenced by age, gender, hormones, immune system activity, and how the host "multi-omes" (genome, transcriptome, proteome, and metabolome) interact with the skin microbiome. Additionally, we review current strategies to modify skin microbiome functions, including the role of diseases and medication, as well as topical microbiome-targeting biotic and bacteriophage therapies. Overall, this review highlights current knowledge and key research gaps, offering insights to guide future investigations and therapeutic innovations in skin health.},
}
RevDate: 2026-11-18
Fungal lignocellulose-degradation potential is associated with bacterial metabolic dysbiosis in the human gut.
The ISME journal pii:9089884 [Epub ahead of print].
Fungi encode diverse carbohydrate-processing functions, yet the genomic basis of their lignocellulose-degradation potential and its relevance to the human gut remain poorly understood. Here, we experimentally assessed cellulase-, xylanase-, and laccase-associated activities across 762 environmentally derived fungal isolates and sequenced 170 representative strains, retaining 160 genomes for genome-phenotype analyses. By integrating functional annotations with orthogroup presence-absence variation and machine-learning models, we identified lignocellulose-degradation-associated genomic features that improved phenotype prediction beyond conventional annotation alone. We then applied this framework to 2,116 publicly available fungal genomes and 704 cultivated gut fungal genomes from a previously published collection to construct a non-redundant catalogue of lignocellulose-degradation-associated genes (LDAGs), comprising canonical degradative enzymes, annotated phenotype-associated features, and candidate orthogroups. Across fungal lineages, xylanase-associated potential was broadly distributed, cellulase-associated potential showed an intermediate pattern, whereas laccase-associated oxidative potential was concentrated in a more restricted subset of taxa. Analysis of approximately 1,500 publicly available human gut metagenomes identified disease-associated differences in LDAG profiles in atherosclerotic cardiovascular disease (ACVD), inflammatory bowel disease (IBD), and obesity. Under stringent read-remapping criteria, total LDAG abundance differences remained significant in ACVD and IBD but were attenuated in obesity, whereas compositional differences persisted across all three cohorts with modest effect sizes. These fungal genomic signatures covaried with bacterial taxa, including Escherichia coli, and pathways involved in central carbon and carbohydrate metabolism. Together, our findings establish a phenotype-informed genomic framework for resolving fungal lignocellulose-degradation potential and reveal its consistent association with disease-related bacterial and metabolic configurations in the human gut.
Additional Links: PMID-43049611
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43049611,
year = {2026},
author = {Liu, F and Liu, MY and Zeng, ZQ and Zhuang, WY and Cao, B and Zhao, RL},
title = {Fungal lignocellulose-degradation potential is associated with bacterial metabolic dysbiosis in the human gut.},
journal = {The ISME journal},
volume = {},
number = {},
pages = {},
doi = {10.1093/ismejo/wrag287},
pmid = {43049611},
issn = {1751-7370},
abstract = {Fungi encode diverse carbohydrate-processing functions, yet the genomic basis of their lignocellulose-degradation potential and its relevance to the human gut remain poorly understood. Here, we experimentally assessed cellulase-, xylanase-, and laccase-associated activities across 762 environmentally derived fungal isolates and sequenced 170 representative strains, retaining 160 genomes for genome-phenotype analyses. By integrating functional annotations with orthogroup presence-absence variation and machine-learning models, we identified lignocellulose-degradation-associated genomic features that improved phenotype prediction beyond conventional annotation alone. We then applied this framework to 2,116 publicly available fungal genomes and 704 cultivated gut fungal genomes from a previously published collection to construct a non-redundant catalogue of lignocellulose-degradation-associated genes (LDAGs), comprising canonical degradative enzymes, annotated phenotype-associated features, and candidate orthogroups. Across fungal lineages, xylanase-associated potential was broadly distributed, cellulase-associated potential showed an intermediate pattern, whereas laccase-associated oxidative potential was concentrated in a more restricted subset of taxa. Analysis of approximately 1,500 publicly available human gut metagenomes identified disease-associated differences in LDAG profiles in atherosclerotic cardiovascular disease (ACVD), inflammatory bowel disease (IBD), and obesity. Under stringent read-remapping criteria, total LDAG abundance differences remained significant in ACVD and IBD but were attenuated in obesity, whereas compositional differences persisted across all three cohorts with modest effect sizes. These fungal genomic signatures covaried with bacterial taxa, including Escherichia coli, and pathways involved in central carbon and carbohydrate metabolism. Together, our findings establish a phenotype-informed genomic framework for resolving fungal lignocellulose-degradation potential and reveal its consistent association with disease-related bacterial and metabolic configurations in the human gut.},
}
▼ ▼ LOAD NEXT 100 CITATIONS
RJR Experience and Expertise
Researcher
Robbins holds BS, MS, and PhD degrees in the life sciences. He served as a tenured faculty member in the Zoology and Biological Science departments at Michigan State University. He is currently exploring the intersection between genomics, microbial ecology, and biodiversity — an area that promises to transform our understanding of the biosphere.
Educator
Robbins has extensive experience in college-level education: At MSU he taught introductory biology, genetics, and population genetics. At JHU, he was an instructor for a special course on biological database design. At FHCRC, he team-taught a graduate-level course on the history of genetics. At Bellevue College he taught medical informatics.
Administrator
Robbins has been involved in science administration at both the federal and the institutional levels. At NSF he was a program officer for database activities in the life sciences, at DOE he was a program officer for information infrastructure in the human genome project. At the Fred Hutchinson Cancer Research Center, he served as a vice president for fifteen years.
Technologist
Robbins has been involved with information technology since writing his first Fortran program as a college student. At NSF he was the first program officer for database activities in the life sciences. At JHU he held an appointment in the CS department and served as director of the informatics core for the Genome Data Base. At the FHCRC he was VP for Information Technology.
Publisher
While still at Michigan State, Robbins started his first publishing venture, founding a small company that addressed the short-run publishing needs of instructors in very large undergraduate classes. For more than 20 years, Robbins has been operating The Electronic Scholarly Publishing Project, a web site dedicated to the digital publishing of critical works in science, especially classical genetics.
Speaker
Robbins is well-known for his speaking abilities and is often called upon to provide keynote or plenary addresses at international meetings. For example, in July, 2012, he gave a well-received keynote address at the Global Biodiversity Informatics Congress, sponsored by GBIF and held in Copenhagen. The slides from that talk can be seen HERE.
Facilitator
Robbins is a skilled meeting facilitator. He prefers a participatory approach, with part of the meeting involving dynamic breakout groups, created by the participants in real time: (1) individuals propose breakout groups; (2) everyone signs up for one (or more) groups; (3) the groups with the most interested parties then meet, with reports from each group presented and discussed in a subsequent plenary session.
Designer
Robbins has been engaged with photography and design since the 1960s, when he worked for a professional photography laboratory. He now prefers digital photography and tools for their precision and reproducibility. He designed his first web site more than 20 years ago and he personally designed and implemented this web site. He engages in graphic design as a hobby.
RJR Picks from Around the Web (updated 11 MAY 2018 )
Old Science
Weird Science
Treating Disease with Fecal Transplantation
Fossils of miniature humans (hobbits) discovered in Indonesia
Paleontology
Dinosaur tail, complete with feathers, found preserved in amber.
Astronomy
Mysterious fast radio burst (FRB) detected in the distant universe.
Big Data & Informatics
Big Data: Buzzword or Big Deal?
Hacking the genome: Identifying anonymized human subjects using publicly available data.